AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MARCH 31, 2006

================================================================================

                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   ----------

                                    FORM 20-F

[_]  REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES
     EXCHANGE ACT OF 1934

                                       OR

[X]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934

                  FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2005.

                                       OR

[_]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

           FOR THE TRANSITION PERIOD FROM ___________ TO ___________.

                                       OR

[_]  SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

             DATE OF EVENT REQUIRING THIS SHELL COMPANY REPORT ____
                         COMMISSION FILE NUMBER 1-15419

                                   CELANESE AG
             (Exact name of Registrant as specified in its charter)

                              CELANESE CORPORATION
                 (Translation of Registrant's name into English)

                           FEDERAL REPUBLIC OF GERMANY
                 (Jurisdiction of incorporation or organization)

                             FRANKFURTER STRASSE 111
                         61476 KRONBERG/TAUNUS, GERMANY
                    (Address of principal executive offices)

           Securities registered pursuant to Section 12(b) of the Act:

       TITLE OF EACH CLASS             NAME OF EACH EXCHANGE ON WHICH REGISTERED
Ordinary Shares with no par value                         None

   Securities registered or to be registered pursuant to Section 12(g) of the
                                    Act: NONE
        Securities for which there is a reporting obligation pursuant to
                         Section 15(d) of the Act: NONE
                  Indicate the number of outstanding shares of
   each of the issuer's classes of capital or common stock as of the close of
                    the period covered by the Annual Report:

Ordinary Shares with no par value ___________________________________ 50,365,018
                                       (as of September 30, 2005)

     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                                 Yes [X] No [_]

     Indicate by check mark which financial statement item the registrant has
elected to follow.

                             Item 17 [_] Item 18 [X]

     If this is an annual report, indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act).

                                 Yes [_] No [X]

================================================================================



                                TABLE OF CONTENTS

                                     PART I

Item 1.   Identity of Directors, Senior Management and Advisers...........     1
Item 2.   Offer Statistics and Expected Timetable.........................     1
Item 3.   Key Information.................................................     2
          Selected Financial Data.........................................     2
          Exchange Rate Information.......................................     3
          Risk Factors....................................................     4
Item 4.   Information on the Company......................................    12
          Acquisition of Celanese.........................................    12
          Introduction....................................................    16
          Business Summary................................................    16
          Segment Overview................................................    17
          Other Activities................................................    18
          Strategy........................................................    18
          Business Segments...............................................    19
          Other Activities................................................    27
          Divestitures....................................................    27
          Raw Materials and Energy........................................    27
          Research and Development........................................    28
          Intellectual property...........................................    29
          Environmental and Other Regulation..............................    29
          Organizational Structure........................................    32
          Description of Property.........................................    32
Item 4A.  Unresolved Staff Comments.......................................    34
Item 5.   Operating and Financial Review and Prospects....................    35
          Basis of Presentation...........................................    35
          Acquisition of Celanese and Organizational Restructuring........    37
          Major Events in 2005............................................    41
          Financial Highlights............................................    42
          Overview - Twelve Months Ended September 30, 2005 Compared With
             Twelve Months Ended September 30, 2004.......................    45
          Summary by Business Segment - Twelve Months Ended September 30,
             2005 Compared with Twelve Months Ended September 30, 2004....    50
          Summary of Consolidated Results - Combined Twelve Months Ended
             September 30, 2005 Compared With Twelve Months Ended
             September 30, 2004...........................................    52
          Summary by Business Segment - Nine Months Ended September 30,
             2004 Compared with Nine Months Ended September 30, 2003......    55
          Summary of Consolidated Results - Nine Months Ended September
             30, 2004 Compared With Nine Months Ended September 30, 2003..    58
          Liquidity and Capital Resources.................................    60
          Recent Accounting Pronouncements................................    66
          Critical Accounting Policies and Estimates......................    66
          Outlook.........................................................    69


                                        i



Item 6.    Directors, Senior Management and Employees.....................    72
           Directors and Senior Management................................    72
           Compensation of Directors and Officers.........................    75
           Incentive Plans................................................    79
           Board Practices................................................    80
           Employees......................................................    83
           Share Ownership................................................    83
Item 7.    Major Shareholders and Related Party Transactions..............    83
           Major Shareholders.............................................    83
           Related Party Transactions.....................................    84
Item 8.    Financial Information..........................................    85
           Export Sales...................................................    86
           Legal Proceedings..............................................    86
           Dividend Policy................................................    88
           Significant Changes............................................    88
Item 9.    The Offer and Listing..........................................    88
           Nature of Trading Market.......................................    88
Item 10.   Additional Information.........................................    90
           Articles of Association........................................    90
           Material Contracts.............................................    93
           Exchange Controls and Other Limitations Affecting Security
              Holders.....................................................    94
           Taxation.......................................................    95
           Documents on display...........................................    97
Item 11.   Quantitative and Qualitative Disclosures About Market Risk.....    98
           Interest-Rate Risk Management..................................    98
           Foreign-Exchange Risk Management...............................    98
           Foreign Currency Forward Contracts.............................    99
Item 12.   Description of Securities Other Than Equity Securities.........    99
Item 13.   Defaults, Dividend Arrearages and Delinquencies................    99
Item 14.   Material Modifications to the Rights of Security Holders and
              Use of Proceeds.............................................    99
Item 15.   Controls and Procedures........................................    99
Item 16.   Reserved.......................................................   100
Item 16A.  Audit Committee Financial Expert...............................   100
Item 16B.  Code of Ethics and Governance Matters..........................   100
Item 16C.  Principal Accountant Fees and Services.........................   101
           Pre-Approval Policies and Procedures of the Finance and Audit
              Committee...................................................   102
Item 16D.  Exemption from the Listing Standards for Audit Committees......   103
Item 16E   Purchases of Equity Securities by the Issuer and Affiliated
              Purchasers..................................................   103
Item 17.   Financial Statements...........................................   103
Item 18.   Financial Statements...........................................   103
Item 19.   Exhibits.......................................................   103


                                       ii



                                  INTRODUCTION

     Celanese AG is incorporated as a stock corporation organized under the laws
of the Federal Republic of Germany. As used in this annual report, "Celanese" or
"the Company" refers to Celanese AG, its consolidated subsidiaries and, except
for accounting purposes, its non-consolidated affiliates. For accounting
purposes, "Celanese" refers solely to Celanese AG and its majority owned
subsidiaries over which Celanese exercises control, as well as a special purpose
entity, which is a variable interest entity where Celanese is deemed the primary
beneficiary.

     Approximately 98 percent of Celanese's outstanding shares are held by
Celanese Europe Holding GmbH & Co. KG), a German limited partnership
(Kommanditgesellschaft), and an indirect wholly-owned subsidiary of Celanese
Corporation, a Delaware corporation whose shares have been listed on the New
York Stock Exchange since January 2005 and are traded under the symbol CE.
Affiliates of The Blackstone Group own a majority of the shares of Celanese
Corporation. As a dominating company, Celanese Europe Holding GmbH & Co. KG is
required, at the request of each minority shareholder, to acquire minority
shares in exchange for "fair cash compensation." Accordingly, pursuant to the
requirements of German law, Celanese Europe Holding GmbH & Co. KG commenced an
offer on September 2, 2004 for minority shares, which offer will continue until
two months after the day on which the decision on the last motion in the award
proceedings (Spruchverfahren) and any related appeals, as described in Item 8.
Financial Information - Legal Proceedings, has been disposed of and has been
published. For a more complete discussion of the relationship between Celanese
AG and Celanese Europe Holding GmbH & Co. KG, see - Item 4. Information on the
Company - Acquisition of Celanese - Domination and Profit and Loss Transfer
Agreement.

     Celanese Europe Holding GmbH & Co. KG is, except for accounting purposes,
referred to in this annual report as "Celanese Europe Holding". For accounting
purposes, Celanese Europe Holding GmbH & Co. KG is referred to as "Purchaser".
See Note 3 to the Consolidated Financial Statements contained in this annual
report (the "Consolidated Financial Statements").

                                   ----------

                              BASIS OF PRESENTATION

    The financial position, results of operations, statement of cash flows and
related disclosures for the periods prior to August 24, 2005, the effective date
of the acquisition of CAG shares, which resulted in the Purchaser owning more
than 95% of Celanese AG and the requirement to apply push down accounting are
presented as the results of the Predecessor. The financial position, results of
operations, statement of cash flows and related disclosures subsequent to August
24, 2005, are presented as the results of the Successor. The results of the
Successor may not be comparable to the results of the Predecessor due to the
difference in the basis of presentation of push down accounting as compared to
historical cost. To facilitate a meaningful comparison of the Company's
performance, the following discussion of results of operations is presented on a
comparative basis for both 2005 and 2004. Accordingly, the results of operations
for the twelve months ended September 30, 2005 represent the mathematic addition
of the historical amounts of the Predecessor for the period October 1, 2004 to
August 24, 2005 and the Successor for the period August 25 to September 30,
2005. Management believes that a combined discussion of Predecessor and
Successor periods is reasonable and appropriate because the successor period is
short and there were no material adjustments to the presented items other than
cost of sales and depreciation and amortization resulting from the push down of
purchase accounting. The results of the Successor and Predecessor periods,
individually, have been audited. The combined results for the twelve months
ended September 30, 2005 and 2004 have not been audited and should not be taken
as an indication of the results of operations to be reported for any subsequent
period or for the full fiscal year.

    Push Down Accounting: The Purchaser accounted for its acquisitions of the
CAG Shares using the purchase value method of accounting resulting in a new
basis of accounting. The purchase price was allocated based on the fair value of
the underlying assets acquired and liabilities assumed. The assets acquired and
liabilities assumed are reflected at the Purchaser's accounting basis for the
approximate 96% portion acquired and at Celanese's historical basis for the
remaining minority interest of approximately 4%. The difference in the total
purchase price and the fair value of the net assets acquired was allocated to
goodwill, and this indefinite lived asset is subject to an annual impairment
review. In the twelve months ended September 30, 2005, the Company decreased
goodwill (euro)247 million as a result of the push down accounting adjustments
related to the acquisition of CAG's shares. In addition, Celanese's results of
operations were impacted by the push down accounting adjustments as follows: the
effect on depreciation expense decreased by less than (euro)1 million due to the
step up of property, plant and equipment and offset by the effect of the change
in useful lives, amortization expense increased by (euro)2 million due to the
step up of intangible assets and cost of sales increased by (euro)5 million due
to the step up and subsequent sale of inventory. (See Notes 2, 12 and 13 to the
Consolidated Financial Statements).

    In October 2004, CAC was transferred out of Celanese AG as part of the
organizational restructuring (see below). As a result of the restructuring, CAC
assets, liabilities and results of operations have been treated as discontinued
operations for all periods presented. (see Discontinued Operations below).

     The Consolidated Financial Statements were prepared in accordance with
accounting principles generally accepted in the United States ("U.S. GAAP") for
all periods presented. The Consolidated Financial Statements and other financial
information included in this annual report, unless otherwise specified, have
been presented to separately show the effects of discontinued operations.

                 FORWARD-LOOKING STATEMENTS MAY PROVE INACCURATE

     Investors are cautioned that the forward-looking statements contained in
this annual report involve both risk and uncertainty. Many important factors
could cause actual results to differ materially from those anticipated by these
statements. Many of these statements are macroeconomic in nature and are,
therefore, beyond the control of management. See "Forward-Looking Statements May
Prove Inaccurate" in Item 5. Operating and Financial Review and Prospects.

                                     PART I

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

     Not applicable.

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

     Not applicable.


                                       1



ITEM 3. KEY INFORMATION

SELECTED FINANCIAL DATA

     The following table presents selected consolidated financial information of
Celanese. You should read this table in conjunction with Item 5. Operating and
Financial Review and Prospects, the audited Consolidated Financial Statements
and the notes to those statements that are included elsewhere in this annual
report.

     The balance sheet data shown below as of September 30, 2005 and 2004, and
the statement of operations data for the period from August 25, 2005 to
September 30, 2005, the period from October 1, 2004 to August 24, 2005, the nine
months ended September 30, 2004 and for the year ended December 31, 2003, all of
which are set forth below, are derived from the audited Consolidated Financial
Statements included elsewhere in this annual report and should be read in
conjunction with those financial statements and the notes thereto. The balance
sheet data as of December 31, 2003, 2002 and 2001, and the statement of
operations data for the years ended December 31, 2002 and 2001 are derived from
audited Consolidated Financial Statements not included in this annual report.
The results of operations and cash flows for the nine months ended September 30,
2003 are presented on an unaudited basis.


                                                      SUCCESSOR                           PREDECESSOR
                                                     ----------------------------------------------------------------------
                                                       PERIOD       PERIOD
                                                        FROM         FROM
                                                     AUGUST 25,   OCTOBER 1,
                                                       2005 TO      2004 TO
                                                      SEPTEMBER   AUGUST 24,   NINE MONTHS ENDED
                                                      30, 2005       2005         SEPTEMBER 30,     YEAR ENDED DECEMBER 31,
                                                     ----------------------------------------------------------------------
                                                                                 2004     2003      2003     2002     2001
                                                     ----------------------------------------------------------------------
                                                                                       (UNAUDITED)
                                                     ----------------------------------------------------------------------
                                                                                     (EURO)
                                                     ----------------------------------------------------------------------
                                                               (IN MILLIONS, EXCEPT FOR SHARE AND PER SHARE DATA,
                                                                       PERCENTAGES AND NUMBER OF EMPLOYEES)
                                                     ----------------------------------------------------------------------

STATEMENT OF OPERATIONS DATA:
Net sales.........................................        238        1,972       1,520    1,579     2,041    1,855    1,905
Cost of sales.....................................       (218)      (1,481)     (1,193)  (1,263)   (1,655)  (1,480)  (1,540)
Selling, general and administrative expenses......        (18)        (153)       (154)    (153)     (207)    (184)    (172)
Research and development expenses.................         (4)         (36)        (33)     (32)      (43)     (29)     (32)
Special charges(1)................................         (1)         (49)        (26)     (89)     (101)       5        3
Operating profit (loss)...........................         (2)         256         112       43        38      175      164
Interest and other income, net(2).................          7           75          45       40        28       42       46
Income tax benefit (provision)....................         (1)         (77)        (39)     (24)      (30)     (71)      (1)
Minority interests................................         (2)         (43)        (18)      (7)      (12)      (8)     (18)
Earnings (loss) from continuing operations........          2          211         100       52        24      138      191
Earnings (loss) from discontinued operations......         --           18        (170)      64       108       27     (598)
Cumulative effect of changes in accounting
   principles, net of income tax..................         --           --          --       --        --       10       --
Net earnings (loss)...............................          2          229         (70)     116       132      175     (407)
Earnings (loss) per common share - basic(3).......       0.04         4.56       (1.42)    2.34      2.67     3.48    (8.08)
Earnings (loss) per common share - diluted(3).....       0.04         4.55       (1.42)    2.34      2.67     3.48    (8.08)
BALANCE SHEET DATA:
Total assets......................................      3,920           --       5,340       --     5,395    6,121    7,071
Debt..............................................        332           --         501       --       504      551      777
Shareholders' equity..............................      2,456           --       1,888       --     2,044    1,999    2,217
Dividends paid per share..........................         --           --        0.12       --      0.44       --     0.40
Dividends paid per share (US$)....................         --           --        0.10       --      0.40       --     0.45
Common stock......................................        140           --         140       --       140      140      143
Weighted average shares -basic (in thousands).....     50,365       50,269      49,402   49,488    49,446   50,329   50,332
Weighted average share - diluted (in thousands)...     50,365       50,332      49,402   49,488    49,457   50,329   50,332
OTHER DATA:
Operating margin (%)..............................       (0.8)%         13%        7.4%     2.7%      1.9%     9.4%     8.6%
Depreciation and amortization.....................          7           62          74       74        97       81       83
Capital expenditures..............................          8           68          42       56        87      100       61


(1)  Special charges include impairment charges, provisions for restructuring,
     which include costs associated with employee termination benefits and,
     plant and office closures, and other expenses and income incurred outside
     the normal course of ongoing operations. See 26 to the Consolidated
     Financial Statements.

(2)  Interest and other income, net, represents equity in net earnings of
     affiliates, interest expense, and interest and other income, net, as set
     forth in the Consolidated Financial Statements.

(3)  Earnings (loss) per common share - basic and diluted, is calculated by
     dividing net earnings (loss) by the weighted average diluted shares
     outstanding.


                                        2



EXCHANGE RATE INFORMATION

     Celanese uses the euro as its reporting currency and will make the
guaranteed fixed annual payment (Ausgleich) to minority shareholders pursuant to
the Domination and Profit and Loss Transfer Agreement between Celanese AG and
Celanese Europe Holding (the "Domination Agreement") in euro. Furthermore,
prices quoted for Celanese ordinary shares ("CAG Shares") on the Frankfurt Stock
Exchange are quoted in euro.

     Fluctuations in the exchange rate between the euro and the U.S.$ may
affect:

     o    The U.S.$ equivalent for the guaranteed fixed annual payment
          (Ausgleich) pursuant to the Domination Agreement received by U.S.
          holders of CAG shares;

     o    The U.S.$ equivalent for the fair cash compensation (Abfindung)
          pursuant to the Domination Agreement received by U.S. holders
          tendering CAG Shares; and

     o    The trading market price of CAG Shares on the Frankfurt Stock
          Exchange.

     For more information on the Domination Agreement see Item 4. Information on
the Company - Acquisition of Celanese. The table below shows the Noon Buying
Rates for the euro in U.S.$. The average amounts set forth below under "Average"
are calculated as the average of the noon buying rate in New York City for cable
transfers in foreign currencies announced by the Federal Reserve Bank of New
York for customs purposes (the "Noon Buying Rate") on the last business day of
each month.

YEAR                                            LOW     HIGH    AVERAGE     END
-------------------------------------------   ------   ------   -------   ------
2001.......................................   0.8370   0.9535    0.8952   0.8901
2002.......................................   0.8594   1.0485    0.9454   1.0485
2003.......................................   1.0361   1.2597    1.1321   1.2597
2004 (January 1 through September 30)......   1.1801   1.2853    1.2255   1.2417
2005
   April...................................   1.2819   1.3093    1.2943   1.2919
   May                                        1.2349   1.2936    1.2697   1.2349
   June....................................   1.2035   1.2320    1.2155   1.2098
   July....................................   1.1917   1.2200    1.2041   1.2129
   August..................................   1.2147   1.2434    1.2295   1.2330
   September...............................   1.2011   1.2538    1.2234   1.2058
   October.................................   1.1914   1.2148    1.2022   1.1995
   November................................   1.1667   1.2067    1.1789   1.1790
   December................................   1.1699   1.2041    1.1861   1.1842
2006
   January.................................   1.1980   1.2287    1.2126   1.2158
   February ...............................   1.1886   1.2100    1.1940   1.1925
   March (through March 15, 2006)             1.1886   1.2045    1.1959   1.2045

     For a more complete discussion of exchange rate fluctuations and the
hedging techniques used by Celanese to manage its exposure to these
fluctuations, please see "Risk Factors" set forth below and Item 5. Operating
and Financial Review and Prospects - Market Risks, Item 11. Quantitative and
Qualitative Disclosures About Market Risk. and Item 9. The Offer and Listing -
Nature of the Trading Market.


                                       3



RISK FACTORS

     Many factors could have an effect on Celanese's financial condition, cash
flows and results of operations. Celanese is subject to various risks resulting
from changing economic, environmental, political, industry, business and
financial conditions. The principal factors are described below.

CELANESE IS AN INTERNATIONAL COMPANY AND IS EXPOSED TO GENERAL ECONOMIC,
POLITICAL AND REGULATORY CONDITIONS AND RISKS IN THE COUNTRIES IN WHICH IT HAS
SIGNIFICANT OPERATIONS.

     Celanese operates in the global market and has customers in many countries.
Celanese has major facilities located in Europe and Asia, including facilities
in Germany, China and Korea operated through ventures. Its principal customers
are similarly global in scope, and the prices of its most significant products
are typically world market prices. Consequently, Celanese's business and
financial results are affected directly and indirectly by world economic,
political and regulatory conditions.

     Conditions such as the uncertainties associated with war, terrorist
activities, epidemics, pandemics, or political instability in any of the
countries in which Celanese operates could affect Celanese by causing delays or
losses in the supply or delivery of raw materials and products as well as
increased security costs, insurance premiums and other expenses. These
conditions could also result in or lengthen economic recession in Europe, Asia,
the Americas, or elsewhere. Moreover, changes in laws or regulations, such as
unexpected changes in regulatory requirements (including import or export
licensing requirements), or changes in the reporting requirements of United
States, German or European Union governmental agencies, could increase the cost
of doing business in these regions. Any of these conditions may have an effect
on Celanese's business and financial results as a whole and may result in
volatile current and future prices for CAG Shares.

     From time to time, certain of Celanese Corporation's foreign subsidiaries,
including subsidiaries of the Company, have made sales of acetate, sweeteners
and polymer products to customers in countries that are or have previously been
subject to sanctions and embargoes imposed by the U.S. government. These
countries include Cuba, Iran, Sudan and Syria, four countries currently
identified by the U.S. State Department as terrorist-sponsoring states and other
countries that previously have been identified by the U.S. State Department as
terrorist-sponsoring states, or countries to which sales have been regulated in
connection with other foreign policy concerns. In September 2005, Celanese
Corporation began an investigation of these transactions and initially
identified approximately (euro)9 million of sales by Celanese Corporation's
foreign subsidiaries that may be in violation of regulations of the United
States Treasury Department's Office of Foreign Assets Control, or OFAC, or the
United States Department of Commerce's Bureau of Industry and Security. Celanese
Corporation now believes that approximately (euro)4 million of these sales may
actually be in violation of U.S. laws or regulations. Approximately (euro)4
million of the sales initially identified and less than (euro)1 million of the
sales that may actually be in violation were made by the Company or its
subsidiaries. The potential violations uncovered by the investigation include
approximately (euro)150,000 of sales of emulsions to Cuba. Sales to Cuba are
violations of OFAC regulations. In addition, we have recently discovered that
the Company's sales office in Turkey sold polymer products to companies in Iran
and Syria, including indirectly selling product through other companies located
in non-embargoed locations. These transactions may have involved an intentional
violation of our policies and U.S. federal regulations by employees of the
Company's office in Turkey. However, sales from our office in Turkey to all
customers are approximately (euro) 10 million annually. The investigation of
potentially prohibited sales is ongoing and we can not yet be certain of the
number of these transactions, the sales amounts or the identity of every
individual who may have been involved.

         Celanese Corporation has voluntarily disclosed these matters to the
U.S. Treasury Department and the U.S. Department of Commerce, and they are
currently engaged in discussions with them. None of the aforementioned sales
were in violation of German law. Celanese Corporation and the Company have also
taken corrective actions, including directives to senior business leaders
prohibiting such sales, as well as modifications to our accounting systems that
are intended to prevent the initiation of sales to countries that are subject to
the U.S. Treasury Department or the U.S. Department of Commerce restrictions.

         If violations of the U.S. export control laws are found Celanese
Corporation and the Company could be subject to civil penalties of up to $50,000
per violation, and criminal penalties could range up to the greater of $1
million per violation, or five times the value of the goods sold. If such
violations occurred, the U.S. Government could deny Celanese export privileges.
The ultimate resolution of this matter is subject to completion of our
investigation and a final ruling or settlement with the U.S. government.
Accordingly, we cannot estimate the potential sanctions relating to this matter.
There can be no assurance that any governmental investigation or our own
investigation of these matters will not conclude that violations of applicable
laws have occurred or that the results of these investigations will not have a
material adverse effect on our business and results of operations.

CYCLICALITY IN THE INDUSTRIAL CHEMICALS INDUSTRY HAS IN THE PAST AND MAY IN THE
FUTURE RESULT IN REDUCED OPERATING MARGINS OR OPERATING LOSSES.

     Consumption of the basic chemicals that Celanese manufactures, in
particular those in acetyl products, such as acetic acid and vinyl acetate
monomer, has increased significantly over the past 30 years. Despite this growth
in consumption, producers have experienced alternating periods of inadequate
capacity and excess capacity for these products. Periods of inadequate capacity,
including some due to raw material shortages, have usually resulted in increased
selling prices and operating margins. This has often been followed by periods of
capacity additions, which have resulted in declining capacity utilization rates,
selling prices and operating margins. Celanese expects that these cyclical
trends in selling prices and operating margins relating to capacity shortfalls
and additions will likely persist in the future, principally due to the
continuing combined impact of five factors:


                                       4



     o    Significant capacity additions, whether through plant expansion or
          construction, can take two to three years to come on stream and are
          therefore necessarily based upon estimates of future demand.

     o    When demand is rising, competition to build new capacity may be
          heightened because new capacity tends to be more profitable, with a
          lower marginal cost of production. This tends to amplify upswings in
          capacity.

     o    When demand is falling, the high fixed cost structure of the
          capital-intensive chemicals industry leads producers to compete
          aggressively on price in order to maximize capacity utilization.

     o    As competition in these products is focused on price, being a low-cost
          producer is critical to profitability. This favors the construction of
          larger plants, which maximize economies of scale, but which also lead
          to major increases in capacity that can outstrip current growth in
          demand.

     o    Cyclical trends in general business and economic activity produce
          swings in demand for chemicals.

     Celanese believes that the basic chemicals industry, particularly in the
commodity chemicals manufactured by Celanese's Chemical Products segment, is
currently characterized by overcapacity, and that there may be further capacity
additions in the next few years.

THE LENGTH AND DEPTH OF PRODUCT AND INDUSTRY BUSINESS CYCLES OF CELANESE'S
MARKETS, PARTICULARLY IN THE AUTOMOTIVE, ELECTRICAL, CONSTRUCTION AND TEXTILE
INDUSTRIES, MAY RESULT IN REDUCED OPERATING MARGINS OR OPERATING LOSSES.

     Some of the markets in which Celanese's customers participate, such as the
automotive, electrical, construction and textile industries, are cyclical in
nature, thus posing a risk to Celanese which is beyond its control. These
markets are highly competitive, to a large extent driven by end-use markets, and
may experience overcapacity, all of which may affect demand for and pricing of
Celanese's products.

CELANESE IS SUBJECT TO RISKS ASSOCIATED WITH THE INCREASED VOLATILITY IN RAW
MATERIALS PRICES AND THE AVAILABILITY OF KEY RAW MATERIALS.

     Celanese purchases significant amounts of natural gas, ethylene, methanol,
and propylene from third parties for use in its production of basic chemicals in
the Chemical Products segment, principally acetic acid and vinyl acetate
monomer. Celanese uses a portion of its output of these chemicals, in turn, as
inputs in the production of further products in all its segments. Celanese also
purchases significant amounts of natural gas, electricity and fuel oil to supply
the energy required in its production processes.

     Celanese also leases supplies of various precious metals, such as rhodium,
used as catalysts for the production of these chemicals. With growing demand for
these precious metals, most notably in the automotive industry, the cost to
purchase or lease these precious metals has increased, caused by a shortage in
supply. These circumstances are expected to continue into the second half of
2006.

     Prices of natural gas, oil and other hydrocarbons have increased
dramatically in 2005. To the extent this trend continues and Celanese is unable
to pass through these price increases to its customers, Celanese's operating
profit and results of operations may be less favorable than expected.

     Celanese is exposed to any volatility in the prices of its raw materials
and energy. Although Celanese has agreements providing for the supply of natural
gas, ethylene, propylene, electricity and fuel oil, the contractual prices for
these raw materials and energy vary with market conditions and may be highly
volatile. Factors which have caused volatility in Celanese's raw material prices
in the past and which may do so in the future include:

     o    Shortages of raw materials due to increasing demand, e.g., from
          growing uses or new uses;

     o    Capacity constraints, e.g., due to construction delays, strike action
          or involuntary shutdowns;

     o    The general level of business and economic activity; and

     o    The direct or indirect effect of governmental regulation.


                                       5



     Celanese strives to improve profit margins of many of its products through
price increases when warranted and accepted by the market; however, Celanese's
operating margins may decrease if it cannot pass on increased raw material
prices to customers. Even in periods during which raw material prices decline,
Celanese may suffer decreasing operating profit margins if raw material price
reductions occur at a slower rate than decreases in the selling prices of
Celanese's products.

     A substantial portion of Celanese's products and raw materials are
commodities whose prices fluctuate as market supply/demand fundamentals change.
Celanese manages its exposure through the use of long-term supply agreements,
multi-year purchasing and sales agreements. Although Celanese seeks to offset
increases in raw material prices with corresponding increases in the prices of
its products, it may not be able to do so, and there may be periods when such
product price increases lag behind raw material cost increases.

     Celanese has a policy of maintaining, when available, multiple sources of
supply for raw materials. However, some of Celanese's individual plants may have
single sources of supply for some of their raw materials, such as carbon
monoxide and acetaldehyde. Celanese may not be able to obtain sufficient raw
materials as a result of unforeseen developments that would cause an
interruption in supply. Even if Celanese has multiple sources of supply for a
raw material, these sources would not make up for the loss of a major supplier.
Nor can there be any guarantee that profitability will not be affected should
Celanese be required to qualify additional sources of supply in the event of the
loss of a sole or a major supplier.

FAILURE TO DEVELOP NEW PRODUCTS AND PRODUCTION TECHNOLOGIES OR TO IMPLEMENT
PRODUCTIVITY AND COST REDUCTION INITIATIVES SUCCESSFULLY MAY HARM CELANESE'S
COMPETITIVE POSITION.

     Celanese's operating results, especially in its Performance Products and
Technical Polymers Ticona segments, depend significantly on the development of
commercially viable new products, product grades and applications, as well as
production technologies. If Celanese is unsuccessful in developing new products,
applications and production processes in the future, its competitive position
and operating results will be negatively affected. Likewise, Celanese has
undertaken and is continuing to undertake initiatives in all segments to improve
productivity and performance and to generate cost savings. These initiatives may
not be completed or beneficial or the estimated cost savings from such
activities may not be realized.

CELANESE'S FUTURE SUCCESS WILL DEPEND IN PART ON ITS ABILITY TO PROTECT ITS
INTELLECTUAL PROPERTY RIGHTS, AND ITS INABILITY TO ENFORCE THESE RIGHTS COULD
REDUCE ITS ABILITY TO MAINTAIN ITS MARKET POSITION AND ITS MARGINS.

     Celanese attaches great importance to patents, trademarks, copyrights and
product designs in order to protect its investment in research and development,
manufacturing and marketing. Celanese's policy is to seek the widest possible
protection for significant product and process developments in its major
markets. Patents may cover products, processes, intermediate products and
product uses. Protection for individual products extends for varying periods in
accordance with the date of patent application filing and the legal life of
patents in the various countries. The protection afforded, which may also vary
from country to country, depends upon the type of patent and its scope of
coverage. Celanese's continued growth strategy may bring it to regions of the
world where intellectual property protection may be limited and difficult to
enforce.

     As patents expire, the products and processes described and claimed in
those patents become generally available for use by the public. Celanese's
European and U.S. primary production patents for making Sunett, an important
product in Celanese's Performance Products segment, expired at the end of the
second quarter of fiscal year 2005, reducing its ability to realize revenues
from making Sunett due to increased competition and potential limitations and
will result in Celanese's results of operations and cash flows relating to the
product being less favorable than today.

     Celanese also seeks to register trademarks extensively as a means of
protecting the brand names of its products, which brand names become more
important once the corresponding patents have expired. If Celanese is not
successful in protecting its trademark rights, its revenues, results of
operations and cash flows may be adversely affected.


                                       6



FRANKFURT AIRPORT EXPANSION COULD REQUIRE CELANESE TO REDUCE PRODUCTION CAPACITY
OF, LIMIT EXPANSION POTENTIAL OF, OR INCUR RELOCATION COSTS FOR ITS KELSTERBACH
PLANT, WHICH WOULD LEAD TO SIGNIFICANT ADDITIONAL COSTS.

     The Frankfurt airport's expansion plans include the construction of an
additional runway (the northwest option), which would be located in close
proximity to Celanese's Kelsterbach production plant. The construction of this
particular runway could have a negative effect on the plant's current production
capacity and future development. While the government of the state of Hesse and
the owner of the Frankfurt airport promote the expansion of the northwest
option, it is uncertain whether this option is in accordance with applicable
laws. Although the government of the state of Hesse expects the plan approval
for the airport expansion in 2007 and the start of operations in 2009-2010,
neither the final outcome of this matter nor its timing can be predicted at this
time.

ENVIRONMENTAL REGULATIONS AND OTHER OBLIGATIONS RELATING TO ENVIRONMENTAL
MATTERS COULD SUBJECT CELANESE TO LIABILITY FOR FINES, CLEAN-UPS AND OTHER
DAMAGES, REQUIRE IT TO INCUR SIGNIFICANT COSTS TO MODIFY ITS OPERATIONS AND
INCREASE ITS MANUFACTURING AND DELIVERY COSTS.

     Costs related to Celanese's compliance with environmental laws concerning,
and potential obligations with respect to, contaminated sites may have a
significant negative impact on its operating results. These include obligations
related to sites currently or formerly owned or operated by Celanese, or where
waste from its operations was disposed. Celanese also has obligations related to
the indemnity agreement contained in the demerger and transfer agreement between
Celanese AG and Hoechst Aktiengesellschaft or Hoechst, also referred to as the
demerger agreement, for environmental matters arising out of a number of
divestitures that took place prior to the demerger. Celanese's accruals for
environmental remediation obligations, (euro)6 million as of September 30, 2005,
may be insufficient if the assumptions underlying those accruals prove incorrect
or if Celanese is held responsible for currently undiscovered contamination. See
"Celanese may be required to make payments to Hoechst" below, Item 4.
Information on the Company - Environmental and Other Regulation, and Item 5.
Operating and Financial Review and Prospects - Liquidity and Capital Resources.

     Celanese's operations are subject to extensive international, national,
state, local, and other supranational laws and regulations that govern
environmental and health and safety matters. Celanese incurs substantial capital
and other costs to comply with these requirements. If they are violated,
Celanese can be held liable for substantial fines and other sanctions, including
limitations on its operations as a result of changes to or revocations of
environmental permits involved. Stricter environmental, safety and health laws,
regulations and enforcement policies could result in substantial costs and
liabilities to Celanese or limitations on Celanese's operations and could
subject Celanese's handling, manufacture, use, reuse or disposal of substances
or pollutants to more rigorous scrutiny than at present. Consequently,
compliance with these laws could result in significant capital expenditures as
well as other costs and liabilities, and Celanese's business and operating
results may be less favorable than expected. See Item 4. Information on the
Company - Environmental and Other Regulation, and Notes 24 and 25 to the
Consolidated Financial Statements.

     Celanese is also involved in several claims, lawsuits and administrative
proceedings relating to environmental matters. An adverse outcome in any of them
may negatively affect Celanese's earnings and cash flows in a particular
reporting period.


                                       7



CHANGES IN ENVIRONMENTAL, HEALTH AND SAFETY REGULATORY REQUIREMENTS COULD HAVE A
SIGNIFICANT NEGATIVE EFFECT ON THE DEMAND FOR CELANESE'S PRODUCTS.

     New or revised governmental regulations relating to health, safety and the
environment may also affect demand for Celanese's products.

     Pursuant to the European Union regulation on Risk Assessment of Existing
Chemicals, the European Chemicals Bureau of the European Commission has been
conducting risk assessments on approximately 140 major chemicals. Some of the
chemicals initially being evaluated include vinyl acetate monomer or VAM, which
Celanese produces. These risk assessments entail a multi-stage process to
determine to what extent the European Commission should classify the chemical as
a carcinogen and, if so, whether this classification and related labeling
requirements should apply only to finished products that contain specified
threshold concentrations of a particular chemical. In the case of VAM, a final
ruling is not expected until the end of 2007. Celanese and other VAM producers
are participating in this process with detailed scientific analyses supporting
the industry's position that VAM is not a probable human carcinogen and that
labeling of final products should not be required. If labeling is required, then
it should depend on relatively high parts per million of residual VAM in these
end products. It is not possible for Celanese to predict the outcome or effect
of any final ruling.

     Several recent studies have investigated possible links between
formaldehyde exposure and various end points including leukemia. The
International Agency for Research on Cancer, or IARC, recently reclassified
formaldehyde from Group 2A (probable human carcinogen) to Group 1 (known human
carcinogen) based on studies linking formaldehyde exposure to nasopharyngeal
cancer, a rare cancer in humans. IARC also concluded that there is insufficient
evidence for a causal association between leukemia and occupational exposure to
formaldehyde, although it also characterized evidence for such an association as
strong. The results of IARC's review are being examined by government agencies
with responsibility for setting worker and environmental exposure standards and
labeling requirements. Celanese's Technical Polymers Ticona segment produces
plastics derived from formaldehyde as well as the formaldehyde for use in these
plastics. Celanese is participating together with other producers and users in
the evaluations of these findings. Celanese cannot predict the final effect of
IARC's reclassification.

     Other recent initiatives will potentially require toxicological testing and
risk assessments of a wide variety of chemicals, including chemicals used or
produced by Celanese. These initiatives include various European Commission
programs, such as the European Environment and Health Strategy, commonly known
as SCALE, as well as the Proposal for the Registration, Evaluation and
Authorization and Restriction of Chemicals or REACH. REACH, which the European
Commission proposed in October 2003, will establish a system to register and
evaluate chemicals manufactured or imported to the European Union. Depending on
the final ruling, additional testing, documentation and risk assessments will
occur for the chemical industry. This will affect European producers of
chemicals as well as all chemical companies worldwide that export to member
states of the European Union. The final ruling has not yet been decided.

     The above-mentioned assessments may result in heightened concerns about the
chemicals involved, and in additional requirements being placed on the
production, handling, labeling or use of the subject chemicals. Such concerns
and additional requirements could increase the cost incurred by Celanese's
customers to use its chemical products and otherwise limit the use of these
products, which could lead to a decrease in demand for these products.

CELANESE'S PRODUCTION FACILITIES HANDLE THE PROCESSING OF SOME VOLATILE AND
HAZARDOUS MATERIALS THAT SUBJECT CELANESE TO OPERATING RISKS THAT COULD HAVE A
NEGATIVE EFFECT ON CELANESE'S OPERATING RESULTS.

     Celanese's operations are subject to operating risks associated with
chemical manufacturing, including the related storage and transportation of raw
materials, products and wastes. These hazards include, among other things:

     o    Pipeline and storage tank leaks and ruptures;

     o    Explosions and fires; and

     o    Discharges or releases of toxic or hazardous substances.


                                       8



     These operating risks can cause personal injury, property damage and
environmental contamination, and may result in the shutdown of affected
facilities and the imposition of civil or criminal penalties. The occurrence of
any of these events may disrupt production and have a negative effect on the
productivity and profitability of a particular manufacturing facility and
Celanese's operating results and cash flows.

     Celanese maintains property, business interruption and casualty insurance
which it believes is in accordance with customary industry practices, but
Celanese cannot provide any assurance that this insurance will be adequate to
fully cover all potential hazards incidental to its business.

     For more detailed information on environmental issues, see Item 4.
Information on the Company - Environmental and Other Regulations and Note 24 to
the Consolidated Financial Statements.

FLUCTUATIONS IN EXCHANGE AND INTEREST RATES MAY AFFECT CELANESE'S PROFITABILITY.

     Celanese is exposed to market risk through commercial and financial
operations. Celanese's market risk consists principally of exposure to
fluctuations in currency exchange and interest rates.

     Fluctuations in currencies of such countries, especially the U.S. dollar,
may materially affect Celanese's operating results. For example, changes in
currency exchange rates may affect:

     o    The relative prices at which Celanese and its competitors sell
          products in the same market; and

     o    The cost of items required in Celanese's operations.

     Celanese uses financial instruments to hedge its exposure to foreign
currency fluctuations. More than 90 percent of outstanding foreign currency
contracts are used to hedge the foreign currency denominated intercompany net
receivables. The net notional amounts under such foreign currency contracts
outstanding at September 30, 2005 were (euro)420 million. These positive effects
may not be indicative of future effects.

     Celanese is primarily exposed to changes in interest rates in the U.S.
dollar and the euro. To manage these risks, Celanese, from time to time, enters
into interest rate swap agreements to reduce the exposure of interest rate risk
inherent in Celanese's debt portfolio by locking into borrowing rates to acheive
a desired level of fixed/floating rate debt depending on market conditions.
Celanese uses swaps for hedging purposes only.

     Prior to the Restructuring, a substantial portion of Celanese's net sales
was denominated in currencies other than the euro. Following the Restructuring,
the translation effects of changes in the value of other currencies against the
euro have not been eliminated, but were reduced substantially for Celanese. In
its consolidated financial statements, Celanese translates its local currency
financial results into euros based on average exchange rates prevailing during a
reporting period or the exchange rate at the end of that period. During times of
a weakening U.S. dollar, at a constant level of business, reported international
sales, earnings, assets and liabilities will be reduced because the local
currency will translate into fewer euros. We estimate that the translation
effects of changes in the value of other currencies against the euro decreased
net sales by less than 1 percent for the period October 1, 2004 to August 24,
2005 and August 25 to September 30, 2005, 6 percent for the nine months ended
September 30, 2004, and 13 percent for the year ended December 31, 2003. We
estimate that the translation effects of changes in the value of other
currencies against the euro had increased total assets by approximately 2
percent and 1 percent in 2005 and 2004, respectively, and decreased total assets
by approximately 13 percent in 2003.

     Celanese also incurs a currency transaction risk whenever one of its
operating subsidiaries enters into either a purchase or a sales transaction
using a different currency from the currency in which revenues are received.
Given the volatility of exchange rates, Celanese may not be able to manage its
currency transaction and/or translation risks effectively, or volatility in
currency exchange rates may expose its financial condition or results of
operations to a significant additional risk. Since a significant portion of its
indebtedness is and will be denominated in U.S. dollars, a strengthening of the
U.S. dollar could make it more difficult for Celanese to repay its indebtedness.

CELANESE MAY BE REQUIRED TO MAKE PAYMENTS TO HOECHST.

     Under the demerger agreement, Celanese agreed to indemnify Hoechst for
environmental liabilities that Hoechst may incur with respect to Celanese's
German production sites, which were transferred from Hoechst to


                                       9



Celanese in connection with the demerger. Celanese also has an obligation to
indemnify Hoechst against liabilities for environmental damages or contamination
arising under certain divestiture agreements entered into by Hoechst prior to
the demerger. As the indemnification obligations depend on the occurrence of
unpredictable future events, the costs associated with them are not yet
determinable and may materially affect operating results. Celanese's obligation
to indemnify Hoechst against liabilities for environmental contamination in
connection with the divestiture agreements is subject to the following
thresholds:

     o    Celanese will indemnify Hoechst for the total amount of these
          liabilities up to (euro)250 million;

     o    Hoechst will bear the full amount of those liabilities
          between (euro)250 million and (euro)750 million; and

     o    Celanese will indemnify Hoechst for one third of those liabilities for
          amounts exceeding (euro)750 million.

     As of September 30, 2005 and 2004, Celanese has made total cumulative
payments of (euro)13 million and (euro)12 million, respectively, for
environmental contamination liabilities in connection with the divestiture
agreements, and may be required to make additional payments in the future. As of
September 30, 2005, Celanese had reserves of less than (euro)1 million for this
contingency, and may be required to record additional reserves in the future.

     Also, Celanese has undertaken in the demerger agreement to indemnify
Hoechst to the extent that Hoechst is required to discharge liabilities,
including tax liabilities, in relation to assets included in the demerger, where
such liabilities have not been demerged due to transfer or other restrictions.
Celanese did not make any payments to Hoechst in either the period from August
25, 2005 to September 30, 2005, the period from October 1, 2004 to August 24,
2005, the nine months ended September 30, 2004 or in the year ended December 31,
2003 in connection with this indemnity.

     Under the demerger agreement, Celanese will also be responsible, directly
or indirectly, for all of Hoechst's obligations to past employees of businesses
that were demerged to Celanese. Under the demerger agreement, Hoechst agreed to
indemnify Celanese from liabilities (other than liabilities for environmental
contamination) stemming from the agreements governing the divestiture of
Hoechst's polyester businesses, which were demerged to Celanese, insofar as such
liabilities relate to the European part of that business. Hoechst has also
agreed to bear 80 percent of the financial obligations arising in connection
with the government investigation and litigation associated with the sorbates
industry for price fixing described in Item 8. Financial Information - Legal
Proceedings and Note 24 to the Consolidated Financial Statements, and Celanese
has agreed to bear the remaining 20 percent.

UNDER THE DOMINATION AGREEMENT CELANESE'S MAJORITY SHAREHOLDER MAY REQUIRE IT TO
TAKE ACTIONS THAT ARE DISADVANTAGEOUS TO IT.

     Celanese has entered into a domination and profit and loss transfer
agreement (Beherrschungs- und Gewinnabfuehrungsvertrag) or the Domination
Agreement with its majority shareholder, Celanese Europe Holding. Pursuant to
this agreement, Celanese Europe Holding may instruct Celanese's board of
management to take actions that are disadvantageous to Celanese if such
instruction is in the interest of Celanese Europe Holding or its affiliated
companies. In addition, pursuant to the Domination Agreement, Celanese is
obligated to transfer its entire profits to Celanese Europe Holding, while the
Domination Agreement requires Celanese Europe Holding to compensate Celanese for
any annual statutory loss incurred. Furthermore, the net amount of the
guaranteed fixed annual payment (Ausgleich) guaranteed by Celanese Europe
Holding vis-a-vis the minority shareholders of Celanese in lieu of any future
dividend, which, at the time of the entering into of the Domination Agreement,
amounted to (euro)2.89 per share for a full fiscal year, may, depending on
applicable corporate tax rates, in the future be higher, lower or the same as
(euro)2.89. As a dominated company, Celanese may be affected by risks that
affect Celanese Europe Holding and its affiliates, including but not limited to
risks arising out of the debt levels of some of these entities. The Domination
Agreement cannot be terminated by Celanese Europe Holding in the ordinary course
of business until September 30, 2009.

     Irrespective of whether a domination agreement is in place between Celanese
Europe Holding and Celanese, under German law Celanese is effectively controlled
by Celanese Europe Holding because of its 98 percent ownership of all
outstanding CAG Shares. Celanese Europe Holding has the ability, through a
variety of means, to utilize its controlling rights to, among other things, (1)
use its ability, through its 98 percent voting power at any shareholders'
meetings of Celanese, to elect the shareholder representatives on the
supervisory board and to


                                       10



thereby effectively control the appointment and removal of the members of the
Celanese board of management; and (2) effect all decisions that a majority
shareholder is permitted to make under German law.

     For more information on the Domination Agreement, see Item 4. Information
on the Company - Acquisition of Celanese.

AS A DOMINATED COMPANY, CELANESE MAY BE AFFECTED BY RISKS ARISING OUT OF THE
DEBT LEVELS OF CELANESE CORPORATION AND SEVERAL OF ITS SUBSIDIARIES.

     Celanese Corporation and several of its subsidiaries are highly leveraged.
Since Celanese is a consolidated subsidiary of Celanese Corporation, Celanese
Corporation's substantial debt could have an effect on Celanese, including:

     o    Increasing Celanese's vulnerability to general economic and industry
          conditions;

     o    Limiting Celanese's ability to obtain additional financing for working
          capital, capital expenditures, product development, debt service
          requirements, acquisitions and general corporate or other purposes;
          and

     o    Limiting Celanese's ability to adjust to changing market conditions
          and placing Celanese at a competitive disadvantage compared to its
          competitors who have less debt.

ACTIONS TAKEN BY CELANESE AG'S MAJORITY SHAREHOLDER MAY ELIMINATE A LIQUID
MARKET FOR CAG SHARES.

     Celanese Europe Holding currently owns approximately 98 percent of CAG's
shares. In November 2005, Celanese Corporation requested Celanese Europe Holding
to require, as permitted under German law, the transfer of the CAG Shares owned
by the then-outstanding minority shareholders of Celanese in exchange for fair
cash compensation (the "Squeeze-Out"). Celanese Europe Holding later determined
the fair cash compensation to be (euro)62.22 per share, based on an independent
valuation. A Squeeze-Out is permitted under German law once a shareholder
acquires 95 percent or more of Celanese's registered ordinary share capital
(excluding treasury shares). A shareholders' resolution authorizing the
Squeeze-Out is scheduled to be brought before the annual general meeting in May
2006. If the Squeeze-Out is effected, Celanese would cease to be a publicly held
company. For additional information, see Item 4. Information on the Company -
Acquisition of Celanese.

CELANESE'S INTERNAL CONTROLS OVER FINANCIAL REPORTING MAY NOT BE EFFECTIVE AND
ITS INDEPENDENT AUDITORS MAY NOT BE ABLE TO CERTIFY AS TO THEIR EFFECTIVENESS,
WHICH COULD HAVE A SIGNIFICANT AND ADVERSE EFFECT ON CELANESE'S BUSINESS AND
REPUTATION.

     Celanese is evaluating its internal controls over financial reporting in
order to allow management to report on, and its independent auditors to attest
to, internal controls over financial reporting, as required by Section 404 of
the Sarbanes-Oxley Act of 2002 and rules and regulations of the Securities and
Exchange Commission, or the Commission, thereunder, which is referred to as
Section 404. Celanese is currently performing the system and process evaluation
and testing required (and any necessary remediation) in an effort to comply with
management certification and auditor attestation requirements of Section 404.
The management certification and auditor attestation requirements of Section 404
will initially apply to Celanese as of September 30, 2007. In the course of
Celanese's ongoing Section 404 evaluation, areas of internal controls that may
need improvement have been identified, and plans are in place to design enhanced
processes and controls to address these and any other issues that might be
identified through this review. Currently, none of the identified areas that
need improvement have been categorized as significant deficiencies or material
weaknesses, individually or in the aggregate. However, as the evaluation process
is still ongoing, conditions that may result in significant deficiencies or
material weaknesses in the future may still be identified.

     Celanese cannot be certain as to the timing of completion of its
evaluation, testing and any remediation actions or the impact of the same on its
operations. If the requirements of Section 404 cannot be implemented in a


                                       11



timely manner or with adequate compliance, Celanese's independent auditors may
not be able to certify as to the effectiveness of its internal control over
financial reporting and it may be subject to sanctions or investigation by
regulatory authorities, such as the Commission. As a result, there could be a
negative reaction in the financial markets due to a loss of confidence in the
reliability of Celanese's financial statements. In addition, Celanese may be
required to incur costs in improving its internal control system and the hiring
of additional personnel. Any such action could negatively affect Celanese's
results.

CELANESE HAS, IN THE PAST, IDENTIFIED SIGNIFICANT DEFICIENCIES AND MATERIAL
WEAKNESSES IN ITS INTERNAL CONTROLS, AND THE IDENTIFICATION OF ANY SIGNIFICANT
DEFICIENCIES OR MATERIAL WEAKNESSES IN THE FUTURE COULD AFFECT ITS ABILITY TO
ENSURE TIMELY AND RELIABLE FINANCIAL REPORTS.

     In addition to, and separate from, Celanese's evaluation of internal
controls under Section 404 of the Sarbanes-Oxley Act of 2002 and any areas
requiring improvement identified as part of that process, two material
weaknesses and a significant deficiency have been identified in the internal
controls of Celanese Corporation, Celanese's parent company. The Public Company
Accounting Oversight Board ("PCAOB") defines a significant deficiency as a
control deficiency, or a combination of control deficiencies, that adversely
affects the company's ability to initiate, authorize, record, process or report
external financial data reliably in accordance with generally accepted
accounting principles such that there is more than a remote likelihood that a
misstatement of the company's annual or interim financial statements that is
more than inconsequential will not be prevented or detected. The PCAOB defines a
material weakness as a single deficiency, or a combination of deficiencies, that
results in more than a remote likelihood that a material misstatement of the
annual or interim financial statements will not be prevented or detected. For a
description of these weaknesses and the deficiency, see Item 15. Controls and
Procedures.

     During calendar year 2005, Celanese Corporation and its subsidiaries,
including Celanese AG, have been implementing changes to strengthen their
internal controls. Although Celanese believes that the deficiency and material
weaknesses mentioned above were remediated by December 31, 2005, Celanese
continues to monitor its internal controls and procedures, and will take
additional measures as necessary to address any issues it identifies and to
ensure its internal controls continue to be effective. If deficiencies in
internal controls cannot be corrected in a timely manner, Celanese's ability to
record, process, summarize and report financial information within the time
periods specified in the rules and forms of the Commission will be adversely
affected. This failure could materially and adversely impact Celanese's
business, its financial condition and the market value of its securities.

ITEM 4. INFORMATION ON THE COMPANY

ACQUISITION OF CELANESE

     On April 6, 2004, Celanese Europe Holding, formerly known as BCP Crystal
Acquisition GmbH & Co. KG acquired approximately 84 percent of the outstanding
Celanese ordinary shares, excluding treasury stock (the "Tender Offer"),
pursuant to a voluntary tender offer commenced in February 2004. These shares
were acquired at a price of (euro)32.50 per share or an aggregate purchase price
of (euro)1,385 million, including direct acquisition costs of approximately
(euro)56 million. Following the completion of the acquisition, the CAG Shares
were delisted from the New York Stock Exchange on June 2, 2004. CAG Shares
continue to trade on the Frankfurt Stock Exchange in Germany.

     In addition, as a part of the Tender Offer, Celanese Europe Holding agreed
to refinance certain existing debt of Celanese, pre-fund certain pension
obligations of Celanese, pre-fund certain contingencies and certain obligations
linked to the value of CAG Shares, and payment obligations related to
outstanding stock appreciation rights, stock options and interest payments,
provide additional funds for working capital and other general corporate
purposes, and pay related fees and expenses.

     For more information on the acquisition of Celanese, see Note 1 to the
Consolidated Financial Statements.

Post-Tender Offer Events

     After the completion of the Tender Offer, the following events occurred:

     Delisting. CAG's shares were delisted from the New York Stock Exchange, or
NYSE, on June 2, 2004.


                                       12



     Domination and Profit and Loss Transfer Agreement. On June 22, 2004,
Celanese Europe Holding entered into a domination and profit and loss transfer
agreement (Beherrschungs- und Gewinnabfuehrungsvertrag) or, Domination
Agreement, with Celanese, pursuant to which Celanese agreed to submit itself to
the direction of, and to transfer its entire profits to, Celanese Europe
Holding, and Celanese Europe Holding agreed to compensate Celanese for any
annual losses (Jahresfehlbetrag) incurred while the Domination Agreement is in
effect. Several lawsuits, including those seeking to set aside the shareholder
resolutions passed at the extraordinary general meeting held on July 30-31,
2004, as well as public register proceedings that seek to have the registration
of the Domination Agreement in the commercial register revoked, are currently
pending. See Item 8. Financial Information - Legal Proceedings. The Domination
Agreement cannot be terminated by Celanese Europe Holding in the ordinary course
of business until September 30, 2009.

     Under the Domination Agreement, the board of management may be compelled to
take actions that are disadvantageous to Celanese if the board of management is
instructed to do so by Celanese Europe Holding, and provided that such
instructions are in the interest of Celanese Europe Holding or its affiliates.
The board of management may only refuse to comply with any such instruction, if,
at the time such instruction is given, (i) it is, in the opinion of the board of
management of Celanese, obviously not in the interests of Celanese Europe
Holding or its affiliates, (ii) compliance with the instruction would violate
legal or statutory restrictions, (iii) compliance with the instruction would
endanger the existence of Celanese; or (iv) it is doubtful whether Celanese
Europe Holding will be able to fully compensate Celanese, as required by the
Domination Agreement, for its annual loss (Jahresfehlbetrag) incurred during the
fiscal year in which such instruction is given. The supervisory board is not
bound by instructions issued by Celanese Europe Holding under the Domination
Agreement. If Celanese Europe Holding instructs the board of management to take
an action that requires the supervisory board's approval and such approval is
not given, the board of management nevertheless has to comply with such
instruction if Celanese Europe Holding repeats it.

     Pursuant to the Domination Agreement, the entire annual statutory profits
of Celanese, if any, less any loss carried forward from the previous fiscal
year, less any amount to be allocated to the statutory capital reserve
(gesetzliche Ruecklage) and less any amount to be allocated to other profit
reserves (andere Gewinnruecklagen) upon approval by Celanese Europe Holding,
will be transferred to Celanese Europe Holding. If, however, during any fiscal
year during the operative term of the Domination Agreement, Celanese incurs an
annual loss (Jahresfehlbetrag), Celanese Europe Holding would have to pay to
Celanese an amount equal to such loss to the extent that the respective annual
loss is not fully compensated for by dissolving other profit reserves (andere
Gewinnruecklagen) accrued at Celanese since the date on which the Domination
Agreement became operative (Verlustausgleichspflicht). Such payment obligation
would accrue at the end of any fiscal year of Celanese in which an annual loss
was incurred, and such accrual would be independent from the adoption of the
financial statements. The payment obligation would have to be fulfilled by a
cash payment to Celanese by Celanese Europe Holding. Celanese Europe Holding may
be able to reduce or avoid cash payments to Celanese by offsetting against such
loss compensation claims by Celanese any counterclaims of value against Celanese
that Celanese Europe Holding may have. Unless Celanese Europe Holding is able to
obtain funds from a source other than annual profits of Celanese, it may not be
able to satisfy its obligation to fund such shortfall. However, Celanese
Corporation has entered into letters of support with Celanese and Celanese
Europe Holding, pursuant to which Celanese Corporation will guarantee the
obligations of Celanese Europe Holding under the Domination Agreement. BCP
Caylux Holdings Luxembourg S.C.A., or BCP Caylux, and BCP Crystal US Holdings
Corp., or BCP Crystal, both of which are indirect wholly-owned subsidiaries of
Celanese Corporation, have each agreed to provide Celanese Europe Holding with
financing to further strengthen its ability to be in a position at all times to
fulfill all of its obligations when they become due under, or in connection
with, the Domination Agreement and to ensure that it will perform all of its
obligations under, or in connection with, the Domination Agreement when such
obligations become due, including, without limitation, the obligations to pay a
guaranteed fixed annual payment to the outstanding minority shareholders of
Celanese, to offer to acquire all outstanding CAG shares from the minority
shareholders in return for payment of fair cash consideration and to compensate
Celanese for any annual loss it incurs while the Domination Agreement is in
effect.

     As a consequence of entering into the Domination Agreement, Section 305(1)
of the German Stock Corporation Act (Aktiengesetz) requires that, upon the
Domination Agreement becoming operative, Celanese Europe Holding must at the
request of each remaining minority shareholder of Celanese, acquire such
shareholder's registered CAG Shares in exchange for payment of "fair cash
compensation" (angemessene


                                       13



Barabfindung). As required under Section 305(3) sentence 3 of the German Stock
Corporation Act, Celanese Europe Holding will pay to all minority shareholders
who tender into such offer and whose shares are paid for after the day following
the date the Domination Agreement becomes operative, interest on the offer price
from such day until the day preceding the date of settlement at a rate of 2
percent per annum plus the base rate (as defined in Section 247 of the German
Civil Code (BGB)) per annum prevailing from time to time, as reduced by any
guaranteed dividend payments. The Mandatory Offer required pursuant to Section
305(1) of the German Stock Corporation Act is not a voluntary public takeover
offer or any other offer under the German Securities Acquisition and Takeover
Act (Wertpapiererwerbs-und Uebernahmegesetz) or a takeover or tender offer under
any other applicable German law. However, it may be considered a tender offer
under applicable laws of the United States of America. Therefore, in order to
comply with applicable U.S. securities laws, Celanese Europe Holding commenced
an offer on September 2, 2004, which will continue as long as Celanese remains a
defendant in the minority shareholder award proceedings (Spruchverfahren) as
described in Item 8. Financial Information - Legal Proceedings, in which case
the offer will remain open for two months following final resolution of the
award proceedings by the German courts. The terms of this offer are set forth in
the offer document, dated September 2, 2004, which was filed with the Commission
under cover of Schedule TO on the same day. Both the (euro)41.92 per share fair
cash compensation, plus interest offered to minority shareholders under the
Domination Agreement (the "Mandatory Offer") and the increased offer of (euro)51
per share pursuant to the limited offer which commenced on August 30, 2005 and
expired September 29, 2005 (the "Limited Offer") (see Subsequent Purchases of
CAG Shares below) are greater than the Tender Offer price. The amount of fair
cash compensation is currently under review in special award proceedings
(Spruchverfahren) as described in Item 8. Financial Information - Legal
Proceedings. As a result of the special award proceedings, the amount of the
fair cash compensation and the guaranteed fixed annual payment offered under the
Domination Agreement could be increased by the court so that all minority
shareholders, including those who have already tendered their shares into the
Mandatory Offer of (euro)41.92 (but not those who accepted the Limited Offer),
and have received their fair cash compensation, could claim higher amounts.

     Any minority shareholder who elects not to sell shares to Celanese Europe
Holding will be entitled to remain a shareholder of Celanese and to receive a
gross guaranteed fixed annual payment on such shares (Ausgleich) of (euro)3.27
per Celanese ordinary share less certain corporate taxes in lieu of any future
dividend. Taking into account the circumstances and the tax rates at the time of
entering into the Domination Agreement, the net guaranteed fixed annual payment
is (euro)2.89 per share for a full fiscal year. The net guaranteed fixed annual
payment may, depending on applicable corporate tax rates, in the future be
higher, lower or the same as (euro)2.89 in lieu of any future dividends,
determined as described below under - "Determination of the Amount to be Paid to
Minority Shareholders."

     If the Domination Agreement ceases to be operative, Celanese Europe Holding
cannot directly give instructions to the Celanese board of management. However,
irrespective of whether a domination agreement is in place between Celanese
Europe Holding and Celanese, under German law Celanese is effectively controlled
by Celanese Europe Holding because of its 98 percent ownership of all
outstanding CAG Shares. Celanese Europe Holding has the ability, through a
variety of means, to utilize its controlling rights to, among other things, (1)
ultimately cause a domination agreement to become operative; (2) use its
ability, through its approximate 98 percent voting power at any shareholders'
meetings of Celanese, to elect the shareholder representatives on the
supervisory board and to thereby effectively control the appointment and removal
of the members of the Celanese board of management; and (3) effect all decisions
that a majority shareholder is permitted to make under German law.

     Change in Fiscal Year. At the extraordinary general meeting on July 30 -
31, 2004, Celanese shareholders also approved a change of Celanese's fiscal year
and a corresponding change of Celanese's articles of association in order to
take advantage of the consolidated tax filing status. This resolution was
confirmed at the annual general meeting held on May 19-20, 2005. Therefore,
since September 30, 2004, Celanese's fiscal year begins on October 1 and ends on
September 30 of the following year. A short fiscal year ran from January 1, 2004
to September 30, 2004.

     Subsequent Purchases of CAG Shares. Celanese Europe Holding may from time
to time purchase or be required to purchase any or all of the outstanding CAG
Shares not owned by it in market transactions or otherwise. On August 24, 2005,
the Purchaser acquired 5.9 million, or approximately 12 percent, of the
outstanding CAG Shares from two shareholders for the aggregate consideration of
(euro)302 million. In addition, the


                                       14



Purchaser also paid to such shareholders an additional purchase price of
(euro)12 million in consideration for the settlement of certain claims and for
such shareholders agreeing to, among other things, (1) accept the shareholders'
resolutions passed at the extraordinary general meeting of Celanese held on July
30 and 31, 2004 and the annual general meeting of Celanese held on May 19 and
20, 2005, (2) acknowledge the legal effectiveness of the domination and profit
and loss transfer agreement, (3) irrevocably withdraw and abandon all actions,
applications and appeals each brought or joined in legal proceedings related to,
among other things, challenging the effectiveness of the domination and profit
and loss transfer agreement, and amount of fair cash compensation offered by the
Purchaser in the Mandatory Offer required by Section 305(1) of the German Stock
Corporation Act, (4) refrain from acquiring any CAG Shares or any other
investment in Celanese, and (5) refrain from taking any future legal action with
respect to shareholder resolutions or corporate actions of Celanese. The
Purchaser paid the aggregate consideration of (euro)314 million ($384 million)
for the additional CAG Shares that were acquired from such shareholders and for
the agreements described above using available cash. The Purchaser also made all
other shareholders a Limited Offer pursuant to which it increased for a limited
period of time its offer to purchase any remaining outstanding CAG Shares to
(euro)51 per share (plus interest on (euro)41.92 per share) for all minority
shareholders against waiver of the shareholders' rights to participate in an
increase of the offer consideration as a result of the pending award
proceedings. In addition, all shareholders who tendered their shares pursuant to
the Mandatory Offer of (euro)41.92 per share commenced in September 2004, were
entitled to claim the difference between the increased offer of (euro)51 per
share and the Mandatory Offer of (euro)41.92 per share. The Limited Offer
commenced on August 30, 2005 and ended on September 29, 2005. Celanese Europe
Holding acquired an additonal 1,789,023 ordinary shares pursuant to the Limited
Offer. For minority shareholders who did not accept the Limited Offer on or
prior to the September 29, 2005 expiration date, the terms of the original
(euro)41.92 per share Mandatory Offer continued to apply. The Mandatory Offer
will remain open for two months following final resolution of the award
proceedings (Spruchverfahren) by the German courts.

     The ongoing Mandatory Offer of (euro)41.92 relating to the Domination
Agreement, or the mandatory fair cash compensation that has to be paid in
connection with a Squeeze Out, as described below, are examples of instances in
which Celanese Europe Holding may be required to purchase additional shares. As
of March 15, 2006, Celanese Europe Holding had acquired an additional 1,933,385
shares pursuant to the Mandatory Offer of (euro)41.92 (including the 1,789,023
shares purchased pursuant to the Limited Offer). On March 15, 2006, the closing
price of the CAG Shares on the Frankfurt Stock Exchange was (euro)68.85 per
share.

     Squeeze-Out. Because Celanese Europe Holding owns shares representing more
than 95 percent of the registered ordinary share capital (excluding treasury
shares) of Celanese, Celanese Corporation caused Celanese Europe Holding to
require, as permitted under German law, the transfer to Celanese Europe Holding
of the shares owned by the then-outstanding minority shareholders of Celanese in
exchange for fair cash compensation (the "Squeeze-Out") determined as described
below under - "Determination of the Amount to be Paid to Minority Shareholders."
The Squeeze-Out will require the approval by the affirmative vote of the
majority of the votes cast at Celanese's annual general meeting in May 2006 and
will become effective upon its registration in the commercial register. If
Celanese Europe Holding effects the Squeeze-Out, Celanese Europe Holding must
pay the then remaining minority shareholders of Celanese fair cash compensation,
as described below, in exchange for their shares. Celanese Europe Holding has
set the fair cash compensation at (euro)62.22 per share. If the Squeeze-Out is
effected, Celanese would cease to be a public company.

     Determination of the Amount to be Paid to the Minority Shareholders. The
amounts to be paid to the minority shareholders as fair cash compensation in
exchange for their CAG Shares in connection with the Domination Agreement
becoming operative, and the Squeeze-Out being executed have each been determined
on the basis of the fair value of the enterprise of Celanese, determined by
Celanese and/or Celanese Europe Holding in accordance with applicable German
legal requirements, as of the date of the applicable resolution of Celanese's
shareholders' meeting, and examined by a duly qualified auditor chosen and
appointed by the Frankfurt District Court (Landgericht). The amount of the
guaranteed fixed annual payment in connection with the Domination Agreement
becoming effective to minority shareholders who elect not to sell their CAG
Shares to Celanese Europe Holding but to remain a shareholder of Celanese was
determined by Celanese Europe Holding and Celanese in accordance with applicable
German law, on the basis of the hypothetical projected earnings of Celanese
assuming a full distribution of profits. The gross guaranteed fixed


                                       15



annual payment of (euro)3.27 per share (less certain corporate taxes) may be
equal to, higher or lower than the actual otherwise distributable profits per
share of Celanese. The (euro)41.92 per share fair cash compensation, plus
interest, offered to minority shareholders in connection with the Domination
Agreement, the (euro)51 per share previously offered to minority shareholders
pursuant to the Limited Offer, and the (euro)62.22 per share that Celanese
Europe Holdings set as the cash compensation to be offered in the Squeeze-Out
are all greater than the Tender Offer price. Furthermore, each of the guaranteed
fixed annual payment and the fair cash compensation offered pursuant to the
Domination Agreement is subject to review by the court in award proceedings
(Spruchverfahren) pending in the German courts. If, as a result of such award
proceedings, the court increases the amount of the guaranteed fixed annual
payment and/or the fair cash compensation, or if such increase is agreed between
the parties in a court settlement, payments already made to minority
shareholders pursuant to the offer required by the Domination Agreement would
have to be increased accordingly with retroactive effect, with the exception of
payments made to shareholders who accepted the Limited Offer.

     The Squeeze-Out will require approval by the shareholders of Celanese.
While it is to be expected that Celanese Europe Holding will have the requisite
majority in such meeting to assure approval of such measure, minority
shareholders, irrespective of the size of their shareholding, may, within one
month from the date of any such shareholder resolution, file an action with the
court to have such resolution set aside. While such action would only be
successful if the resolution were passed in violation of applicable laws and
cannot be based on the unfairness of the amount to be paid to the minority
shareholders, a shareholder action may substantially delay the implementation of
the challenged shareholder resolution pending final resolution of the action. If
such action proved to be successful, the action could prevent the implementation
of the Squeeze-Out. Accordingly, there can be no assurance that the Squeeze-Out
can be implemented timely or at all.

The Restructuring

     In October 2004, Celanese Europe Holding completed an organizational
restructuring (the "Restructuring"). As a part of the Restructuring, Celanese
Europe Holding instructed Celanese AG to transfer all of the shares of Celanese
Americas Corporation or CAC from Celanese Holding GmbH, a wholly owned
subsidiary of Celanese, ultimately to BCP Caylux. Consequently, substantially
all of Celanese's North American assets, including significant portions of its
Chemical Products and Technical Products Ticona segments, as well as its entire
Acetate Products segment, including that segment's European and Asian assets,
were transferred out of Celanese AG. In addition, CPO Celanese
Aktiengesellschaft & Co. Procurement Olefin KG, Frankfurt am Main ("CPO"), a
wholly-owned subsidiary of Celanese AG, which acts as a purchasing entity on
behalf of Celanese as well as for third parties, was transferred to Celanese
Holding Europe. Thereafter, BCP Caylux transferred certain assets, including its
equity ownership interest in CAC, to BCP Crystal.

     As a result of these transactions, BCP Crystal holds 100 percent of CAC's
equity and, indirectly, all equity owned by CAC in its subsidiaries. In
addition, BCP Crystal holds, indirectly, all of the CAG Shares held by Celanese
Europe Holding. Celanese now serves primarily as the holding company for the
European business and certain Asian businesses.

INTRODUCTION

     Celanese AG was incorporated as Diogenes Erste Vermoegensverwaltungs GmbH
as a stock corporation organized under the German Stock Corporation Act
(Aktiengesetz) on November 22, 1996. It changed its name to Celanese AG upon its
demerger from Hoechst on October 22, 1999. Celanese's registered office is
located at Frankfurter Strasse 111, 61476 Kronberg/Taunus, Germany, telephone
+49 69 305 16000.

BUSINESS SUMMARY

     Celanese is an integrated global industrial chemicals company with strong
competitive positions in its major products and production technologies. Its
business involves processing chemical raw materials, such as ethylene and
propylene, and natural products, including natural gas, into value-added
chemicals and chemical-based products. Celanese's leadership position is based
on two key factors: its significant market shares and competitive cost
structures in its major products. Celanese's competitive cost structures are
based on economies of scale, vertical integration, technical know-how and the
use of advanced technologies. The Celanese portfolio consists of three main
business segments: Chemical Products, Technical Polymers Ticona and Performance
Products. Celanese's entire Acetate Products segment, along with significant
portions of the Chemical Products and


                                       16



Technical Polymers Ticona segments were transferred out of Celanese on October
5, 2004 as part of the Restructuring. See Item 4. Information on the Company -
Acquisition of Celanese.

     For the period from August 25, 2005 to September 30, 2005 and the period
from October 1, 2004 to August 24, 2005, Celanese had net sales of (euro)238
million and (euro)1,972 million, respectively, and operating profit (loss) of
(euro)(2) million and (euro)256 million, respectively. At September 30, 2005,
Celanese had approximately 3,550 employees worldwide. As of September 30, 2005,
Celanese had ten production plants and three research centers in six countries,
including significant ventures. For the period from August 25, 2005 to September
30, 2005 and the period from October 1, 2004 to August 24, 2005, 2 percent and 2
percent of net sales were derived from sales in North America, 67 percent and 50
percent from sales in Europe, 30 percent and 47 percent from sales in Asia and
Australia and 1 percent and 1 percent from sales in the rest of the world,
respectively. Celanese has a large and diverse global customer base consisting
principally of major industrial companies.

     Celanese's aggregate capital expenditures for property, plant and equipment
were (euro)8 million, (euro)68 million, (euro)42 million and (euro)87 million
for the period from August 25, 2005 to September 30, 2005, the period from
October 1, 2004 to August 24, 2005, the nine months ended September 30, 2004 and
for the year ended December 31, 2003. The capital expenditures were financed by
means of Celanese's operating cash flows, cash reserves and additional funds
drawn down from existing credit facilities. See also "Business Segments" for
capital expenditures by business segment. For a description of principal
acquisitions and dispositions of businesses during the last three years, see
"Acquisitions and Divestitures" below, Item 5. Operating and Financial Review
and Prospects - Summary of Consolidated Results - Twelve Months Ended September
30, 2005 Compared to Twelvee Months Ended September 30, 2004 - Discontinued
Operations, and Note 8 to the Consolidated Financial Statements.

     As of September 30, 2005, Celanese had 50,365,018 shares outstanding and
approximately 8,100 shareholders. Its ordinary shares are traded on the
Frankfurt Stock Exchange under the symbol CZZ.

SEGMENT OVERVIEW

     Subsequent to the Restructuring and for the year ended September 30, 2005,
Celanese operated through three principal business segments: Chemical Products,
Technical Polymers Ticona, and Performance Products.

     Chemical Products. This segment produces and supplies acetyl products,
including acetic acid, acetate esters, vinyl acetate monomer, polyvinyl alcohol
and emulsions. These products are generally used as building blocks for
value-added products or in intermediate chemicals used in the paints, coatings,
inks, adhesives, films, textiles and building products industries. Celanese,
together with its affiliates, is a leading global producer of acetic acid.

     Technical Polymers Ticona. This segment develops, produces and supplies a
broad portfolio of high performance technical polymers for application in
automotive and electronics products and in other consumer and industrial
applications, often replacing metal or glass. The primary products within the
Ticona segment are Hostaform polyacetal or POM offerings, and GUR, an
ultra-high molecular weight polyethylene. Hostaform is used in a broad range of
products including automotive components, electronics and appliances. GUR is
used in battery separators, conveyor belts, filtration equipment, coatings and
medical devices.

     Performance Products. This segment operates under the trade name of
Nutrinova and produces and sells Sunett(R) high intensity sweetener and food
protection ingredients, such as sorbates, for the food, beverage and
pharmaceuticals industries.

     The table below illustrates each segment's share of total segment net sales
to external customers for the period from August 25, 2005 to September 30, 2005,
the period from October 1, 2004 to August 24, 2005, the nine months ended
September 30, 2004 and for the year ended December 31, 2003.


                                       17



                   NET SALES TO EXTERNAL CUSTOMERS BY SEGMENT



                               PERIOD FROM AUGUST 25,   PERIOD FROM OCTOBER 1,
                                       2005 TO                  2004 TO               NINE MONTHS            YEAR ENDED
                                 SEPTEMBER 30, 2005         AUGUST 24, 2005      ENDED SEPTEMBER 2004    DECEMBER 31, 2003
                               ----------------------   ----------------------   --------------------   -------------------
                                             % OF                     % OF                    % OF                  % OF
                                 (EURO)   SEGMENT(1)      (EURO)   SEGMENT(1)     (EURO)   SEGMENT(1)   (EURO)   SEGMENT(1)
                                 ------   ----------      ------   ----------     ------   ----------   ------   ----------
                                                              (IN MILLIONS, EXCEPT PERCENTAGES)

Chemical Products...........       175        75%          1,462      76%          1,066       72%       1,444       74%
Technical Polymers Ticona...        43        18%            340      18%            299       20%         365       19%
Performance Products........        16         7%            126       6%            111        8%         150        7%


----------
(1)  The percentages in this column represent the percentage contribution of
     each segment to the total of all segments.

OTHER ACTIVITIES

     The portfolio of Celanese contains other businesses and activities separate
from its principal chemical operations, which consists primarily of general
corporate functions, its interest in Pemeas GmbH or Pemeas, companies that
provide infrastructure services, and other ancillary businesses. Pemeas is a
venture with a consortium of investors led by Conduit Ventures, a London based
venture capital company, to develop high temperature membrane assemblies or MEAs
for fuel cells. Celanese contributed its MEA activity to Pemeas in April 2004.
On December 28, 2005, Celanese sold its common stock interest to Pemeas
Corporation.

STRATEGY

     As a dominated company, Celanese will implement the strategy of Celanese
Corporation by focusing on operating cash flows, profitability, return on
investment and shareholder value. It is believed that these goals can be
achieved through the following business strategies:

     o    Maintain Cost Advantage and Productivity Leadership. Celanese
          continually seeks to reduce its production and raw material costs,
          using six sigma and other cost management tools. The Kelsterbach site
          achieved more than a (euro)2 million reduction in combined
          maintenance, turnaround, and other period costs. The Oberhausen site
          achieved a reduction in raw material and catalyst costs of over
          (euro)6 million. In addition, given current sold-out market
          conditions, there is significant focus on increasing manufacturing
          capacities with little or no capital. The Frankfurt site generated
          approximately (euro)5 million of additional revenue by successfully
          debottlenecking several units.

     o    Focused Business Investment. Celanese intends to continue investing
          strategically in growth areas, including new production capacity, to
          extend its global market leadership position. Historically, Celanese's
          strong market position has enabled it to initiate capacity growth to
          take advantage of projected demand growth. Celanese increased the
          capacity of its GUR ultra-high molecular weight polyethylene plant in
          Germany by one-third to 10,000 tons per year in the third calendar
          quarter of 2004. Celanese expects to continue to benefit from its
          investments and capacity expansion that enables it to meet increases
          in global demand.

     o    Maximize Cash Flow and Reduce Debt. Despite a difficult operating
          environment over the past several years, Celanese has generated a
          significant amount of operating cash flow. Celanese believes there are
          opportunities to further improve its operating cash flow through
          increasing productivity, receiving cash dividends from its ventures
          and pursuing additional cost reduction efforts. Celanese believes in a
          focused capital expenditure plan that is dedicated to attractive
          investment projects.

     o    Deliver Value-Added Solutions. Celanese continually develops new
          products and industry leading production technologies that solve its
          customers' problems. For example, Ticona has worked closely with fuel
          system suppliers to develop an acetal copolymer with the chemical and
          impact resistance necessary to withstand exposure to hot diesel fuels.
          Celanese's emulsions business pioneered a technological solution that
          leads the industry in product offerings for ecologically friendly
          emulsions for solvent-free


                                       18



          interior paints. Celanese believes that its customers value its
          expertise, and it will continue to work with them to enhance the
          quality of their products.

     o    Enhance Value of Portfolio. Celanese will continue to further optimize
          its business portfolio through divestitures, acquisitions and
          strategic investments that enable it to focus on businesses in which
          it can achieve market, cost and technology leadership over the long
          term. In addition, Celanese intends to continue to expand its product
          mix into higher value-added products. Celanese also divested non-core
          businesses, such as acrylates, which was sold to Dow in February 2004.

BUSINESS SEGMENTS

Chemical Products

     The Chemical Products segment consists of six business lines: Acetyls,
Acetyl Derivatives and Polyols, Polyvinyl Alcohol, Emulsions, Specialties, and
other chemical activities. All business lines in this segment mainly conduct
business using the "Celanese" trade name, except Polyvinyl Alcohol, which uses
the trademark Celvol(R), and Emulsions, which uses the trademarks Mowilith(R)
and Celvolit(R). The following table lists key products and their major end use
markets.

--------------------------------------------------------------------------------
KEY CHEMICAL PRODUCTS   MAJOR END USE MARKETS
--------------------------------------------------------------------------------
Acetic Acid             Vinyl Acetate Monomer, Acetic Anhydride and Purified
                        Terephthalic Acid or PTA, an intermediate used in the
                        production of polyester resins, films and fibers
--------------------------------------------------------------------------------
Acetic Anhydride        Cellulose Acetate and Pharmaceuticals
--------------------------------------------------------------------------------
Vinyl Acetate Monomer   Paints, Adhesives, Paper Coatings, Films and Textiles
--------------------------------------------------------------------------------
Acetate Esters          Coatings, Inks
--------------------------------------------------------------------------------
Oxo Alcohols            Plasticizers, Acrylates, Esters, Solvents and Inks
--------------------------------------------------------------------------------
Polyvinyl Alcohol       Adhesives, Building Products, Paper Coatings, Films and
                        Textiles
--------------------------------------------------------------------------------
Emulsions               Water-Based Quality Surface Coatings, Adhesives,
                        Non-Woven Textiles
--------------------------------------------------------------------------------
Carboxylic Acids        Lubricants, Detergents and Specialties
--------------------------------------------------------------------------------
Amines                  Agricultural Products and Water Treatments
--------------------------------------------------------------------------------

     Business Lines

     Acetyls. During the periods presented, the acetyls business line produced:

          o    Acetic acid, used to manufacture vinyl acetate monomer and other
               acetyl derivatives. Celanese manufactures acetic acid for its own
               use, as well as for sale to third parties, including producers of
               purified terephthalic acid, or PTA, and to other participants in
               the acetyl derivatives business.

          o    Vinyl acetate monomer, used in a variety of adhesives, paints,
               films, coatings and textiles. Celanese manufactures vinyl acetate
               monomer for its own use, as well as for sale to third parties.

          o    Acetaldehyde, a major feedstock for the production of polyols.
               Acetaldehyde is also used in other organic compounds such as
               pyridines, which are used in agricultural products.

     The manufacturing operations for acetic anhydride were transferred out of
Celanese as part of the Restructuring, but Celanese still purchases this product
from its U.S. affiliates and resells it in Europe and Asia.


                                       19



     Celanese, together with its subsidiaries and affiliates, is a leading
global producer of acetic acid and the world's leading producer of vinyl acetate
monomer according to the Tecnon Orbichem's Acetic Acid and Vinyl Acetate
1999-2009 World Survey.

     Acetic acid and vinyl acetate monomer, like other commodity products, are
characterized by cyclicality in pricing. The principal raw materials in these
products are natural gas and ethylene, which are purchased from numerous
sources; carbon monoxide, which is purchased by Celanese under long-term
contracts; methanol, which Celanese purchases from affiliates and third parties
under short-term contracts; and butane, which is purchased from one supplier.
All these raw materials, except carbon monoxide, are themselves commodities and
are available from a wide variety of sources.

     Celanese's production of acetyl products employs leading proprietary and
licensed technologies, including Celanese's proprietary AO Plus(TM)
acid-optimization technology for the production of acetic acid and VAntage(TM)
vinyl acetate monomer technology. AO Plus enables plant capacity to be increased
with minimal investment, while VAntage enables significant increases in
production efficiencies, lower operating costs and increases in capacity at 10
to 15 percent of the cost of building a new plant.

     Acetyl Derivatives and Polyols. The acetyl derivatives and polyols business
line produces a variety of solvents, polyols, and other chemicals, which in turn
are used in the manufacture of paints, coatings, adhesives and other products.

     Many acetyl derivatives products are derived from Celanese's production of
acetic acid and oxo alcohols. Primary products are:

     o    Ethyl acetate, an acetate ester that is a solvent used in coatings,
          inks and adhesives and in the manufacture of photographic films and
          coated papers;

     o    Butyl acetate, an acetate ester that is a solvent used in inks,
          pharmaceuticals and perfume;

     o    Propyl acetate, an acetate ester that is a solvent used in inks,
          lacquers and plastics;

     o    Methyl ethyl ketone, a solvent used in the production of printing inks
          and magnetic tapes;

     o    Formic acid, an organic acid used in textile dyeing and leather
          tanning.

     Polyols are derivatives of methanol and are made up of the following
     products:

     o    Polyol products such as neopentyl glycol, used in powder coatings.

     Oxo alcohols and intermediates are produced from propylene and ethylene and
     include:

     o    Butanol, used as a solvent for lacquers, dopes and thinners, and as an
          intermediate in the manufacture of chemicals, such as butyl acrylate;

     o    Propanol, used as an intermediate in the production of amines for
          agricultural chemicals, and as a solvent for inks, resins,
          insecticides and waxes;

     o    Synthesis gas, used as an intermediate in the production of oxo
          alcohols and specialties.

     Oxo alcohols are produced by European Oxo GmbH, Celanese's non-consolidated
European oxo chemicals venture with Degussa AG. European Oxo GmbH began
operations in October 2003.

     The manufacturing operations for the acetyl derivatives propyl acetate,
methyl ethyl ketone and formic acid, and the polyols pentaerythritol and 1,3
butylene glycol were transferred out of Celanese as part of the Restructuring,
but Celanese still purchases this product from its U.S. affiliates and resells
it in Europe and Asia.

     Acetyl derivatives and polyols are commodity products characterized by
cyclicality in pricing. The principal raw materials used in the acetyl
derivatives business line are acetic acid, various alcohols, methanol,
acetaldehyde, propylene, ethylene and synthesis gas. Celanese manufactures many
of these raw materials for its own use as well as for sales to third parties,
including its competitors in the acetyl derivatives business. Celanese purchases
propylene and ethylene from a variety of sources. Celanese manufactures
acetaldehyde for its European production. Acetaldehyde is also available from
other sources.


                                       20



     Polyvinyl Alcohol. Polyvinyl alcohol, or PVOH, is a performance chemical
engineered to satisfy particular customer requirements. It is used in adhesives,
building products, paper coatings, films and textiles. The primary raw material
to produce polyvinyl alcohol is vinyl acetate monomer, while acetic acid is
produced as a by-product. Prices vary depending on industry segment and end use
application. Products are sold on a global basis, and competition is from all
regions of the world. Therefore, regional economies and supply and demand
balances affect the level of competition in other regions. Although the
manufacturing operations for polyvinyl alcohol, which are in the United States,
were transferred out of Celanese as part of the Restructuring, Celanese
purchases these products from its U.S. affiliates and resells them in Europe and
Asia. According to Stanford Research International's December 2003 report on
PVOH, Celanese Corporation is the largest North American producer of polyvinyl
alcohol and the third largest producer in the world.

     Emulsions. The products in Celanese's emulsions business are sold under the
Mowilith(R) and Celvolit(R) brands and include conventional emulsions and
high-pressure vinyl acetate ethylene emulsions. Emulsions are made from vinyl
acetate monomer, acrylate esters and styrene. Emulsions are a key component of
water-based quality surface coatings, adhesives, non-woven textiles and other
applications. In September 2005, Celanese sold its emulsion powders business to
National Starch and Chemical Company (NSC) and Elotex AG, both subsidiaries of
Imperial Chemical Industries PLC.

     Specialties. The specialties business line produces:

     o    Carboxylic acids such as pelargonic acid, used in detergents and
          synthetic lubricants, and heptanoic acid, used in plasticizers and
          synthetic lubricants;

     o    Amines such as methyl amines, used in agrochemicals, monoisopropynol
          amines, used in herbicides, and butyl amines, used in the treatment of
          rubber and in water treatment; and

     o    Oxo derivatives and special solvents, such as crotonaldehyde, which is
          used by the Performance Products segment for the production of
          sorbates, as well as raw materials for the fragrance and food
          ingredients industry.

     The prices for these products are relatively stable due to long-term
contracts with customers whose industries are not generally subject to the
cyclical trends of commodity chemicals.

     The primary raw materials for these products are olefins and ammonia, which
are purchased from world market suppliers based on international prices.

     In March 2002, Celanese formed Estech, a venture with Hatco Corporation, a
leading producer of synthetic lubricants, for the production and marketing of
neopolyol esters or NPEs. This venture, in which Celanese held a 51 percent
interest, built and operated a 7,000 metric ton per year NPE plant at Celanese's
Oberhausen, Germany site. Neopolyol esters are used as base stocks for synthetic
lubricants in refrigeration, automotive, aviation and industrial applications,
as well as in hydraulic fluids. In August 2005, Celanese and Hatco agreed to
wind up this venture. Celanese recorded an impairment charge of approximately
(euro)8 million related to this matter during the third quarter of fiscal year
2005. Estech stopped production and marketing activity during the first quarter
of fiscal year 2006. As of September 30, 2005, the Estech venture had a (euro)0
net book value. Celanese supplies Estech with carboxylic acids and polyols, the
main raw materials for producing NPEs.

     Facilities

     The Chemical Products segment has production sites in Singapore, Spain,
Sweden, Slovenia and Germany. The emulsions business line also has tolling
arrangements in France.

     Capital Expenditures

     The Chemical Products segment's capital expenditures were (euro)6 million,
(euro)44 million, (euro)22 million and (euro)51 million for the period from
August 25, 2005 to September 30, 2005, the period from October 1, 2004 to August
24, 2005, the nine months ended September 30, 2004 and the year ended December
31, 2003. The capital expenditures incurred during the last three years related
primarily to efficiency and safety improvement-related items associated with the
normal operations of the business, as well as spending for a new plant for
synthesis gas, an important raw material for the production of oxo alcohols and
specialties, at Celanese's Oberhausen site. The new plant, which supplies
European Oxo GmbH and Celanese, came on stream in the third quarter of 2003 and


                                       21



has improved reliability and reduced production costs. Capital expenditures in
2003 also included the integration of a company-wide SAP system.

     Markets

     The following table illustrates net sales by destination of the Chemical
Products segment by geographic region for the period from August 25, 2005 to
September 30, 2005, the period from October 1, 2004 to August 24, 2005, the nine
months ending September 30, 2004 and the year ended December 31, 2003.

       NET SALES TO EXTERNAL CUSTOMERS BY DESTINATION - CHEMICAL PRODUCTS



                    PERIOD FROM AUGUST 25,   PERIOD FROM OCTOBER 1,
                            2005 TO                2004 TO             NINE MONTHS ENDED       YEAR ENDED
                      SEPTEMBER 30, 2005        AUGUST 24, 2005       SEPTEMBER 30, 2004   DECEMBER 31, 2003
                    ----------------------   ----------------------   ------------------   -----------------
                                 % OF                     % OF                   % OF                 % OF
                       (EURO)   SEGMENT         (EURO)   SEGMENT       (EURO)   SEGMENT     (EURO)   SEGMENT
                       ------   -------         ------   -------       ------   -------     ------   -------
                                                (IN MILLIONS, EXCEPT PERCENTAGES)

North America....        --        0%              --       0%            --       0%           --      0%
Europe/Africa....       141       65%             959      66%           743      70%        1,027     71%
Asia/Australia...        60       34%             499      34%           320      30%          413     29%
Rest of World....         1        1%               4       0%             3       0%            4      0%


     The Chemical Products segment markets its products both directly to
customers and through distributors. It also utilizes a number of "e-channels",
including its website at www.chemvip.com, as well as system to system linking
through its industry portal, Elemica.

     In the acetyls business line, acetic acid and vinyl acetate monomer are
global businesses which have several large customers. Generally, Celanese
supplies these global customers under multi-year contracts. The customers of
acetic acid and vinyl acetate monomer produce polymers used in water-based
paints, adhesives, paper coatings, film modifiers and textiles. Celanese has
long-standing relationships with most of these customers.

     Polyvinyl alcohol is sold to a diverse group of regional and multinational
customers mainly under single year contracts. The customers of the polyvinyl
alcohol business line are primarily engaged in the production of adhesives,
paper, films, building products and textiles.

     Emulsions are sold to a diverse group of regional and multinational
customers. Customers for emulsions are manufacturers of water-based quality
surface coatings, adhesives and non-woven textiles.

     Acetyl derivatives and polyols are sold to a diverse group of regional and
multinational customers both under multi-year contracts and on the basis of
long-standing relationships. The customers of acetyl derivatives are primarily
engaged in the production of paints, coatings and adhesives. Polyols are sold
globally to a wide variety of customers, primarily in the coatings and resins
and the specialty products industries. Oxo products are sold to a wide variety
of customers, primarily in the construction and automotive industries. The oxo
market is characterized by oversupply and numerous competitors.

     The specialties business line primarily serves global markets in the
synthetic lubricant, agrochemical, rubber processing and other specialty
chemical areas. Much of the specialties business line involves "one customer,
one product" relationships, where the business develops customized products with
the customer, but the specialties business line also sells several chemicals
which are priced more like commodity chemicals.

     Competition

     Principal competitors of Celanese in the Chemical Products segment include
Air Products and Chemicals, Inc., Atofina S.A., BASF Aktiengesellschaft
("BASF"), Borden Chemical, Inc., BP p.l.c. ("BP"), Chang Chun Petrochemical Co.,
Ltd., Daicel, Dow, Eastman Chemical Corporation ("Eastman"), E. I. Du Pont de
Nemours and Company ("DuPont"), Lyondell Chemical Company ("Lyondell"), Nippon
Gohsei, Perstorp Inc., Rohm & Haas Company, Showa Denko K.K., and Kuraray Co.
Ltd.


                                       22



Technical Polymers Ticona

     Ticona develops, produces and supplies a broad portfolio of high
performance technical polymers. The following table lists key Ticona products,
their trademarks and their major markets.

--------------------------------------------------------------------------------
KEY TICONA PRODUCTS                       MAJOR MARKETS
--------------------------------------------------------------------------------
Hostaform(R), Amcel(R) (Polyacetals)      Automotive, Electronics, Consumer
                                          Products and Medical
--------------------------------------------------------------------------------
GUR(R)(Ultra High Molecular Weight        Profiles, Battery Separators,
Polyethylene or PE-UHMW)                  Industrial Specialties, Filtration,
                                          Coatings and Medical
--------------------------------------------------------------------------------
Celanex(R)/Vandar(R)/Riteflex(R)/Impet    Electrical, Electronics, Automotive
(R) (Polyester Engineering Resins)        and Appliances
--------------------------------------------------------------------------------
Vectra(R) (Liquid Crystal Polymers)       Electronics, Telecommunications,
                                          Consumer and Medical
--------------------------------------------------------------------------------
Fortron(R)* (Polyphenylene Sulfide or     Electronics, Automotive and Industrial
PPS)
--------------------------------------------------------------------------------
Celstran(R), Compel(R)(long fiber         Automotive and Industrial
reinforced thermoplastics)
--------------------------------------------------------------------------------
* Fortron is a registered trademark of Fortron Industries.

     Ticona's technical polymers have chemical and physical properties enabling
them, among other things, to withstand high temperatures, resist chemical
reactions with solvents and resist fracturing or stretching. These products are
used in a wide range of performance-demanding applications in the automotive and
electronics sectors and in other consumer and industrial goods, often replacing
metal or glass.

     Ticona is a business oriented to enable innovations for its customers while
closely working together with them for a new development. Ticona focuses its
efforts on developing new markets and applications for its product lines, often
developing custom formulations to satisfy the technical and processing
requirements of a customer's applications. For example, Ticona has worked
closely with fuel system suppliers to develop an acetal copolymer with the
chemical and impact resistance necessary to withstand exposure to hot diesel
fuels in the new generation of common rail diesel engines. The product can also
be used in automotive fuel sender units where it remains stable at the high
operating temperatures present in direct-injection diesel engines.

     Ticona's customer base consists primarily of a large number of plastic
molders and component suppliers, which are often the primary suppliers to
original equipment manufacturers, or OEMs. Ticona works with these molders and
component suppliers as well as directly with the OEMs to develop and improve
specialized applications and systems.

     Prices for most of these products, particularly specialized product grades
for targeted applications, generally reflect the value added in complex polymer
chemistry, precision formulation and compounding, and the extensive application
development services provided. The specialized product lines are not
particularly susceptible to cyclical swings in pricing. Polyacetals pricing,
mainly in standard grades, is, however, somewhat more price competitive, with
many minimum-service providers competing for volume sales.

     Business Lines

     Celanese sells polyacetals under the trademarks Hostaform(R) and Amcel(R)
in all regions but North America, where Celanese Corporation sells them under
the trademark Celcon(R). Polyplastics, in which Celanese Corporation holds a 45
percent ownership interest, and Korea Engineering Plastics, in which Celanese
holds a 50 percent ownership interest, are leading suppliers of polyacetals and
other engineering resins in the Asia/Pacific region. Polyacetal products are
used for mechanical parts, including door locks and seat belt mechanisms, in
automotive applications and in electrical, consumer and industrial applications
such as gears for appliances and medical applications such as drug delivery
systems.


                                       23



     The primary raw material for polyacetals is formaldehyde, which is
manufactured from methanol. Ticona manufactures formaldehyde from purchased
methanol.

     GUR(R), an ultra high molecular weight polyethylene or PE-UHMW, is an
engineered material used in heavy-duty automotive and industrial applications
such as car battery separator panels and industrial conveyor belts, as well as
in specialty medical and consumer applications, such as porous tips for marker
pens, sports equipment and prostheses. GUR Micro powder grades are used for high
performance filters, membranes, diagnostic devices, coatings and additives for
thermoplastics & elastomers. PE-UHMW fibers are also used in protective
ballistic applications. The basic raw material for GUR is ethylene.

     Celstran(R) and Compel(R) are long fiber reinforced thermoplastics, which
impart extra strength and stiffness, making them more suitable for larger parts
than conventional thermoplastics.

     Polyesters such as Celanex(R) polybutylene terephthalate, or PBT, and
Vandar(R), a series of PBT-polyester blends, are used in a wide variety of
automotive, electrical and consumer applications, including ignition system
parts, radiator grilles, electrical switches, appliance housings, boat fittings
and perfume bottle caps. Raw materials for polyesters vary. Base monomers, such
as dimethyl terephthalate or DMT and PTA, are widely available with pricing
dependent on broader polyester fiber and packaging resins market conditions.
Smaller volume specialty co-monomers for these products are typically supplied
by a few companies.

     Liquid crystal polymers, or LCPs, such as Vectra(R), are used in electrical
and electronics applications and for precision parts with thin walls and complex
shapes. Fortron, a polyphenylene sulphide, or PPS, product, is used in a wide
variety of automotive and other applications, especially those requiring heat
and/or chemical resistance, including fuel system parts, radiator pipes and
halogen lamp housings, and often replaces metal in these demanding applications.
Fortron is manufactured by Fortron Industries, Celanese Corporation's 50-50
venture with Kureha Corporation of Japan.

     The manufacturing operations for polyesters and LCPs, as well as Ticona's
interest in Fortron Industries, were transferred out of Celanese as part of the
Restructuring. However, Ticona still purchases polyesters and LCPs from its US
affiliates and resells them to customers in Europe. Ticona also has marketing
arrangements with Fortron Industries for the sale of PPS in Europe, whereby
Ticona sells the product for the account of Fortron Industries.

     Facilities

     Ticona has polymerization, compounding and research and technology centers
in Germany and Brazil. Ticona's Kelsterbach, Germany production site is located
in close proximity to the site being considered for a new runway under the
Frankfurt airport's expansion plans. The construction of this particular runway
could have a negative effect on the plant's current production capacity and
future development. While the state government of Hesse and the owner of the
airport promote the expansion of this option, it is uncertain whether this
option is in accordance with applicable laws. Although the government of the
state of Hesse expects the plan approval for the airport expansion in 2007 and
the start of operations in 2009-2010, neither the final outcome of this matter
nor its timing can be predicted at this time.

     Capital Expenditures

     Ticona's capital expenditures were (euro)2 million, (euro)19 million,
(euro)19 million and (euro)31 million for the period from August 25, 2005 to
September 30, 2005, the period from October 1, 2004 to August 24, 2005, the nine
months ended September 30, 2004 and the year ended December 31, 2003,
respectively. Ticona had expenditures in each of these three years relating
primarily to efficiency and safety improvement-related items associated with the
normal operations of the business. In 2004, Ticona completed its expansion of
its Oberhausen GUR PE-UHMW capacity by 10,000 metric tons per year. The capital
expenditures for 2003 also included the integration of a company-wide SAP
system.


                                       24



     Markets

     The following table illustrates the destination of the net sales of the
Technical Polymers Ticona segment by geographic region for the period from
August 25, 2005 to September 30, 2005, the period from October 1, 2004 to August
24, 2005, the nine months ended September 30, 2004 and the years ending December
31, 2003.

                NET SALES TO EXTERNAL CUSTOMERS BY DESTINATION -
                            TECHNICAL POLYMER TICONA



                    PERIOD FROM AUGUST 25,       PERIOD FROM
                     2005 TO SEPTEMBER 30,   OCTOBER 1, 2004 TO    NINE MONTHS ENDED       YEAR ENDED
                             2005              AUGUST 24, 2005    SEPTEMBER 30, 2004   DECEMBER 31, 2003
                    ----------------------   ------------------   ------------------   -----------------
                                  % OF                   % OF                 % OF                 % OF
                       (EURO)   SEGMENT       (EURO)   SEGMENT     (EURO)   SEGMENT     (EURO)   SEGMENT
                       ------   -------       ------   -------     ------   -------     ------   -------
                                              (IN MILLIONS, EXCEPT PERCENTAGES)

North America....        --        0%            --       0%          --       0%          --       0%
Europe/Africa....        41       95%           323      95%         286      96%         349      96%
Asia/Australia...        --        0%            --       0%          --       0%          --       0%
Rest of World....         2        5%            17       5%          13       4%          16       4%


     Ticona's sales in the Asian market were made mainly through its venture,
Korea Engineering Plastics, which is accounted for under the equity method and
therefore not included in Ticona's consolidated net sales. If Ticona's portion
of the sales made by this venture were included in the chart above, the
percentage of sales sold in Asia/Australia would be substantially higher. A
number of Ticona's polyacetals customers, particularly in the appliance,
electrical components, toys and certain sections of the
electronics/telecommunications fields, have moved tooling and molding operations
to Asia, particularly southern China. To meet the expected increased demand in
this region, Celanese Corporation, along with Polyplastics, Mitsubishi Gas
Chemical Company Inc., and Korea Engineering Plastics agreed on a venture to
construct and operate a world-scale 60,000 metric ton polyacetals facility in
China. Work on the new facility commenced in July 2003, and the new plant
started operations during 2005. Celanese Corporation indirectly owns
approximately 38 percent of this venture, of which Celanese indirectly holds
approximately 6 percent.

     Ticona's principal customers are suppliers to the automotive industries as
well as industrial suppliers. These customers primarily produce engineered
products, and Ticona works closely with its customers to assist them to develop
and improve specialized applications and systems. Ticona has long-standing
relationships with most of its major customers, but it also uses distributors
for most of its major products, as well as a number of electronic channels, such
as its BuyTiconaDirect(TM) on-line ordering system, and other electronic
marketplaces to reach a larger customer base. For most of Ticona's product
lines, contracts with customers typically have a term of one to two years. A
significant swing in the economic conditions of the end markets of Ticona's
principal customers could significantly affect the demand for Ticona's products.

     Competition

     Ticona's principal competitors include BASF, DuPont, General Electric
Company and Solvay S.A. Smaller regional competitors include Asahi Kasei
Corporation, DSM NV, Mitsubishi Plastics, Inc., Chevron Phillips Chemical
Company, L.P., Braskem S.A., Teijin Limited and Toray Industries Inc.

Performance Products

     The Performance Products segment consists of the food ingredients business
conducted by Nutrinova. This business uses its own trade names to conduct
business. The following table lists key products of the Performance Products
segment and their major markets.

--------------------------------------------------------------------------------
KEY PERFORMANCE PRODUCTS   MAJOR MARKETS
--------------------------------------------------------------------------------
Sunett(R) (Acesulfame-K)   Beverages, Confections, Dairy Products and
                           Pharmaceuticals
--------------------------------------------------------------------------------
Sorbates                   Dairy Products, Baked Goods, Beverages, Animal Feeds,
                           Spreads and Delicatessen Products
--------------------------------------------------------------------------------


                                       25



     Business Lines

     Nutrinova's food ingredients business consists of the production and sale
of high intensity sweeteners and food protection ingredients, such as sorbic
acids and sorbates worldwide, as well as the resale of other food ingredients
mainly in Japan, Australia and Mexico.

     Acesulfame-K, a high intensity sweetener marketed under the trademark
Sunett, is used in a variety of beverages, confections and dairy products
throughout the world. The primary raw materials for this product are diketene
and sulfur trioxide. Sunett pricing for targeted applications reflects the value
added by Nutrinova, such as technical services provided. Nutrinova's strategy is
to be the most reliable and highest quality producer of this product, to develop
new applications for the product and to expand into new markets. Nutrinova
maintains a strict patent enforcement strategy, which has resulted in favorable
outcomes in a number of patent infringement matters in Europe and the United
States. Nutrinova's European and U.S. primary production patents for making
Sunett expired at the end of the second quarter of fiscal year 2005; however
Nutrinova still has an extensive portfolio of process and application patents
for Sunett.

     Nutrinova's food protection ingredients are mainly used in foods, beverages
and personal care products. The primary raw materials for these products are
ketene and crotonaldehyde. Sorbates pricing is extremely sensitive to demand and
industry capacity and is not necessarily dependent on the prices of raw
materials.

     Facilities

     Nutrinova has production facilities in Germany, as well as sales and
distribution facilities in all major world markets.

     Capital Expenditures

     The Performance Products segment's capital expenditures were (euro)0
million, (euro)3 million, (euro)1 million and (euro)2 million for the period
from August 25, 2005 to September 30, 2005, the period from October 1, 2004 to
August 24, 2005, the nine months ended September 30, 2004 and the year ended
December 31, 2003, respectively.

     The capital expenditures incurred during these periods related to
efficiency, debottlenecking, quality and safety improvement items associated
with the normal operation of the business.

     Markets

     The following table illustrates the destination of the net sales of the
Performance Products segment by geographic region for the period from August 25,
2005 to September 30, 2005, the period from October 1, 2004 to August 24, 2005,
the nine months ended September 30, 2004 and the year ended December 31, 2003.

      NET SALES TO EXTERNAL CUSTOMERS BY DESTINATION - PERFORMANCE PRODUCTS



   NET SALES TO
     EXTERNAL
   CUSTOMERS BY
  DESTINATION -     PERIOD FROM AUGUST 25,   PERIOD FROM OCTOBER
   PERFORMANCE       2005 TO SEPTEMBER 30,        1, 2004 TO        NINE MONTHS ENDED       YEAR ENDED
     PRODUCTS                2005              AUGUST 24, 2005     SEPTEMBER 30, 2004   DECEMBER 31, 2003
-----------------   ----------------------   -------------------   ------------------   -----------------
                                  % OF                    % OF                 % OF                 % OF
                       (EURO)   SEGMENT        (EURO)   SEGMENT     (EURO)   SEGMENT     (EURO)   SEGMENT
                       ------   -------        ------   -------     ------   -------     ------   -------
                                              (IN MILLIONS, EXCEPT PERCENTAGES)

North America....         2       13%            28       25%         26       25%         36       26%
Europe/Africa....        12       74%            69       62%         63       61%         85       61%
Asia/Australia...         2       13%            15       13%         14       14%         19       13%
Rest of World....        --        0%            --        0%         --        0%         --        0%


     Nutrinova directly markets Sunett(R) primarily to a limited number of large
multinational and regional customers in the beverage and food industry under
long-term and annual contracts. Nutrinova markets food protection ingredients
primarily through regional distributors to small and medium sized customers and
directly through regional sales offices to large multinational customers in the
food industry.


                                       26



     Competition

     The principal competitors for Nutrinova's Sunett sweetener are Holland
Sweetener Company, The Nutrasweet Company, Ajinomoto Co., Inc. and several
Chinese manufacturers. In sorbates, Nutrinova competes with Nantong AA, Daicel,
Yu Yao/Ningbo, Yancheng AmeriPac and other Chinese manufacturers of sorbates.

OTHER ACTIVITIES

     Other Activities includes revenues from Pemeas GmbH or Pemeas, as well as
corporate activities, several service companies and other ancillary businesses,
which do not have significant sales. Pemeas is a venture with a consortium of
investors led by Conduit Ventures, a London based venture capital company, to
develop high temperature membrane assemblies or MEAs for fuel cells. Celanese
contributed its MEA activity to Pemeas in April 2004. On December 28, 2005,
Celanese sold its common stock interest to Pemeas Corporation.

DIVESTITURES

     Celanese divested the following businesses:

          o    The following divestitures occurred in December 2005:

               o    Celanese sold the omega-3 DHA business of Nutrinova
                    Nutrition Specialties and Food Ingredients GmbH to Lonza
                    Ltd., Switzerland.

               o    Celanese sold its common stock interest in Pemeas GmbH to
                    Pemeas Corporation.

               o    Celanese sold its cyclo-olefin co-polymers ("COC") business
                    to a venture between Daicel and Polyplastics

          o    In September 2005, Celanese sold its emulsion powders business to
               National Starch and Chemical Company and to Elotex AG, both
               subsidiaries of ICI.

          o    In August 2005, Celanese announced its intention to wind up
               Estech GmbH, its venture with Hatco Corporation for neopropyl
               esters.

          o    The following divestitures occurred in October 2004:

               o    Celanese sold its travel services company, OnBoard GmbH, to
                    Carlson Wagonlit Travel.

               o    Celanese transferred all of the shares of Celanese Americas
                    Corporation ultimately to BCP Crystal.

               o    Celanese transferred its purchasing entity, CPO Celanese
                    Aktiengesellschaft & Co. Procurement Olefin KG, Frankfurt am
                    Main ("CPO") to Celanese Holding Europe.

          o    In February 2004, Celanese sold its acrylates business to Dow.

          o    In December 2003, the Technical Polymers Ticona segment completed
               the sale of its nylon business line to BASF.

     For further information on the acquisitions and divestitures discussed
above, see Item 5. Operating and Financial Review and Prospects - Summary of
Consolidated Results - Twelve Months ended September 30, 2005 Compared with the
Twelve Months Ended September 30, 2004 - Discontinued Operations, and Note 8 to
the Consolidated Financial Statements.

RAW MATERIALS AND ENERGY

     Celanese purchases or leases a variety of raw materials from sources in
many countries for use in its production processes. Celanese has a policy of
maintaining, when available, multiple sources of supply for materials. However,
some of Celanese's individual plants may have single sources of supply for some
of their raw materials, such as carbon monoxide and acetaldehyde. Although
Celanese has been able to obtain sufficient supplies of raw materials, there can
be no assurance that unforeseen developments will not affect Celanese's raw
material supply. Even if Celanese has multiple sources of supply for a raw
material, there can be no assurance that these sources can make up for the loss
of a major supplier. Nor can there be any guarantee that profitability


                                       27



will not be affected should Celanese be required to qualify additional sources
of supply in the event of the loss of a sole supplier. In addition, the price of
raw materials varies, often substantially, from year to year.

     A substantial portion of Celanese's products and raw materials are
commodities whose prices fluctuate as market supply/demand fundamentals change.
For example, the volatility of prices for natural gas and ethylene (the cost of
which is in part linked to natural gas prices) has increased in recent years.
Celanese's production facilities rely largely on fuel oil, natural gas and
electricity for energy. Most of the raw materials for Celanese's European
operations are centrally purchased by an affiliate of Celanese, which also buys
raw materials on behalf of third parties. Celanese manages its exposure through
the use of long-term supply agreements, and multi-year purchasing and sales
agreements.

     Celanese also leases supplies of various precious metals, such as rhodium,
used as catalysts for use in the manufacture of products in its Chemical
Products segment. With growing demand for these precious metals, most notably in
the automotive industry, the cost to purchase or lease these precious metals has
increased, caused by a shortage in supply. These circumstances are expected to
continue into the second half of 2006. For precious metals, the leases are
distributed between a minimum of three lessors per product and are divided into
several contracts. A reassessment of the long term strategy regarding the lease
or purchase of precious metals, reflecting the changed market conditions for
some metals, is under way. Although Celanese seeks to offset increases in raw
material prices with corresponding increases in the prices of its products, it
may not be able to do so, and there may be periods when such product price
increases lag behind raw material cost increases.

RESEARCH AND DEVELOPMENT

     All of Celanese's businesses conduct research and development activities to
increase competitiveness. Celanese's Technical Polymers Ticona and Performance
Products segments in particular are innovation-oriented businesses that conduct
research and development activities to develop new, and optimize existing,
production technologies, as well as to develop commercially viable new products
and applications.

     The Chemical Products segment has been focusing on improving core
production technologies, such as improving catalyst development, and supporting
both debottlenecking and cost reduction efforts.

     In the Emulsions business line, research and development is focused on new
products, new applications and new technology platforms. In particular, an
emphasis is placed on continuously upgrading existing products, particularly in
the paints and coatings area. For example, research is done on developing
greater stability under various environmental conditions, thus allowing for use
in diverse regional climates and global coverage; furthermore, existing grades
are given additional performance features to meet customers' specific needs as
they are developing their new paint formulations. Celanese also concentrates on
new technology development, particularly for adhesives applications.

     Research in the Technical Polymers Ticona segment is focused on the
development of new formulations and applications for its products, improved
manufacturing processes and new polymer materials with varying chemical and
physical properties in order to meet customer needs and to generate growth. This
effort involves the entire value chain from new or improved monomer production,
polymerization and compounding, to working closely with end-users to identify
new applications that can take advantage of these high performance features.
Ticona is continually improving compounding recipes to extend product properties
and grades, while offering grade consistency on a global basis. In addition,
Ticona is developing new polymerization and manufacturing technology in order to
meet economic and ecological goals without sacrificing high quality processing.

     The research and development activities of the Performance Products segment
are conducted at Nutrinova's Frankfurt, Germany location. They are directed
towards expanding its existing technologies and developing new applications for
existing products in close cooperation with its customers.

     Research and development costs are included in expenses as incurred.
Celanese's research and development costs for the period from August 25, 2005 to
September 30, 2005, the period from October 1, 2004 to August 24, 2005, the nine
months ended September 30, 2004 and the year ended December 31, 2003 were
(euro)4 million, (euro)36 million, (euro)33 million and (euro)43 million,
respectively.


                                       28



INTELLECTUAL PROPERTY

     Celanese attaches great importance to patents, trademarks, copyrights and
product designs in order to protect its investment in research and development,
manufacturing and marketing. Celanese's policy is to seek the widest possible
protection for significant product and process developments in its major
markets. Patents may cover products, processes, intermediate products and
product uses. Protection for individual products extends for varying periods in
accordance with the date of patent application filing and the legal life of
patents in the various countries. The protection afforded, which may also vary
from country to country, depends upon the type of patent and its scope of
coverage.

     In most industrial countries, patent protection exists for new substances
and formulations, as well as for unique applications and production processes.
However, Celanese does business in regions of the world where intellectual
property protection may be limited and difficult to enforce. Celanese maintains
strict information security policies and procedures wherever it does business.
Such information security policies and procedures include data encryption,
controls over the disclosure and safekeeping of confidential information, as
well as employee awareness training. Moreover, Celanese monitors its competitors
and vigorously challenges patent and trademark infringement.

     As patents expire, the products and processes described and claimed in
those patents become generally available for use by the public. Celanese's
European and U.S. patents for making Sunett, an important product in the
Performance Products segment, expired at the end of the second quarter of fiscal
year 2005, thereby reducing Celanese's ability to realize revenues from making
Sunett due to increased competition and potential limitations, and possibly
causing results of operations and cash flows relating to the product being less
favorable than today. Celanese believes that the loss of no other single patent
which may expire in the next several years will materially adversely affect the
business or financial results of Celanese.

     Celanese also seeks to register trademarks extensively as a means of
protecting the brand names of its products, which brand names become more
important once the corresponding patents have expired. Celanese protects its
trademarks vigorously against infringement and also seeks to register design
protection where appropriate.

ENVIRONMENTAL AND OTHER REGULATION

     Obtaining, producing and distributing many of Celanese's products involves
the use, storage, transportation and disposal of toxic and hazardous materials.
Celanese is subject to extensive, evolving and increasingly stringent national
and local environmental laws and regulations, which address, among other things,
the following:

     o    Emissions to the air;

     o    Discharges to surface and subsurface waters;

     o    Other releases into the environment;

     o    Generation, handling, storage, transportation, treatment and disposal
          of waste materials;

     o    Maintenance of safe conditions in the workplace; and

     o    Production, handling, labeling or use of chemicals used or produced by
          Celanese.

     Celanese is subject to environmental laws and regulations that may require
it to remove or mitigate the effects of the disposal or release of chemical
substances at various sites. Under some of these laws and regulations, a current
or previous owner or operator of property may be held liable for the costs of
removal or remediation of hazardous substances on, under, or in its property,
without regard to whether the owner or operator knew of, or caused the presence
of the contaminants, and regardless of whether the practices that resulted in
the contamination were legal at the time they occurred. As many of Celanese's
production sites have an extended history of industrial use, it is impossible to
predict precisely what effect these laws and regulations will have on Celanese
in the future. Soil and groundwater contamination has occurred at some Celanese
sites, and might occur or be discovered at other sites. Celanese's worldwide
expenditures during the period from August 24, 2005 to September 30, 2005 and
the period from October 1, 2004 to August 24, 2005, including those with respect
to third party and divested sites, and those for compliance with environmental
control regulations and


                                       29



internal company initiatives totaled (euro)2 million and (euro)22 million,
respectively, of which (euro)0 million and (euro)1 million, respectively, was
for capital projects. It is anticipated that stringent environmental regulations
will continue to be imposed on Celanese and the industry in general. It is
difficult to estimate the future costs of environmental protection and
remediation because of many uncertainties, including uncertainties about the
status of laws, regulations, and information related to individual locations and
sites. Subject to the foregoing, but taking into consideration Celanese's
experience to date regarding environmental matters of a similar nature and facts
currently known, Celanese believes that capital expenditures and remedial
actions to comply with existing laws governing environmental protection will not
have a material adverse effect on its business and financial results.

Air Issues

     In December 1997, the Conference of the Parties of the United Nations
Framework Convention on Climate Change drafted the Kyoto Protocol, which would
establish significant emission reduction targets for six gases considered to
have global warming potential (referred to as greenhouse gases) and would drive
mandatory reductions in developed nations subject to the Protocol. With Russia's
ratification in November 2004, the Protocol was adopted by enough of the larger,
industrialized countries (defined in Annex I to the Protocol) and came into
effect in February 2005 in all nations that ratified it. The European Union or
EU, including Germany and other countries where Celanese has interests, ratified
the Kyoto Protocol in 2002 and has formulated applicable regulations. Recent
European Union regulations required all EU member states to have implemented a
trading system covering carbon dioxide emissions by January 1, 2005.
Accordingly, an emission trading system came into effect at the start of 2005.
The new regulation directly affects Celanese's power plants at the Kelsterbach
and Oberhausen sites as well as the power plants being operated by other
InfraServ entities on sites at which Celanese operates. The Celanese power
plants and the InfraServ entities may be required to purchase carbon dioxide
credits, which could result in increased operating costs, or may be required to
develop additional cost-effective methods to reduce carbon dioxide emissions
further, which could result in increased capital expenditures. Celanese has
determined that the impact of this legislation on future capital spending and
operating costs will not be material. The new regulation indirectly affects
Celanese's other operations in the EU, which may experience higher energy costs
from third party providers.

Chemical Products Issues

     Other new or revised regulations may place additional requirements on the
production, handling, labeling or use of some chemical products. Pursuant to a
European Union regulation on Risk Assessment of Existing Chemicals, the European
Chemicals Bureau of the European Commission has been conducting risk assessments
on approximately 140 major chemicals. Some of the chemicals initially being
evaluated include vinyl acetate monomer or VAM, which Celanese produces. These
risk assessments entail a multi-stage process to determine whether and to what
extent the Commission should classify the chemical as a carcinogen and, if so,
whether this classification, and related labeling requirements, should apply
only to finished products that contain specified threshold concentrations of a
particular chemical. In the case of VAM, we currently do not expect a final
ruling until fiscal year 2007. We and other VAM producers are participating in
this process with detailed scientific analyses supporting the industry's
position that VAM is a possible but not a probable human carcinogen and that
labeling end products as toxic substances should not be required, but if it is,
should only be at relatively high parts per million of residual VAM levels in
the end products. It is not possible for us to predict the outcome or effect of
any final ruling.

     Several recent studies have investigated possible links between
formaldehyde exposure and various medical conditions, including leukemia. The
International Agency for Research on Cancer or IARC recently reclassified
formaldehyde from Group 2A (probable human carcinogen) to Group 1 (known human
carcinogen) based on studies linking formaldehyde exposure to nasopharyngeal
cancer, a rare cancer in humans. IARC also concluded that there is insufficient
evidence for a causal association between leukemia and occupational exposure to
formaldehyde, although it also characterized evidence for such an association as
strong. The results of IARC's review will be examined by government agencies
with responsibility for setting worker and environmental exposure standards and
labeling requirements.

     We are a producer of plastics derived from formaldehyde, as well as of the
formaldehyde used in such plastics. We, together with other producers and users,
are evaluating these findings. We cannot predict the final effect of IARC's
reclassification.


                                       30



     Other recent initiatives will potentially require toxicological testing and
risk assessments of a wide variety of chemicals, including chemicals used or
produced by us. These initiatives include the European Environment and Health
Strategy, commonly known as SCALE, and the proposal for the Registration,
Evaluation and Authorization and Restriction of Chemicals or REACH. REACH, which
was proposed by the European Commission in October 2003, will establish a system
to register and evaluate chemicals manufactured or imported to the European
Union. Depending on the final ruling, additional testing, documentation and risk
assessments will occur for the chemical industry. This will affect European
producers of chemicals as well as all chemical companies worldwide that export
to EU member states . The final ruling has not yet been decided.

     The above-mentioned assessments may result in heightened concerns about the
chemicals involved, and in additional requirements being placed on the
production, handling, labeling or use of the subject chemicals. Such concerns
and additional requirements could increase the cost incurred by our customers to
use our chemical products and otherwise limit the use of these products, which
could adversely affect the demand for these products.

Remediation Issues

     Our wholly-owned subsidiary, InfraServ Verwaltungs GmbH, is the general
partner of the InfraServ companies that provide on-site general and
administrative services at German sites in Frankfurt am Main-Hoechst, Gendorf,
Huerth-Knapsack, Wiesbaden, Oberhausen and Kelsterbach. Producers at the sites,
including our subsidiaries, are owners of limited partnership interests in the
respective InfraServ companies. The InfraServ companies are liable for any
residual contamination and other pollution because they own the real estate on
which the individual facilities operate. In addition, Hoechst, as the
responsible party under German public law, is liable to third parties for all
environmental damage that occurred while it was still the owner of the plants
and real estate. However, the InfraServ companies have agreed to indemnify
Hoechst from any environmental liability arising out of or in connection with
environmental pollution of any InfraServ site. The partnership agreements
provide that, as between the limited partners, each limited partner is
responsible for any contamination caused predominantly by such partner. The
limited partners have also undertaken to indemnify Hoechst against such
liabilities. Any liability that cannot be attributed to an InfraServ partner and
for which no third party is responsible, is required to be borne by the
InfraServ company in question. In view of this potential obligation to eliminate
residual contamination, the InfraServ companies in which we have an interest,
have recorded provisions totaling less than (euro)1 million as of September 30,
2005. If the InfraServ companies default on their respective indemnification
obligations to eliminate residual contamination, the limited partners in the
InfraServ companies have agreed to fund such liabilities, subject to a number of
limitations. To the extent that any liabilities are not satisfied by either the
InfraServ companies or the limited partners, these liabilities are to be borne
by us in accordance with the demerger agreement.

     As between Hoechst and Celanese, Hoechst has agreed to indemnify Celanese
for two-thirds of these demerged residual liabilities. Likewise, in some
circumstances Celanese could be responsible for the elimination of residual
contamination on a few sites that were not transferred to Infraserv companies,
in which case Hoechst must reimburse Celanese for two-thirds of any costs so
incurred.

     Some of Celanese's facilities in Germany are over 100 years old, and there
may be significant contamination at these facilities. Provisions are not
recorded for potential soil or groundwater contamination liability at facilities
still in operation, as German law does not currently require owners or operators
to investigate and remedy soil or groundwater contamination until the facility
is closed and dismantled, unless the authorities otherwise direct. However, soil
or groundwater contamination known to the owner or operator must be remedied if
such contamination is likely to have an adverse effect on the public. If we were
to terminate operations at one of our facilities or if German law were changed
to require such removal or clean up, the cost could be material to us. We cannot
accurately determine the ultimate potential liability for investigation and
clean up at such sites. We adjust provisions as new remedial commitments are
made. See Notes 24 and 25 to the Consolidated Financial Statements.

     In the Demerger Agreement, Celanese agreed to indemnify Hoechst against
environmental liabilities for environmental contamination that could arise under
some divestiture agreements regarding chemical businesses, participations or
assets located in Germany, the U.S., and other countries that were entered into
by Hoechst prior to the demerger. Celanese and Hoechst have agreed that Celanese
will indemnify Hoechst against those liabilities


                                       31



up to an amount of (euro)250 million. Hoechst will bear those liabilities
exceeding (euro)250 million, but Celanese will reimburse Hoechst for one-third
of those liabilities for amounts that exceed (euro)750 million. As of September
30, 2005 and 2004, Celanese has made total cumulative payments of (euro)13
million and (euro)12 million, respectively, for environmental contamination
liabilities in connection with the divestiture agreements. As of September 30,
2005, Celanese has reserves of less than (euro)1 million for this contingency
and may be required to record additional reserves in the future. See Notes 25
and 26 to the Consolidated Financial Statements.

     As of September 30, 2005 and 2004, Celanese had reserves of (euro)6 million
and (euro)6 million, respectively, for environmental matters worldwide. We
regularly review the liabilities for these sites and have accrued our best
estimate of an ultimate liability for investigation or cleanup costs, but, due
to the many variables involved in such estimation, the ultimate liability may
vary from these estimates.

ORGANIZATIONAL STRUCTURE

Significant Subsidiaries

     Celanese operates its businesses through subsidiaries in Europe, the
Americas and Asia, most of which are owned indirectly through a German holding
company and wholly-owned subsidiary, Celanese Holding GmbH. Celanese Chemicals
Europe GmbH and Ticona GmbH are owned directly by Celanese.

     The table below sets forth Celanese's significant subsidiaries as of
September 30, 2005.



------------------------------------------------------------------------------------------------
                                                                                     PERCENTAGE
NAME OF COMPANY                                           COUNTRY OF INCORPORATION      OWNED
------------------------------------------------------------------------------------------------

Celanese Chemicals Europe GmbH                            Germany                        100.00%
Celanese Holding GmbH                                     Germany                        100.00%
Nutrinova Nutrition Specialties & Food Ingredients GmbH   Germany                        100.00%
Ticona GmbH                                               Germany                        100.00%
Celanese Singapore Pte. Ltd.                              Singapore                      100.00%
------------------------------------------------------------------------------------------------


DESCRIPTION OF PROPERTY

     Celanese's principal executive offices are located in Kronberg/Taunus,
Germany.

     As of September 30, 2005, Celanese had numerous production and
manufacturing facilities throughout the world. Celanese also owns or leases
other properties, including office buildings, warehouses, pipelines, research
and development facilities and sales offices. Celanese continuously reviews and
evaluates the utilization of its facilities as part of its strategy to optimize
its business portfolio.

     The following table sets forth a list of the principal production and other
facilities of Celanese throughout the world as of September 30, 2005.

--------------------------------------------------------------------------------
CORPORATE CENTER
--------------------------------------------------------------------------------
SITE                        LEASED/OWNED                 PRODUCTS/FUNCTION
--------------------------------------------------------------------------------
Kronberg/Taunus, Germany    Leased                       Administrative offices
--------------------------------------------------------------------------------


                                       32



--------------------------------------------------------------------------------
CHEMICAL PRODUCTS
--------------------------------------------------------------------------------
SITE                        LEASED/OWNED                 PRODUCTS/FUNCTION
--------------------------------------------------------------------------------
Frankfurt am Main, Germany  Owned by InfraServ GmbH &    Acetaldehyde
                            Co. Hoechst KG, in which     Butyl acetate
                            Celanese holds a 31.2        Vinyl acetate monomer
                            percent limited partnership  Conventional emulsions
                            interest                     Vinyl acetate ethylene
                                                         emulsions
--------------------------------------------------------------------------------
Oberhausen, Germany         Owned by InfraServ GmbH &    Amines
                            Co. Oberhausen KG, in which  Carboxylic Acids
                            Celanese holds an 84.0       Neopentyl Glycols
                            percent limited partnership
                            interest
--------------------------------------------------------------------------------
Jurong Island, Singapore    Owned                        Acetic acid
                                                         Butyl acetate
                                                         Ethyl acetate
                                                         Vinyl acetate monomer
--------------------------------------------------------------------------------
Koper, Slovenia             Owned                        Conventional emulsions
--------------------------------------------------------------------------------
Tarragona, Spain            Owned by Complejo            Vinyl acetate monomer
                            Industrial Taqsa AIE, in     Vinyl acetate ethylene
                            which Celanese holds a 15.0  emulsions Conventional
                            percent share                emulsions
--------------------------------------------------------------------------------
Perstorp, Sweden            Owned                        Conventional emulsions
                                                         Vinyl acetate ethylene
                                                         emulsions
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------
TECHNICAL POLYMERS TICONA
--------------------------------------------------------------------------------
SITE                        LEASED/OWNED                 PRODUCTS/FUNCTION
--------------------------------------------------------------------------------
Kelsterbach, Germany        Owned by InfraServ GmbH &    LFT (Celstran(R))
                            Co. Kelsterbach KG, in       Polyacetals
                            which Celanese holds a       (Hostaform(R)),
                            100.0% limited partnership   Polymerization and
                            interest                     Compounding
--------------------------------------------------------------------------------
Oberhausen, Germany         Owned by InfraServ GmbH &    PE-UHMW (GUR)
                            Co. Oberhausen KG, in which
                            Celanese holds an 84.0%
                            limited partnership
                            interest
--------------------------------------------------------------------------------
Suzano, Brazil              Owned                        Compounding
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------
PERFORMANCE PRODUCTS
--------------------------------------------------------------------------------
SITE                        LEASED/OWNED                 PRODUCTS/FUNCTION
--------------------------------------------------------------------------------
Frankfurt am Main, Germany  Owned by InfraServ GmbH &    Sorbates
                            Co. Hoechst KG, in which     Sunett(R)
                            Celanese holds a 31.2%
                            limited partnership
                            interest
--------------------------------------------------------------------------------

     Korea Engineering Plastics has its principal production facilities in South
Korea. Celanese's Chemical Products segment has ventures with manufacturing
facilities in Germany.

     For the period from August 25, 2005 to September 30, 2005 and the period
from October 1, 2004 to August 24, 2005, Celanese and its consolidated
subsidiaries, in the aggregate, had capital expenditures for the expansion and
modernization of production, manufacturing, research and administrative
facilities of (euro)8 million and (euro)68


                                       33



million, respectively. During the nine months ended September 30, 2004, and the
year ended December 31, 2003, these expenditures amounted to (euro)42 million
and (euro)87 million, respectively. Celanese believes that its current
facilities and those of its consolidated subsidiaries are adequate to meet the
requirements of Celanese's present and foreseeable future operations. Celanese
continues to review its capacity requirements as part of its strategy to
maximize its global manufacturing efficiency.

     For information on environmental issues associated with Celanese's
properties, see "Information on the Company - Environmental and Other
Regulation" and Item 5. Operating and Financial Review and Prospects - Liquidity
and Capital Resources - Environmental Matters. Additional information with
respect to Celanese's property, plant and equipment, and leases is contained in
Notes 12 and 25 to the Consolidated Financial Statements.

ITEM 4A. UNRESOLVED STAFF COMMENTS

     Not applicable.


                                       34



ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

     You should read the following discussion and analysis of the financial
condition and the results of operations of Celanese AG and its subsidiaries
(collectively "Celanese" or the "Company") together with the Consolidated
Financial Statements and the notes to those financial statements, which were
prepared in accordance with U.S. GAAP.

     The application of push down accounting due to the Celanese Europe Holding
Gmbh & Co. KG, formerly known as BCP Crystal Acquisition Gmbh & Co. KG ("the
Purchaser") acquiring more than 95% ownership of Celanese resulted in a new
basis of accounting. Therefore, the following discussion and analysis of
financial condition and results of operations covers periods prior
("Predecessor") and subsequent ("Successor") to the August 24, 2005, purchase of
Celanese ordinary shares ("CAG Shares")(See Acquisition of Celanese below).
Accordingly, the discussion and analysis of historical periods do not reflect
the significant impact that the push down accounting adjustments has had and
will have on the Successor. In addition, investors are cautioned that the
forward-looking statements contained in this section involve both risk and
uncertainty. Several important factors could cause actual results to differ
materially from those anticipated by these statements. Many of these statements
are macroeconomic in nature and are, therefore, beyond the control of
management. See "Forward-Looking Information" located at the end of this
section.

     In July 2004, the majority of Celanese's shareholders approved a change of
the Celanese fiscal accounting year to commence October 1st and end September
30th. As a result, Celanese's 2004 fiscal year ended on September 30, 2004. To
facilitate a meaningful comparison the results of operations and cash flows for
the nine months ended September 30, 2004 are compared to the results of
operations and cash flows for the nine months ended September 30, 2003. The
results of operations and cash flows for the nine months ended September 30,
2003 have not been audited and should not be taken as an indication of the
results of operations to be reported for any subsequent period or for the full
fiscal year.

     Reconciliation of Non-U.S. GAAP Measures: Management compensates for the
limitations of using non-U.S. GAAP financial measures by using them to
supplement U.S. GAAP results to provide a more complete understanding of the
factors and trends affecting the business other than U.S. GAAP results alone. In
this regard, we disclose net debt and trade working capital, which are non-U.S.
GAAP financial measures. Net debt is defined as total debt less cash and cash
equivalents, and trade working capital is defined as trade accounts receivable
from third parties, affiliates and related entities net of allowance for
doubtful accounts, plus inventories, less trade accounts payable to third
parties, affiliates and related entities. Management uses net debt to evaluate
capital structure and trade working capital to evaluate investment in
receivables and inventory, net of payables. Net debt and trade working capital
are not a substitute for any U.S. GAAP financial measure. In addition,
calculations of net debt and trade working capital contained in this report may
not be consistent with that of other companies. The most directly comparable
financial measures presented in accordance with U.S. GAAP in our financial
statements for net debt and trade working capital are total debt and the working
capital components, respectively. For a reconciliation of net debt and total
debt and a reconciliation of trade working capital to the working capital
components, see "Financial Hightlights" below.

BASIS OF PRESENTATION

     The financial position, results of operations, statement of cash flows and
related disclosures for the periods prior to August 24, 2005, the effective date
of the acquisition of CAG shares, which resulted in the Purchaser owning more
than 95% of Celanese AG and the requirement to apply push down accounting are
presented as the results of the Predecessor. The financial position, results of
operations, statement of cash flows and related disclosures subsequent to August
24, 2005, are presented as the results of the Successor. The results of the
Successor may not be comparable to the results of the Predecessor due to the
difference in the basis of presentation of push down accounting as compared to
historical cost. To facilitate a meaningful comparison of the Company's
performance, the following discussion of results of operations is presented on a
comparative basis for both 2005 and 2004. Accordingly, the results of operations
for the twelve months ended September 30, 2005 represent the mathematic addition
of the historical amounts of the Predecessor for the period October 1, 2004 to
August 24, 2005 and the Successor for the period August 25 to September 30,
2005. Management believes that a combined discussion of Predecessor and
Successor periods is reasonable and appropriate because the successor period is
short and there were no material adjustments to the presented items other than
cost of sales and depreciation and amortization resulting from the push down of
purchase accounting. The results of the Successor


                                       35



and Predecessor periods, individually, have been audited. The combined results
for the twelve months ended September 30, 2005 and 2004 have not been audited
and should not be taken as an indication of the results of operations to be
reported for any subsequent period or for the full fiscal year.

     Push Down Accounting: The Purchaser accounted for its acquisitions of the
CAG Shares using the purchase value method of accounting resulting in a new
basis of accounting. The purchase price was allocated based on the fair value of
the underlying assets acquired and liabilities assumed. The assets acquired and
liabilities assumed are reflected at the Purchaser's accounting basis for the
approximate 96% portion acquired and at Celanese's historical basis for the
remaining minority interest of approximately 4%. The difference in the total
purchase price and the fair value of the net assets acquired was allocated to
goodwill, and this indefinite lived asset is subject to an annual impairment
review. In the twelve months ended September 30, 2005, the Company decreased
goodwill (euro)247 million as a result of the push down accounting adjustments
related to the acquisition of CAG's shares. In addition, Celanese's results of
operations were impacted by the push down accounting adjustments as follows: the
effect on depreciation expense decreased by less than (euro)1 million due to the
step up of property, plant and equipment and offset by the effect of the change
in useful lives, amortization expense increased by (euro)2 million due to the
step up of intangible assets and cost of sales increased by (euro)5 million due
to the step up and subsequent sale of inventory. (See Notes 2, 12 and 13 to the
Consolidated Financial Statements).

     In October 2004, CAC was transferred out of Celanese AG as part of the
organizational restructuring (see below). As a result of the restructuring, CAC
assets, liabilities and results of operations have been treated as discontinued
operations for all periods presented. (see Discontinued Operations below).

     In January 2003, and subsequently revised in December 2003, the FASB issued
FIN No. 46, Consolidation of Variable Interest Entities and FIN No. 46 Revised
(collectively, "FIN No. 46"), respectively. FIN No. 46 clarifies the application
of Accounting Research Bulletin No. 51, "Consolidation of Financial Statements"
requiring the consolidation of certain variable interest entities ("VIE") which
are defined as entities having equity that is not sufficient to permit such
entities to finance their activities without additional subordinate financial
support or whose equity holders lack certain characteristics of a controlling
financial interest. If the Company is deemed to be the primary beneficiary, it
is required to consolidate the VIE. FIN No. 46 requires VIEs that meet the
definition of a special purpose entity to be consolidated by the primary
beneficiary as of December 31, 2003. For VIEs that do not meet the definition of
a special purpose entity, consolidation is not required until March 31, 2004;
however, expanded disclosure is required at December 31, 2003.

     Celanese has a lease agreement for its cyclo-olefin copolymer ("COC") plant
with Dacron GmbH, a special purpose entity. This special purpose entity was
created primarily for the purpose of constructing and subsequently leasing the
COC plant to Celanese. This arrangement qualifies as a VIE. Based upon the terms
of the lease agreement and the residual value guarantee Celanese provided to the
lessors, Celanese is deemed the primary beneficiary of the VIE. The
consolidation of this entity had a material impact on Celanese's financial
position, results of operations and cash flows for the twelve months ended
September 30, 2005. (See Note 28 to the Consolidated Financial Statements). The
consolidation of this entity did not have a material impact on Celanese's
financial position or results of operations and cash flows for the nine months
ended September 30, 2004. In December 2005, Celanese divested its COC business
to a venture between Japan's Daicel Chemical Industries Ltd. and Polyplastics
Co. Ltd., a 45% held venture of Celanese AG's ultimate parent, Celanese
Corporation.

     In April 2004, Celanese and a group of investors led by Conduit Ventures
Ltd. entered into a venture, which was named Pemeas GmbH. This venture was
formed in order to advance the commercialization of Celanese's fuel cell
technology. Pemeas GmbH is considered a variable interest entity as defined
under FIN No. 46. Celanese is deemed the primary beneficiary of this variable
interest entity and, accordingly, consolidates this entity in its consolidated
financial statements. The consolidation of this entity did not have a material
impact on Celanese's financial position or results of operations and cash flows
for all periods presented. In December 2005, Celanese sold a majority of its
interest in Pemeas Gmbh as part of Celanese's strategy to divest non-core
businesses. As a result of the sale, Celanese will no longer consolidate Pemeas
GmbH.

     Impact of the sale of emulsion powders business: In September 2005, in
connection with Celanese Corporation's acquisition of Vinamul, the Company sold
its emulsion powders business to Imperial Chemical Industries PLC ("ICI") for
approximately (euro)21 million. The transaction includes a supply agreement
whereby the Company will supply product to ICI for a period of up to fifteen
years. The fair value of the supply contract was (euro)9 million and was
recorded as deferred revenue to be amortized over fifteen years. Net sales and
loss before


                                       36



income taxes and minority interests for the emulsion powders business for the
twelve months ended September 30, 2005 were (euro)32 million and (euro)1
million, respectively.

ACQUISITION OF CELANESE AND ORGANIZATIONAL RESTRUCTURING

     On April 6, 2004, the Purchaser acquired approximately 84% of CAG shares,
pursuant to a voluntary tender offer commenced in February 2004. These shares
were acquired at a price of (euro)32.50 per share or an aggregate purchase price
of (euro)1,385 million, including direct acquisition costs of approximately
(euro)56 million. Following the completion of the acquisition, the CAG shares
were delisted from the New York Stock Exchange on June 2, 2004. CAG shares
continue to trade on the Frankfurt Stock Exchange in Germany.

     During the period August 25, 2005 to September 30, 2005 and the period
October 1, 2004 to August 24, 2005, the Purchaser acquired additional CAG shares
for a purchase price of (euro)0 million and (euro)325 million, respectively. As
of September 30, 2005 and 2004, the Purchaser's ownership percentage was
approximately 96% and 84%, respectively. The additional CAG shares were acquired
pursuant to either i) the mandatory offer (See Note 3) commenced in September
2004 or ii) the purchase of additional CAG shares as described below. On
November 4, 2005, the Purchaser advised Celanese AG of its request to commence
the process for affecting a squeeze-out of the remaining shareholders (See Note
3 to the Consolidated Financial Statements).

Organizational Restructuring

     In October 2004, the parent of the Purchaser, Celanese Corporation,
completed an organizational restructuring ("Restructuring"). As part of the
Restructuring, Celanese Corporation, by causing the Purchaser to give
corresponding instruction under the Domination Agreement, effected the transfer
of all of the shares of CAC from Celanese Holding GmbH, a wholly owned
subsidiary of Celanese, to BCP Caylux Holdings Luxembourg S.C.A. ("BCP Caylux")
which resulted in BCP Caylux owning 100% of the equity of CAC and, indirectly,
all of its assets, including subsidiary stock. The transfer was effected under
the Domination Agreement as follows: (1) Celanese Holding GmbH distributed all
outstanding shares in CAC to Celanese, (2) Celanese sold all outstanding shares
in CAC to the Purchaser for a note in an amount equal to CAC's fair market value
of (euro)291 million and (3) the Purchaser transferred all outstanding capital
stock of CAC to BCP Caylux for (euro)291 million. In addition, CPO, a wholly
owned subsidiary of Celanese, which acted as a purchasing agent on behalf of
Celanese as well as third parties, was transferred to the Purchaser. This
transfer was made equal to CPO's fair market value of (euro)13 million in the
form of a note. As a result of these transfers, Celanese AG now serves primarily
as the holding company for the European business and certain Asian businesses of
Celanese Corporation, the ultimate parent of the Purchaser and Celanese.

     As a result of the Restructuring, the term notes, pollution control bonds,
variable rate term loan payable to BCP Caylux and a portion of the capital
leases are no longer obligations of Celanese AG. Celanese AG and its
subsidiaries are no longer named parties under the credit facilities after the
Restructuring. As of September 30, 2004, Celanese AG had net intercompany notes
with consolidated subsidiaries, which previously were eliminated in
consolidation. As part of the Restructuring and pursuant to instructions issued
by the Purchaser under the Domination Agreement, these intercompany notes were
replaced with notes due from the Purchaser of (euro)1,034 million. Celanese
Corporation has provided letters of support for the repayment of these notes.
The repayment of these notes depends upon sufficient liquidity of the Purchaser
and Celanese Corporation and its other subsidiaries. The major portion of these
notes bear interest of 4.67% per annum and mature in 2009.

     As a result of the Restructuring, CAC is no longer a wholly-owned
subsidiary of Celanese. CAC's assets, liabilities and results of operations have
been included as discontinued operations (See Note 8).

     As this is a transaction between entities under common control, the
transfers of CAC and CPO were recorded at the historical cost net book value of
CAC and CPO, and resulted in a deemed distribution from additional paid in
capital.

     Prior to the Restructuring of Celanese, the Company's portfolio consisted
of four main business segments: Chemical Products, Acetate Products, Technical
Polymers Ticona and Performance Products. The entire Acetate Products segment,
along with significant portions of the Chemical Products segment were
transferred out of Celanese on October 5, 2004. As of September 30, 2005,
Celanese's portfolio consists of three main business segments: Chemical
Products, Technical Polymers Ticona and Performance Products.


                                       37



Purchase of Additional CAG Shares

     On August 24, 2005, the Purchaser acquired approximately 5.9 million, or
approximately 12%, of the outstanding CAG shares from two shareholders for the
aggregate consideration of approximately (euro)302 million. In addition, the
Purchaser also paid to such shareholders an additional purchase price of
(euro)12 million in consideration for the settlement of certain claims and for
such shareholders agreeing to, among other things, (1) accept the shareholders'
resolutions passed at the extraordinary general meeting of Celanese held on July
30 and 31, 2004 and the annual general meeting of Celanese held on May 19 and
20, 2005, (2) acknowledge the legal effectiveness of the domination and profit
and loss transfer agreement, (3) irrevocably withdraw and abandon all actions,
applications and appeals each brought or joined in legal proceedings related to,
among other things, challenging the effectiveness of the domination and profit
and loss transfer agreement, and amount of fair cash compensation offered by the
Purchaser in the mandatory offer required by Section 305(1) of the German Stock
Corporation Act, (4) refrain from acquiring any CAG shares or any other
investment in Celanese, and (5) refrain from taking any future legal action with
respect to shareholder resolutions or corporate actions of Celanese. The
Purchaser paid the aggregate consideration of (euro)314 million for the
additional CAG shares that were acquired from such shareholders and for the
agreements described above using available cash. The Purchaser also made all
other shareholders a limited offer pursuant to which it increased for a limited
period of time its offer to purchase any remaining outstanding CAG shares to
(euro)51 per share (plus interest on (euro)41.92 per share) for all minority
shareholders against waiver of the shareholders' rights to participate in an
increase of the offer consideration as a result of the pending award
proceedings. In addition, all shareholders who tendered their shares pursuant to
the mandatory offer of (euro)41.92 per share commenced in September 2004, were
entitled to claim the difference between the increased offer of (euro)51 per
share and the mandatory offer of (euro)41.92 per share. The limited offer ran
from August 30, 2005 to September 29, 2005. For minority shareholders who did
not accept the limited offer on or prior to the September 29, 2005 expiration
date, the terms of the original (euro)41.92 per share mandatory offer continue
to apply. The mandatory offer will remain open for two months following final
resolution of the award proceedings (Spruchverfahren) by the German courts.

Domination Agreement

     Domination Agreement

     On October 1, 2004, a domination and profit and loss transfer agreement
(the "Domination Agreement") between Celanese and the Purchaser became
effective. When the Domination Agreement became operative, the Purchaser became
obligated to offer to acquire all outstanding CAG shares from the minority
shareholders of Celanese in return for payment of fair cash compensation. The
amount of this fair cash compensation was determined to be (euro)41.92 per
share, plus interest, in accordance with applicable German law. The Purchaser
may elect, or be required, to pay a purchase price in excess of (euro)41.92 to
acquire the remaining CAG shares. Any minority shareholder who elects not to
sell its CAG shares to the Purchaser will be entitled to remain a shareholder of
Celanese and to receive from the Purchaser a gross guaranteed fixed annual
payment on their CAG shares of (euro)3.27 per CAG share less certain corporate
taxes in lieu of any future dividend. Taking into account the circumstances and
the tax rates at the time of entering into the Domination Agreement, the net
guaranteed fixed annual payment is (euro)2.89 per CAG share for a full fiscal
year, which commences on or after October 1, 2004. The net guaranteed fixed
annual payment may, depending on applicable corporate tax rates, in the future
be higher, lower or the same as (euro)2.89 per CAG share.

     Beginning October 1, 2004, under the terms of the Domination Agreement, the
Purchaser, as the dominating entity, among other things, is required to
compensate Celanese AG for any statutory annual loss incurred by Celanese AG,
the dominated entity, on a non-consolidated basis, at the end of the fiscal year
when the loss was incurred. This obligation to compensate Celanese AG for annual
losses will apply during the entire term of the Domination Agreement.

     There is no assurance that the Domination Agreement will remain operative
in its current form. If the Domination Agreement ceases to be operative, the
Purchaser will not be able to directly give instructions to the Celanese board
of management. The Domination Agreement cannot be terminated by the Purchaser in
the ordinary course until September 30, 2009. However, irrespective of whether a
domination agreement is in place between the Purchaser and Celanese, under
German law, Celanese is effectively controlled by the Purchaser because of the
Purchaser's more than 95% ownership of the outstanding CAG shares. The Purchaser
does have the ability, through a variety of means, to utilize its controlling
rights to, among other things, (1) cause a domination agreement to become
operative; (2) use its ability, through its more than 95% voting power at any


                                       38



shareholders' meetings of Celanese, to elect the shareholder representatives on
the Supervisory Board and to thereby effectively control the appointment and
removal of the members of the Celanese board of management; and (3) effect all
decisions that a majority shareholder who owns more than 95% is permitted to
make under German law. The controlling rights of the Purchaser constitute a
controlling financial interest for accounting purposes and result in the
Purchaser being required to consolidate Celanese as of the date of acquisition.
In addition, as long as the Domination Agreement remains effective, the
Purchaser is entitled to give instructions directly to the management board of
Celanese, including, but not limited to, instructions that are disadvantageous
to Celanese, as long as such disadvantageous instructions benefit the Purchaser
or the companies affiliated with either the Purchaser or Celanese. As a
dominated company, Celanese may be affected by risks that affect the Purchaser
and its affiliates, including, but not limited to, risks arising out of the debt
levels of some of these companies.

Shareholder Litigation

     A number of minority shareholders of Celanese have filed lawsuits in the
Frankfurt District Court (Landgericht) that, among other things, request the
court to set aside shareholder resolutions passed at the extraordinary general
meeting held on July 30 and 31, 2004, as well as the confirmatory resolutions
passed at the annual general meeting held on May 19 and 20, 2005. On March 6,
2006, Celanese Europe Holding and Celanese signed a settlement agreement with
eleven minority shareholders who had filed such lawsuits (the "Settlement
Agreement"). Pursuant to the Settlement Agreement, the plaintiffs agreed to
withdraw the actions to which they are a party and to recognize the validity of
the Domination Agreement in exchange for Celanese Europe Holding to offer at
least (euro)51.00 per share as cash consideration to each shareholder who will
cease to be a shareholder in the context of the Squeeze-Out. The Celanese Europe
Holding further agreed to make early payment of the guaranteed annual payment
(Ausgleich) pursuant to the Domination Agreement for the financial year
2005/2006, ending on September 30, 2006. Such guaranteed annual payment normally
would have come due following the annual general meeting in 2007; however,
pursuant to the Settlement Agreement, it will be made on the first banking day
following the Celanese's annual general meeting that commences on May 30, 2006.
To receive the early compensation payment, the respective minority shareholder
will have to declare that (i) his claim for payment of compensation for the
financial year 2005/2006 pursuant to the Domination Agreement is settled by such
early payment and that (ii) in this respect, he indemnifies Celanese Europe
Holding against compensation claims by any legal successors to his shares.

     During August 2004, nine actions were brought by minority shareholders
against Celanese in the Frankfurt District Court (Landgericht), all of which
were consolidated in September 2004. Several minority shareholders joined these
proceedings via a third party intervention in support of the plaintiffs. The
Purchaser joined the proceedings via a third party intervention in support of
Celanese. Among other things, these actions request the court to set aside
shareholder resolutions passed at the extraordinary general meeting held on July
30 and 31, 2004 based on allegations that include the alleged violation of
procedural requirements and information rights of the shareholders. These
actions will be withdrawn pursuant to the Settlement Agreement.

     Twenty-seven minority shareholders filed lawsuits in May and June of 2005
in the Frankfurt District Court (Landgericht) contesting the shareholder
resolutions passed at the annual general meeting held May 19-20, 2005, which
confirmed the resolutions passed at the July 30-31, 2004 extraordinary general
meeting approving the Domination Agreement and a change in Celanese's fiscal
year. In February 2006 the Frankfurt District Court dismissed many of these
claims. This decision is subject to appeal. In conjunction with the acquisition
of 5.9 million ordinary shares of Celanese from two shareholders in August 2005,
two of those lawsuits were withdrawn in August 2005 and another ten lawsuits
will be withdrawn pursuant to the Settlement Agreement.

     Celanese is also a defendant in five actions filed in the Frankfurt
District Court (Landgericht) requesting that the court declare some or all of
the shareholder resolutions passed at the extraordinary general meeting of
Celanese on July 30 and 31, 2004 null and void (Nichtigkeitsklage), based on
allegations that certain formal requirements in connection with the invitation
to the extraordinary general meeting of Celanese had been violated.

     The Frankfurt District Court (Landgericht) has suspended the proceedings
regarding the resolutions passed at the July 30-31, 2004 extraordinary general
meeting described above as long as the lawsuits contesting the confirmatory
resolutions are pending.

     Further, on August 2, 2004, two minority shareholders instituted public
register proceedings with each of the Koenigstein Local Court (Amtsgericht) and
the Frankfurt District Court (Landgericht), both with a view to have the
registration of the Domination Agreement in the Commercial Register deleted
(Amtsloeschungsverfahren). These actions are based on an alleged violation of
procedural requirements at the extraordinary general meeting, an alleged
undercapitalization of the Purchaser and an alleged misuse of discretion by the
competent court with respect to the registration of the Domination Agreement in
the Commercial Register. In April 2005, the court of appeals rejected the demand
by one shareholder for injunctive relief, and in June 2005 the Frankfurt
District Court (Landgericht) ruled that it does not have jurisdiction over this
matter. One of the  claims in the Koenigstein Local Court (Amtsgericht) is still
pending and the other will be withdrawn pursuant to the Settlement Agreement.

     If legal challenges of the Domination Agreement by dissenting shareholders
of Celanese are successful, some or all actions taken under the Domination
Agreement, including the transfer of Celanese Americas Corporation ("CAC"), an
indirect subsidiary of Celanese (see Organizational Restructuring above for
discussion regarding the CAC transfer) may be required to be reversed and the
Purchaser may be required to compensate Celanese for damages caused by such
actions.

     Squeeze-Out: Because the Purchaser owns CAG shares representing more than
95 percent of the registered ordinary share capital (excluding treasury shares)
of Celanese, Celanese Corporation caused the Purchaser to require, as permitted
under German law, the transfer to the Purchaser of the CAG shares owned by the
then-outstanding minority shareholders of Celanese in exchange for fair cash
compensation (the "Squeeze-Out"). The


                                       39



Squeeze-Out requires the approval by the affirmative vote of the majority of the
votes cast at Celanese's annual general meeting in May 2006 and would become
effective upon its registration in the commercial register. Once the Purchaser
effects the Squeeze-Out, the Purchaser must pay the then remaining minority
shareholders of Celanese fair cash compensation, in exchange for their CAG
shares. The amount of the fair cash compensation per share has been set at
(eurodollar)62.22. The amount to be paid to the minority shareholders as fair
cash compensation in exchange for their CAG shares in connection with the
Squeeze-Out was determined on the basis of the fair value of the enterprise of
Celanese, determined by the Purchaser in accordance with applicable German legal
requirements, as of the date of the applicable resolution of Celanese's
shareholder's meeting, and examined by a duly qualified auditor chosen and
appointed by the Frankfurt District Court (Landericht).

     The Squeeze-Out requires approval by the shareholders of Celanese. While it
is to be expected that in each case, the Purchaser will have the requisite
majority in such meeting to assure approval of such measures, minority
shareholders, irrespective of the size of their shareholding, may, within one
month from the date of any such shareholder resolution, file an action with the
court to have such resolution set aside. While such action would only be
successful if the resolution were passed in violation of applicable laws and
cannot be based on the unfairness of the amount to be paid to the minority
shareholders, a shareholder action may substantially delay the implementation of
the challenged shareholder resolution pending final resolution of the action. If
such action proved to be successful, the action could prevent the implementation
of the Squeeze-Out. Accordingly, there can be no assurance that the Squeeze-Out
can be implemented timely or at all.


                                       40



MAJOR EVENTS IN 2005

     In October 2004, Celanese Corporation, the ultimate parent of Celanese,
completed an organizational restructuring ("Restructuring"). As part of the
Restructuring, Celanese Corporation, by causing the Purchaser to give
corresponding instruction to Celanese under the Domination Agreement, effected
the transfer of all shares of CAC from Celanese Holding GmbH, a wholly owned
subsidiary of Celanese, to BCP Caylux which resulted in BCP Caylux owning 100%
of the equity of CAC and, indirectly, all of its assets, including subsidiary
stock. In connection with the Restructuring and pursuant to instructions issued
by the Purchaser under the Domination Agreement, Celanese exchanged current
amounts due from certain related parties for long term notes due from the
Purchaser for approximately (euro)1,034 million.

     In September 2005, Celanese sold its emulsion powders business to National
Starch and Chemical Company, a subsidiary of ICI.

     In August 2005, Celanese announced its intention to wind up Estech GmbH,
its venture with Hatco Corporation for neopropyl esters.

     In November 2005, Celanese Corporation resolved in a regular meeting of its
Board of Directors to commence the Squeeze-Out of outstanding CAG shares. The
Purchaser, a subsidiary of Celanese Corporation, currently holds greater than
95% of issued CAG shares of Celanese, thus fulfilling the legal requirements
necessary for a Squeeze-Out.

     In December 2005, the Company sold its cyclo-olefin copolymer business. The
transaction resulted in a loss of approximately (euro)30 million.

     On December 28, 2005, Celanese sold a majority of its interest in Pemeas
Gmbh as part of Celanese's strategy to divest non-core businesses.

     The Company announced its intention to build a state-of-the-art vinyl
acetate ethylene and conventional emulsion polymer facility in China. Startup is
targeted for the first half of 2007. The China operations are expected to be
transferred to Celanese Corporation in 2006.


                                       41



FINANCIAL HIGHLIGHTS



                                                 SUCCESSOR                            PREDECESSOR
                                                ----------   -------------------------------------------------------------
                                    COMBINED
                                     TWELVE                                  TWELVE       NINE
                                     MONTHS     AUGUST 25,   OCTOBER 1,      MONTHS       MONTHS        NINE
                                     ENDED         2005         2004,        ENDED        ENDED        MONTHS       YEAR
                                   SEPTEMBER        TO           TO        SEPTEMBER    SEPTEMBER      ENDED        ENDED
                                      30,        SEPTEMBER   AUGUST 24,       30,          30,       SEPTEMBER    DECEMBER
                                      2005       30, 2005       2005          2004         2004       30, 2003    31, 2003
                                  -----------   ----------   ----------   -----------   ---------   -----------   --------
                                  (UNAUDITED)                             (UNAUDITED)               (UNAUDITED)
                                                  (IN (EURO) MILLIONS, EXCEPT FOR SHARE AND PER SHARE DATA)

STATEMENT OF
   OPERATIONS DATA:
Net sales                            2,210          238         1,972        1,982         1,520       1,579        2,041
Cost of sales                       (1,699)        (218)       (1,481)      (1,584)       (1,193)     (1,263)      (1,655)
Special charges
   Sorbates antitrust matters          --            --            --           --            --         (84)         (84)
   Restructuring, impairment
      and other special charges        (50)          (1)          (49)         (37)          (26)         (5)         (17)
Operating profit (loss)                254           (2)          256          109           112          43           38
Earnings (loss) from
   continuing operations
   before tax and minority
   interests                           336            5           331          139           157          83           66
Income tax provision                   (78)          (1)          (77)         (45)          (39)        (24)         (30)
Earnings (loss) from
   continuing operations               213            2           211           72           100          52           24
Earnings (loss) from
   discontinued operations              22           --            22         (127)         (170)         64          108
Net earnings (loss)                    235            2           233          (55)          (70)        116          132
Earnings (loss) per common
   share - basic:
   from continuing operations         4.24         0.04          4.20         1.46          2.02        1.05         0.47
   from discontinued
      operations                      0.44           --          0.44        (2.57)        (3.44)       1.29         2.20
                                    ------         ----        ------       ------        ------      ------       ------
Net earnings (loss)                   4.68         0.04          4.64        (1.11)        (1.42)       2.34         2.67
                                    ======         ====        ======       ======        ======      ======       ======
Earnings (loss) per common
   share - diluted:
   from continuing operations         4.23         0.04          4.19         1.46          2.02        1.05         0.47
   from discontinued
      operations                      0.44           --          0.44        (2.57)        (3.44)       1.29         2.20
                                    ======         ====        ======       ======        ======      ======       ======
Net earnings (loss)                   4.67         0.04          4.63        (1.11)        (1.42)       2.34         2.67
                                    ======         ====        ======       ======        ======      ======       ======



                                       42





                                                                             SUCCESSOR      PREDECESSOR
                                                                           -------------   -------------
                                                                               AS OF           AS OF
                                                                           SEPTEMBER 30,   SEPTEMBER 30,
                                                                                2005            2004
                                                                           -------------   -------------
                                                                                (IN (EURO) MILLIONS)

BALANCE SHEET DATA:
Trade receivables, net - third party, affiliates and related entities...         360             416
Plus: Inventories.......................................................         178             157
Less: Trade payables - third party, affiliates and related entities.....         269             280
                                                                               -----           -----
Trade working capital...................................................         269             293
                                                                               =====           =====
Short-term borrowings and current installments of long-term debt -
   third party, affiliates and related entities.........................         252             170
Plus: Long-term debt....................................................          80             331
                                                                               -----           -----
Total debt..............................................................         332             501
Less: Cash and cash equivalents.........................................         176              91
                                                                               -----           -----
Net debt................................................................         156             410
                                                                               =====           =====
Total assets............................................................       3,920           5,340
Shareholders' equity....................................................       2,456           1,888




                                               SUCCESSOR                            PREDECESSOR
                                              ----------   -------------------------------------------------------------
                                  COMBINED
                                   TWELVE
                                   MONTHS     AUGUST 25,   OCTOBER 1,      TWELVE        NINE
                                   ENDED         2005         2004         MONTHS       MONTHS    NINE MONTHS     YEAR
                                 SEPTEMBER        TO           TO          ENDED        ENDED        ENDED       ENDED
                                    30,        SEPTEMBER   AUGUST 24,    SEPTEMBER    SEPTEMBER    SEPTEMBER    DECEMBER
                                    2005       30, 2005       2005        30, 2004     30, 2004     30, 2003    31, 2003
                                -----------   ----------   ----------   -----------   ---------   -----------   --------
                                (UNAUDITED)                             (UNAUDITED)               (UNAUDITED)

OTHER DATA
Depreciation and amortization        69             7           62          100           74           74          97
Operating margin(1)                11.5%         (0.8)%       13.0%         5.5%         7.4%         2.7%        1.9%
Earnings (loss) from
   continuing operations
   before tax and minority
   interests as a percentage
   of net sales                    15.2%          2.1%        16.8%         7.0%        10.3%         5.3         3.2%


----------
(1)Defined as operating profit (loss) divided by net sales.


                                       43



FOR DISCUSSION OF CONSOLIDATED STATEMENT OF OPERATIONS ONLY

(SEE BASIS OF PRESENTATION)

                          CELANESE AG AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS



                                                               SUCCESSOR     PREDECESSOR      COMBINED      PREDECESSOR
                                                             -------------   -----------   -------------   -------------
                                                               AUGUST 25,     OCTOBER 1,   TWELVE MONTHS   TWELVE MONTHS
                                                                2005 TO        2004 TO         ENDED           ENDED
                                                             SEPTEMBER 30,    AUGUST 24,   SEPTEMBER 30,   SEPTEMBER 30,
                                                                  2005           2005           2005            2004
                                                             -------------   -----------   -------------   -------------
                                                                                            (UNAUDITED)     (UNAUDITED)

                                                                                 (IN (EURO) MILLIONS)
                                                             -----------------------------------------------------------

Net sales.................................................        238           1,972          2,210           1,982
Cost of sales.............................................       (218)         (1,481)        (1,699)         (1,584)
Selling, general and administrative expenses..............        (18)           (153)          (171)           (208)
Research and development expenses.........................         (4)            (36)           (40)            (43)
Special charges:
   Sorbates antitrust matters.............................         --              --             --              --
   Restructuring, impairment and other special charges....         (1)            (49)           (50)            (37)
Foreign exchange gain (loss)..............................          1               3              4              (1)
Gain on disposition of assets.............................         --              --             --              --
                                                                 ----          ------         ------          ------
   Operating profit (loss)................................         (2)            256            254             109
Equity in net earnings of affiliates......................          3               9             12              17
Interest expense..........................................         (3)            (10)           (13)            (16)
Interest and other income, net............................          7              76             83              29
                                                                 ----          ------         ------          ------
   Earnings from continuing operations before tax and
      minority interests..................................          5             331            336             139
Income tax provision......................................         (1)            (77)           (78)            (45)
                                                                 ----          ------         ------          ------
   Earnings (loss) from continuing operations before
      minority interests..................................          4             254            258              94
Minority interests........................................         (2)            (43)           (45)            (22)
                                                                 ----          ------         ------          ------
   Earnings (loss) from continuing operations.............          2             211            213              72
Earnings (loss) from discontinued operations:
   Earnings from operation of discontinued operations.....         --              --             --               3
   Gain (loss) on disposal of discontinued operations.....         --              22             22              --
   Income tax benefit (expense)...........................         --              --             --            (130)
                                                                 ----          ------         ------          ------
   Earnings (loss) from discontinued operations...........         --              22             22            (127)
   Net earnings (loss)....................................          2             233            235             (55)
                                                                 ====          ======         ======          ======



                                       44



FOR DISCUSSION OF CONSOLIDATED STATEMENT OF OPERATIONS ONLY

(SEE BASIS OF PRESENTATION)

                          CELANESE AG AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS



                                                                                   PREDECESSOR
                                                                  --------------------------------------------
                                                                   NINE MONTHS     NINE MONTHS
                                                                      ENDED           ENDED        YEAR ENDED
                                                                  SEPTEMBER 30,   SEPTEMBER 30,   DECEMBER 31,
                                                                       2004            2003           2003
                                                                  -------------   -------------   ------------
                                                                                   (UNAUDITED)

                                                                              (IN (EURO) MILLIONS)
                                                                  --------------------------------------------

Net sales......................................................       1,520           1,579           2,041
Cost of sales..................................................      (1,193)         (1,263)         (1,655)
Selling, general and administrative expenses...................        (154)           (153)           (207)
Research and development expenses..............................         (33)            (32)            (43)
Special charges:
   Sorbates antitrust matters..................................          --             (84)            (84)
   Restructuring, impairment and other special charges.........         (26)             (5)            (17)
Foreign exchange gain (loss)...................................          (2)              1               2
Gain on disposition of assets..................................          --              --               1
                                                                     ------          ------          ------
   Operating profit............................................         112              43              38
Equity in net earnings of affiliates...........................          15              12              14
Interest expense...............................................         (11)            (10)            (15)
Interest and other income, net.................................          41              38              29
                                                                     ------          ------          ------
   Earnings from continuing operations before tax and
      minority interests.......................................         157              83              66
Income tax provision...........................................         (39)            (24)            (30)
                                                                     ------          ------          ------
   Earnings (loss) from continuing operations before
      minority interests.......................................         118              59              36
Minority interests.............................................         (18)             (7)            (12)
                                                                     ------          ------          ------
   Earnings (loss) from continuing operations..................         100              52              24
Earnings (loss) from discontinued operations:
   Earnings (loss) from operation of discontinued operations...         (31)             93             127
   Gain (loss) on disposal of discontinued operations..........          --              (1)             (1)
   Income tax benefit (provision)..............................        (139)            (28)            (18)
                                                                     ------          ------          ------
   Earnings (loss) from discontinued operations................        (170)             64             108
Cumulative effect of changes in accounting principles, net of
   income tax of (euro)1 million in 2003.......................          --              --              --
                                                                     ------          ------          ------
   Net earnings (loss).........................................         (70)            116             132
                                                                     ======          ======          ======


OVERVIEW - TWELVE MONTHS ENDED SEPTEMBER 30, 2005 COMPARED WITH TWELVE MONTHS
ENDED SEPTEMBER 30, 2004

     Strong demand, high industry utilization and selling price increases were
only partially offset by higher raw material costs resulting in strong earnings
from continuing operations for the twelve months ended September 30, 2005
compared to the same period in 2004. Interest and other income, net
significantly increased primarily due to increased interest income associated
with notes receivable from related entities. Also, contributing to stronger net
earnings was the gain resulting from the sale of Vinnolit.


                                       45



     Volumes rose modestly in the Performance Product segment and only slightly
in the Chemical Product segment. However, volumes were flat in the Technical
Polymers Ticona segment due to the weak European automotive sector. Overall,
selling prices increased as higher pricing in the Chemical Products and Ticona
segment more than offset pricing declines in the Performance Products segment.

     Operating profit improved as a result of selling price increases along with
slight volume increases that were only partially offset by higher raw material
costs. The absence of stock appreciation rights expense of (euro)6 million and
the elimination of certain corporate functions due to the Restructuring of
Celanese operations also contributed to the improved operating profit. Special
charges for the twelve months ended September 30, 2005 were primarily the result
of asset impairments related to the COC restructuring of (euro)45 million.
Special charges for the twelve months ended September 30, 2004 largely consisted
of advisory services associated with the tender offer of CAG shares in the
amount of (euro)20 million.

     Net earnings of (euro)235 million for the twelve months ended September 30,
2005 compared to a net loss of (euro)55 million for the same period in 2004 is
primarily due to a increase in operating profit and the absence of losses from
discontinued operations of (euro)127 million.

     Total debt and net debt decreased by (euro)169 million and (euro)254
million as of September 30, 2005 compared to September 30, 2004. The decrease in
total debt is primarily due to the restructuring of Celanese. The decrease in
total debt was partially offset by increases in cash pooling with non
consolidated affiliates and related entities and notes with Infraserv, an
affiliate of Celanese. Net debt decreased due to an increase in cash and cash
equivalents of (euro)85 million.


                                       46



SELECTED DATA BY BUSINESS SEGMENT



                                                                                         TWELVE MONTHS ENDED SEPTEMBER 30,
                                                                               -------------------------------------------------
                                                                                        COMBINED
                                                                                          2005                     2004
                                                                                       (UNAUDITED)              (UNAUDITED)
                                                                               -----------------------   -----------------------
                                                                                              % OF                      % OF
                                                                               (EURO)(2)   SEGMENTS(1)   (EURO)(2)   SEGMENTS(1)
                                                                               ---------   -----------   ---------   -----------
                                                                                         (IN MILLIONS, EXCEPT PERCENTAGES)

NET SALES
Chemical Products ..........................................................     1,693          76         1,462          74
Technical Polymers Ticona ..................................................       383          17           381          19
Performance Products .......................................................       142           7           145           7
                                                                                 -----         ---         -----         ---
Segment Total ..............................................................     2,218         100         1,988         100
                                                                                               ===                       ===
Other Activities ...........................................................        --                         2
Intersegment Eliminations ..................................................        (8)                       (8)
                                                                                 -----                     -----
Total Net Sales ............................................................     2,210                     1,982
                                                                                 =====                     =====
SPECIAL CHARGES
Chemical Products ..........................................................        (4)          8            (3)         18
Technical Polymers Ticona:
   Restructuring, impairment and other special charges, net ................       (46)         92           (14)         82
Performance Products:
   Sorbates antitrust matters ..............................................        --          --            --          --
                                                                                 -----         ---         -----         ---
Segment Total ..............................................................       (50)        100           (17)        100
                                                                                               ===                       ===
Other Activities ...........................................................        --                       (20)
                                                                                 -----                     -----
Total Special Charges ......................................................       (50)                      (37)
                                                                                 =====                     =====
OPERATING PROFIT (LOSS)
Chemical Products ..........................................................       237          79           118          62
Technical Polymers Ticona ..................................................        14           5            30          16
Performance Products .......................................................        46          16            42          22
                                                                                 -----         ---         -----         ---
Segment Total ..............................................................       297         100           190         100
                                                                                               ===                       ===
Other Activities ...........................................................       (43)                      (81)
                                                                                 -----                     -----
Total Operating Profit .....................................................       254                       109
                                                                                 =====                     =====
EARNINGS (LOSS) FROM CONTINUING OPERATIONS BEFORE TAX AND MINORITY INTERESTS
Chemical Products ..........................................................       233          77           127          62
Technical Polymers Ticona ..................................................        26           9            30          16
Performance Products .......................................................        41          14            40          22
                                                                                 -----         ---         -----         ---
Segment Total ..............................................................       300         100           197         100
                                                                                               ===                       ===
Other Activities ...........................................................        36                       (58)
                                                                                 -----                     -----
Total Earnings from Continuing Operations Before Tax and Minority Interests        336                       139
                                                                                 =====                     =====



                                       47



SELECTED DATA BY BUSINESS SEGMENT - (CONTINUED)



                                                                                         NINE MONTHS ENDED SEPTEMBER 30,
                                                                               -------------------------------------------------
                                                                                          2004                     2003
                                                                               -----------------------   -----------------------
                                                                                                                (UNAUDITED)
                                                                                              % OF                      % OF
                                                                               (EURO)(2)   SEGMENTS(1)   (EURO)(2)   SEGMENTS(1)
                                                                               ---------   -----------   ---------   -----------
                                                                                        (IN MILLIONS, EXCEPT PERCENTAGES)

NET SALES
Chemical Products ..........................................................     1,115          73         1,178          75
Technical Polymers Ticona ..................................................       299          20           284          18
Performance Products .......................................................       111           7           117           7
                                                                                 -----         ---         -----         ---
Segment Total ..............................................................     1,525         100         1,579         100
                                                                                               ===                       ===
Other Activities ...........................................................         1                        --
Intersegment Eliminations ..................................................        (6)                       --
                                                                                 -----                     -----
Total Net Sales ............................................................     1,520                     1,579
                                                                                 =====                     =====
SPECIAL CHARGES
Chemical Products ..........................................................        (2)         33            (2)          2
Technical Polymers Ticona:
     Restructuring, impairment and other special charges, net ..............        (4)         67            (3)          3
Performance Products:
     Sorbates antitrust matters ............................................        --          --           (84)         95
                                                                                 -----         ---         -----         ---
Segment Total ..............................................................        (6)        100            89         100
                                                                                               ===                       ===
Other Activities ...........................................................       (20)                       --
                                                                                   ---                       ---
Total Special Charges ......................................................       (26)                       89
                                                                                   ===                       ===
OPERATING PROFIT (LOSS)
Chemical Products ..........................................................       107          60           115         125
Technical Polymers Ticona ..................................................        40          22            25          27
Performance Products .......................................................        33          18           (48)        (52)
                                                                                 -----         ---         -----         ---
Segment Total ..............................................................       180         100            92         100
                                                                                               ===                       ===
Other Activities ...........................................................       (68)                      (49)
                                                                                 -----                     -----
Total Operating Profit .....................................................       112                        43
                                                                                 =====                     =====
EARNINGS (LOSS) FROM CONTINUING OPERATIONS BEFORE TAX AND MINORITY INTERESTS
Chemical Products ..........................................................       119          62           123         121
Technical Polymers Ticona ..................................................        43          22            27          26
Performance Products .......................................................        32          16           (48)        (47)
                                                                                 -----         ---         -----         ---
Segment Total ..............................................................       194         100           102         100
                                                                                               ===                       ===
Other Activities ...........................................................       (37)                      (19)
                                                                                 -----                     -----
Total Earnings from Continuing Operations Before Tax and Minority Interests        157                        83
                                                                                 =====                     =====


(1)  The percentages in this column represent the percentage contributions of
     each segment to the total of all segments.

(2)  Derived from the accompanying Consolidated Financial Statements.

n.m. = not meaningful


                                       48



SELECTED DATA BY BUSINESS SEGMENT - (CONTINUED)



                                                                                        TWELVE MONTHS ENDED SEPTEMBER 30,
                                                                               -------------------------------------------------
                                                                                       COMBINED
                                                                                         2005                      2004
                                                                               -----------------------   -----------------------
                                                                                     (UNAUDITED)                (UNAUDITED)
                                                                                               % OF                     % OF
                                                                               (EURO)(2)   SEGMENTS(1)   (EURO)(2)   SEGMENTS(1)
                                                                               ---------   -----------   ---------   -----------
                                                                                                    (millions)

STOCK APPRECIATION RIGHTS
Chemical Products ..........................................................      --             --           --          --
Technical Polymers Ticona ..................................................      --             --           (2)        100
Performance Products .......................................................      --             --           --          --
                                                                                 ---            ---          ---         ---
Segment Total ..............................................................      --             --           (2)        100
                                                                                                ===                      ===
Other Activities ...........................................................      --                          (4)
Total Stock Appreciation Rights ............................................      --                          (6)
                                                                                 ===                         ===
DEPRECIATION & AMORTIZATION
Chemical Products ..........................................................      41             62           64          66
Technical Polymers Ticona ..................................................      21             32           28          29
Performance Products .......................................................       4              6            5           5
                                                                                 ---            ---          ---         ---
Segment Total ..............................................................      66            100           97         100
                                                                                                ===                      ===
Other Activities ...........................................................       3                           3
                                                                                 ---                         ---
Total Depreciation and Amortization ........................................      69                         100
                                                                                 ===                         ===


----------
(1)  The percentages in this column represent the percentage contributions of
     each segment to the total of all segments.

(2)  Derived from the accompanying Consolidated Financial Statements.


                                       49



SUMMARY BY BUSINESS SEGMENT - TWELVE MONTHS ENDED SEPTEMBER 30, 2005 COMPARED
WITH TWELVE MONTHS ENDED SEPTEMBER 30, 2004

     Chemical Products



                                                        COMBINED
                                                     TWELVE MONTHS   TWELVE MONTHS
                                                         ENDED           ENDED
                                                     SEPTEMBER 30,   SEPTEMBER 30,       TWELVE            TWELVE
                                                          2005           2004            MONTHS            MONTHS
IN (EURO) MILLIONS (EXCEPT FOR PERCENTAGES)           (UNAUDITED)     (UNAUDITED)    CHANGE IN (EURO)   CHANGE IN %
--------------------------------------------------   -------------   -------------   ----------------   -----------

Net sales ........................................      1,693            1,462             231              16%
Net sales variance:
   Volume ........................................          1%
   Price .........................................         16%
   Currency ......................................         (1)%
Operating profit .................................        237              118             119             101%
Operating margin .................................       14.0%             7.4%
Special charges ..................................         (4)              (3)             (1)            (33)%
Earnings from continuing operations before tax and
   minority interests ............................        233              127             106              83%
Depreciation and amortization ....................         41               64             (23)            (36)%
                                                        -----            -----             ---             ---


     Chemical Products' net sales increased by 16% to (euro)1,693 million for
the twelve months ended September 30, 2005 compared to the same period in 2004.
The increase is primarily due to selling price increases of 16% and slightly
higher volumes of 1%. The increases were partially offset by unfavorable
currency effects of (1)%.

     Selling prices increased significantly for most Chemical products,
particularly vinyl acetate, acetic acid, and acetyl derivatives. The price
increases were driven by strong demand, high utilization of base products across
the chemical industry and higher raw material costs.

     Operating profit increased to (euro)237 million for the twelve months ended
September 30, 2005 from (euro)118 million in the same period in 2004. The
increase is primarily due to higher selling prices for base products which were
only partly offset by higher raw material costs. A decrease in depreciation
expense also contributed to the increase in operating profit. The decrease in
depreciation expense is due to changes in the useful life of certain property,
plant and equipment in 2005.

     Earnings from continuing operations before tax and minority interest
increased to (euro)233 million for the twelve months ended September 30, 2005
from (euro)127 million in the same period in 2004 mainly due to the increased
operating profit.

     Technical Polymers Ticona



                                                        COMBINED
                                                     TWELVE MONTHS
                                                         ENDED          TWELVE MONTHS
                                                     SEPTEMBER 30,          ENDED              TWELVE
                                                          2005       SEPTEMBER 30, 2004        MONTHS       TWELVE MONTHS
IN (EURO) MILLIONS (EXCEPT FOR PERCENTAGES)           (UNAUDITED)       (UNAUDITED)       CHANGE IN (EURO)   CHANGE IN %
--------------------------------------------------   -------------   ------------------   ---------------   -------------

Net sales ........................................        383                381                  2                1%
Net sales variance:
   Volume ........................................         --
   Price .........................................          1%
   Currency ......................................         --
Operating profit .................................         14                 30                (16)             (53)%
Operating margin .................................        3.7%               7.9%
Special charges:
Restructuring, impairment and other special
   charges, net ..................................        (46)               (14)               (32)            (229)%
Earnings (loss) from continuing operations before
   tax and minority interests ....................         26                 30                 (4)             (13)%
Depreciation and amortization ....................         21                 28                 (7)             (25)%
                                                          ---                ---                ---             ----



                                       50



     Net sales for Ticona increased from (euro)381 to (euro)383 million for the
twelve months ended September 30, 2005 compared to the same period in 2004. This
increase is primarily due to slightly higher selling prices of approximately 1%.
The overall volumes were flat for the periods.

     Volumes increased in most business lines due to the successful introduction
of new applications. Polyacetal volumes declined due to a weak European
automotive market and the Company's focus on high-end business customers within
the Polyacetal business line. Selling price increases for primary products with
lower volumes assisted by increased volume of lower average priced product lines
contributed to Ticona's net sales growth in the twelve months ended September
30, 2005 compared to the same period in 2004. The lower average priced product
line is due to the commercialization of new applications with lower cost grades.

     Special charges increased to (euro)46 million for the twelve month period
ended September 30, 2005 compared to (euro)14 million in the same period in 2004
as a result of a (euro)45 million non-cash impairment charge associated with the
plan to dispose of the COC business. Special charges in 2004 consisted of
restructuring costs, largely for the redesign of the European operations.

     Operating profit decreased to (euro)14 million for the twelve month period
ended September 30, 2005 compared to (euro)30 million in the same period in
2004. The decrease is primarily due to higher special charges and increased raw
material and energy costs. Offsetting the higher costs were increased selling
prices, productivity savings, reduced spending and the affects of an inventory
build for a planned maintenance turnaround. The decrease in depreciation expense
was due to a change in useful life of certain property, plant and equipment.

     Earnings from continuing operations before tax and minority interests
decreased to (euro)26 million from (euro)30 million for the same period in 2004.
This decrease resulted primarily from a lower operating profit.

     Performance Products



                                                        COMBINED
                                                     TWELVE MONTHS
                                                         ENDED          TWELVE MONTHS
                                                     SEPTEMBER 30,          ENDED              TWELVE
                                                         2005        SEPTEMBER 30, 2004        MONTHS        TWELVE MONTHS
IN (EURO) MILLIONS(EXCEPT FOR PERCENTAGES)            (UNAUDITED)       (UNAUDITED)       CHANGE IN (EURO)    CHANGE IN %
--------------------------------------------------   -------------   ------------------   ----------------   -------------

Net sales ........................................        142                145                 (3)              (2)%
Net sales variance:
   Volume ........................................          6%
   Price .........................................         (7)%
   Currency ......................................         (1)%
Operating profit .................................         46                 42                  4               10%
Operating margin .................................       32.4%              29.0%
Special charges:
   Sorbates antitrust matters ....................         --                 --                 --               --
   Restructuring, impairment and other special
      charges, net ...............................         --                 --                 --               --
Earnings from continuing operations before tax
   and minority interests ........................         41                 40                  1                3%
Depreciation and amortization ....................          4                  5                 (1)             (20)%
                                                         ----               ----                ---              ---


     Net sales for the Performance Products segment decreased by 2% to (euro)142
million for the twelve months ended September 30, 2005 compared to the same
period in 2004. The decrease is the result of lower prices and negative currency
impacts partially offset by increased volumes. Volumes for Sunett(R) sweetener
increased, reflecting continuous growth from new and existing applications
mainly in the U.S. and European beverage and confectionary markets. Pricing for
Sunett declined on lower unit selling prices associated with higher volumes to
major customers which is consistent with the Company's positioning strategy for
the product. Pricing for Sorbates increased in the current year, although
worldwide overcapacity still prevailed in the industry.

     Operating profit and earnings from continuing operations before tax and
minority interests increased for the twelve months ended September 30, 2005
compared to the same period in 2004. The increase is driven by the improved
conditions for the Sorbates business, as well as the results of various cost
saving initiatives.


                                       51



     Earnings from continuing operations before tax and minority interests
increased to (euro)41 million from (euro)40 million for the same period in 2004.

Other Activities

     Other Activities primarily consist of corporate center costs, including
finance and administrative activities and other non-core operating activities.

     Sales to Pemeas and Ventures rounded to zero in the twelve months ended
September 30, 2005 compared to (euro)1 million in the twelve months ended
September 30, 2004.

     Operating loss decreased by 47% from (euro)81 million in the twelve month
period ended September 30, 2004 to (euro)43 million in the twelve month period
ended September 30, 2005 primarily due to the absence of special charges of
(euro)20 million relating to the advisory services associated with the tender
offer of CAG shares and (euro)15 million related to other one time acquisition
related fees recorded in selling and general adminstrative expenses. Lower
expenses for corporate activities in the twelve month period ended September 30,
2005 also contributed (euro)14 million to the reduced operating loss. This was
primarily driven by the elimination of certain corporate functions due to the
restructuring as well as by an increase of corporate overhead allocations of
(euro)7 million to the primary business segments. The operating loss for the
twelve month period ended September 30, 2004 included (euro)4 million expenses
for stock appreciation rights. The reduction of legal reserves by (euro)3
million in twelve month period ended September 30, 2005 also contributed
favorably to reduce the operating loss. Partially offsetting the reduction in
operating loss was an increase in managment compensation of (euro)11 million.

SUMMARY OF CONSOLIDATED RESULTS - COMBINED TWELVE MONTHS ENDED SEPTEMBER 30,
2005 COMPARED WITH TWELVE MONTHS ENDED SEPTEMBER 30, 2004

     Net Sales

     For the twelve months ended September 30, 2005, net sales increased to
(euro)2,210 million compared to (euro)1,982 million for the same period in 2004.
The net sales increase is due to price increases in the Chemical Products and
Ticona segment coupled with a slight volume increase within the Chemical
Products segment which were partially offset by an unfavorable currency effect
of approximately (1%) resulting mainly from the stronger euro versus other
currencies such as the U.S. dollar.

     Cost of Sales

     Cost of sales increased by (euro)115 million to (euro)1,699 million for the
twelve months ended September 30, 2005 compared to the same period in 2004. Cost
of sales increased due to higher raw material and energy costs and a slight
increase in volume.

     Selling, General and Administrative Expenses

     Selling, general and administrative expense decreased by (euro)37 million
to (euro)171 million for the twelve months ended September 30, 2005 compared to
the same period in 2004. This decrease was primarily due to the elimination of
certain corporate functions due to the Restructuring which reduced
administrative and personnel costs by (euro)14, the absence of (euro)15 million
related to advisory services associated with the tender offer of CAG shares
which was partially offset by an increase in management compensation of (euro)11
million. The absence of stock appreciation rights expense of (euro)6 million
also drove down selling, general and administrative expenses.

     Special Charges

     Special charges include provisions for restructuring and other expenses and
income incurred outside the normal course of ongoing operations. Restructuring
provisions represent costs of severance and other benefit programs related to
major activities undertaken to fundamentally redesign business operations, as
well as costs and expenses incurred in connection with a decision to exit
non-strategic businesses. These measures are based on formal management
decisions, establishment of agreements with the employees' representatives or
individual agreements with the affected employees, as well as the public
announcement of the restructuring plan.


                                       52



     The components of special charges for the twelve months ended September 30,
2005 and 2004 were as follows:



                                                             COMBINED
                                                           TWELVE MONTHS        TWELVE MONTHS
                                                              ENDED                ENDED
                                                        SEPTEMBER 30, 2005   SEPTEMBER 30, 2004
                                                        ------------------   ------------------
                                                           (UNAUDITED)           (UNAUDITED)
                                                                 (IN (EURO) MILLIONS)

Employee termination benefits........................            2                   12
Plant/office closures................................            3                    1
Restructuring adjustments............................           --                    4
                                                               ---                  ---
   Total Restructuring...............................            5                   17
Sorbates antitrust matters...........................           --                   --
Plumbing actions.....................................           --                   --
Asset impairments....................................           45                   --
Third-party reimbursements of restructuring charges..           --                   --
Other................................................           --                   20
                                                               ---                  ---
   Total Special Charges.............................           50                   37
                                                               ---                  ---


     Special charges increased by (euro)13 million to (euro)50 million for the
twelve months ended September 30, 2005 versus to the same period in 2004.
Special charges for the twelve months ended September 30, 2005 largely consisted
of asset impairments related to the disposal of COC of (euro)45 million. Special
charges for the same period in 2004 largely consisted of advisory services
associated with the tender offer of CAG shares in the amount of (euro)20
million.

     Operating Profit

     Operating profit increased by (euro)145 million to (euro)254 million
compared to the same period last year. Operating profit for the twelve months
ended September 30, 2005 benefited from higher selling prices and slight volume
increases. In addition, the absence of stock appreciation rights expense,
reduced special charges and the transfer of certain corporate functions to
related entities contributed to the improved operating profit. Higher raw
material costs partially offset the improved operating profit.

     Equity in Net Earnings of Affiliates

     Equity in net earnings of affiliates decreased by (euro)5 million to
(euro)12 million for the twelve months ended September 30, 2005 compared to the
same period in 2004. The decrease in equity in net earnings is primarily related
to the write down of the Estech investment of (euro)8 million which was
partially offset by an increase in equity in net earnings from Asian affiliates
of (euro)1 million due to increased sales volumes. Cash distributions received
from equity affiliates increased to approximately (euro)22 million for the
twelve months ended September 30, 2005 from (euro)14 million in the same period
in 2004 due to increased earnings from the Company's Asian ventures.

     Interest Expense

     Interest expense decreased to (euro)13 million for the twelve months ended
September 30, 2005 from (euro)16 million in the same period in 2004 primarily
due to lower debt levels in 2005.

     Interest and other income, net

     Interest and other income, net increased to (euro)83 million for the twelve
months ended September 30, 2005 from (euro)29 million for the same period last
year, primarily due to increased interest income associated with notes
receivable from related entities. Prior to the Restructuring these notes and
interest income were eliminated in consolidation of the Celanese entities.

     Income Taxes

     Celanese recognized income tax expense of (euro)78 million for the twelve
months ended September 30, 2005 compared to (euro)45 million for the same period
in 2004.

     The effective tax rate for Celanese for the twelve months ended September
30, 2005 was 23% percent compared to 31% percent for the same period a year ago.
The favorable change in tax rate as of September 30, 2005 was primarily due to
higher unrepatriated low-taxed earnings in Singapore.


                                       53



     Discontinued Operations

     The net proceeds from the disposal of discontinued operations represents
cash received from an early contractual settlement of receivables of (euro)22
million related to the sale in 2000 of the company's interest in Vinnolit
Kunststoff GmbH and Vintron GmbH.

     In October 2004, Celanese Corporation, the ultimate parent of Celanese,
completed an organizational restructuring ("Restructuring"). As part of the
Restructuring, Celanese Corporation, by causing the Purchaser to give
corresponding instruction to Celanese under the Domination Agreement, effected
the transfer of all shares of CAC from Celanese Holding GmbH, a wholly owned
subsidiary of Celanese, to BCP Caylux which resulted in BCP Caylux owning 100%
of the equity of CAC and, indirectly, all of its assets, including subsidiary
stock. The transfer was effected under the Domination Agreement as follows: (1)
Celanese Holding GmbH distributed all outstanding shares in CAC to Celanese, (2)
Celanese sold all outstanding shares in CAC to Purchaser for a note in an amount
equal to CAC's fair market value of (euro)291 million and (3) Purchaser
transferred all outstanding capital stock of CAC to BCP Caylux for (euro)291
million.

     The Company recorded a tax expense of (euro)130 million associated with
discontinued operations for the twelve months ended September 30, 2004,
primarily due to US tax laws which restrict the utilization of net operating
loss carryforwards upon a more than 50% change in ownership.

     The following table summarizes the results of the discontinued operations
of CAC as well as the Company's Acrylates and Vinnolit businesses for the twelve
months ended September 30, 2005 and 2004.

                                                        TWELVE MONTHS ENDED
                                                           SEPTEMBER 30,
                                                     -------------------------
                                                       COMBINED
                                                         2005         2004
                                                     (UNAUDITED)   (UNAUDITED)
                                                     -----------   -----------
                                                        (IN (EURO) MILLIONS)
Net sales                                                 --          2,578
Cost of sales                                             --         (2,267)
Gross profit                                              --            310
Operating profit                                          --            (50)
Gain (loss) on disposal of discontinued operations        22             --
Earnings (loss) from discontinued operations              22           (127)

     Net Earnings (Loss)

     As a result of the factors mentioned above, the net earnings (loss) of
Celanese improved to (euro)231 million or (euro)4.68 per basic share and
(euro)4.67 per diluted share for the twelve months ended September 30, 2005 from
a net loss of (euro)55 million or (euro)1.11, basic and diluted, share for the
same period last year.


                                       54



SUMMARY BY BUSINESS SEGMENT - NINE MONTHS ENDED SEPTEMBER 30, 2004 COMPARED WITH
NINE MONTHS ENDED SEPTEMBER 30, 2003

     Chemical Products



                                                               NINE MONTHS        NINE MONTHS
                                                                  ENDED              ENDED
                                                              SEPTEMBER 30,   SEPTEMBER 30, 2003      NINE MONTHS     NINE MONTHS
IN (EURO) MILLIONS (EXCEPT FOR PERCENTAGES)                       2004            (UNAUDITED)      CHANGE IN (EURO)   CHANGE IN %
-----------------------------------------------------------   -------------   ------------------   ----------------   -----------

Net sales..................................................      1,115              1,178                (63)             (5)%
Net sales variance:
   Volume..................................................          7%
   Price...................................................          3%
   Currency................................................         (3)%
   Other...................................................        (12)%
Operating profit...........................................        107                115                 (8)             (7)%
Operating margin...........................................        8.7%               9.8%
Special charges............................................         (2)                (2)                --              --
Earnings from continuing operations before tax and minority
   interests...............................................        119                123                 (4)             (3)%
Depreciation and amortization..............................         48                 48                 --              --
                                                                 -----              -----                ---             ---


     Chemical Products' net sales for the nine months ended September 30, 2004
decreased by 5% to (euro)1,115 million compared to the same period in 2004 as
increased volumes (7%), and higher pricing (3%) were offset by changes in the
composition of the segment (-12%) and unfavorable currency movements (-3%). The
changes in the composition of the segment result from the transfer of the
European oxo business into a venture in the fourth quarter of 2003 (-10%).

     Volumes rose for major chemical products, particularly vinyl acetate
monomer, which increased due to stronger overall demand and a competitor outage.
Volumes also increased for polyvinyl alcohol and emulsions. Pricing increased
for most acetyl and acetyl derivative products, particularly vinyl acetate
monomer in all regions, following rising costs for raw materials, particularly
ethylene.

     Operating profit decreased by 7% to (euro)107 million compared to the same
period in 2003. Higher volumes and higher selling prices were more than offset
by increased raw material costs and distribution costs.

     Technical Polymers Ticona



                                                                NINE MONTHS        NINE MONTHS
                                                                   ENDED              ENDED
                                                               SEPTEMBER 30,   SEPTEMBER 30, 2003      NINE MONTHS     NINE MONTHS
IN (EURO) MILLIONS (EXCEPT FOR PERCENTAGES)                         2004           (UNAUDITED)      CHANGE IN (EURO)   CHANGE IN %
------------------------------------------------------------   -------------   ------------------   ----------------   -----------

Net sales...................................................        299               284                  15               5%
Net sales variance:
   Volume...................................................          5%
   Price....................................................         (1)%
Operating profit............................................         40                25                  15              60%
Operating margin............................................       13.4%              8.8%
Special charges:
Restructuring, impairment and other special charges, net....         (4)               (3)                 (1)            (33)%
Earnings (loss) from continuing operations before tax and
   minority interests.......................................         43                27                  16              59%
Depreciation and amortization...............................         23                19                   4              21%
                                                                   ----               ---                 ---             ---


     Net sales for Ticona for the nine months ended September 30, 2004 increased
by 5% to (euro)299 million compared to the same period last year. Volume
increases (5%) were partly offset by a decline in pricing (-1%).

     Volumes increased in most business lines, particularly in polyacetal,
Vectra liquid crystal polymers and GUR ultra high molecular weight polyethylene.
Polyacetal volumes grew on stronger sales in the medical applications industry
and benefited from greater demand for uses in consumer products and the
commercialization of new applications. Volumes for Vectra rose due to new
commercial applications, such as in


                                       55



household goods, and stronger sales to the electrical/electronics industry. GUR
volumes grew as a result of increased sales for new specialty applications.

     Overall pricing declined due to changes in product mix and ongoing
competitive pricing pressure from Asian exports of polyacetal into Europe.

     Operating profit for the nine months ended September 30, 2004 increased to
(euro)40 million from (euro)25 million due to higher volumes and lower average
production costs for Vectra. These factors were partly offset by lower pricing,
higher energy costs, higher depreciation expenses and redesign costs.

     Earnings from continuing operations before tax and minority interests
increased to (euro)43 million from (euro)27 million in the same period in 2003.
This increase resulted primarily from the higher operating profit and improved
equity earnings from Asian affiliates due to increased sales volumes.

     Performance Products



                                                             NINE MONTHS       NINE MONTHS
                                                                ENDED             ENDED
                                                            SEPTEMBER 30,   SEPTEMBER 30, 2003     NINE MONTHS      NINE MONTHS
IN (EURO) MILLIONS(EXCEPT FOR PERCENTAGES)                       2004           (UNAUDITED)      CHANGE IN (EURO)   CHANGE IN %
---------------------------------------------------------   -------------   ------------------   ----------------   -----------

Net sales................................................        111                117                 (6)              (5)%
Net sales variance:
   Volume................................................         12%
   Price.................................................        (15)%
   Currency..............................................         (2)%
Operating profit (loss)..................................         33                (48)                81             >100%
Operating margin.........................................       29.7%             (41.0)%
Special charges:
   Sorbates antitrust matters............................         --                (84)                84             (100)%
Earnings (loss) from continuing operations before tax and        32
   minority interests....................................                           (48)                80             >100%
Depreciation and amortization............................         4                   5                 (1)             (20)%
                                                                ----              -----                ---             ----


     Net sales in the nine months ended September 30, 2004 for the Performance
Products segment, which consists of the Nutrinova food ingredients business,
decreased by 5% to (euro)111 million compared to the same period in 2003 as
increased volumes (12%) were offset by price decreases (-15%) and unfavorable
currency effects (-2%).

     Increased volumes for Sunett sweetener reflected strong growth from new and
existing applications in the U.S. and European beverage and confectionary
markets. Pricing for Sunett declined on lower unit selling prices associated
with higher volumes to major customers and the anticipated expiration of the
primary European and U.S. production patents in 2005.

     Pricing for sorbates, which had been under pressure from Asian producers,
began to stabilize, although worldwide overcapacity still prevailed in the
industry.

     Operating profit increased to (euro)33 million compared to an operating
loss of (euro)48 million for the same period in 2003, which included special
charges of (euro)84 million related to antitrust actions in the sorbates
industry. Operating profit for the nine months ended September 30, 2004
benefited from strong volumes for Sunett which were offset by lower pricing for
Sunett and sorbates.

Other Activities

     Other Activities primarily consists of corporate center costs, including
financing and certain administrative activities and certain other operating
entities.

     Net sales for Other Activities was (euro)1 million for the nine months
ended September 30, 2004 compared to zero in the same period in 2003, primarily
due to Pemeas and Ventures.

     Operating loss for the nine months ended September 30, 2004 increased to
(euro)68 million compared to an operating loss of (euro)49 million for the same
period last year. This increase was primarily due to special charges of (euro)20
million mainly related to advisory services associated with the tender offer of
CAG shares as well higher employee benefit related costs including severance and
employee incentives. The operating loss for the nine


                                       56



months ended September 30, 2003 included (euro)13 million in expense for stock
appreciation rights as compared to (euro)0 million during the same period in
2004.

     Loss from continuing operations before tax and minority interests increased
to (euro)37 million from (euro)19 million for the same period last year. This
increase is primarily due to a higher operating loss.


                                       57



SUMMARY OF CONSOLIDATED RESULTS - NINE MONTHS ENDED SEPTEMBER 30, 2004 COMPARED
WITH NINE MONTHS ENDED SEPTEMBER 30, 2003

     Net Sales

     For the nine months ended September 30, 2004, net sales decreased to
(euro)1,520 million compared to (euro)1,579 million for the same period in 2003.
Volume increases in all segments were offset by unfavorable currency effects
resulting mainly from the stronger euro versus the U.S. dollar, reductions due
to changes in the composition of the Chemical Products segment and lower pricing
in the Ticona and Performance Products segments.

     The changes in the composition of the segment result from the transfer of
the European oxo business into a venture in the fourth quarter of 2003.

     Cost of Sales

     Cost of sales decreased by (euro)70 million to (euro)1,193 million for the
nine months ended September 30, 2004 versus the comparable period in 2003.
Higher raw material costs were offset by favorable currency effects and
decreases due to changes in the composition of the Chemical Products segment.

     Selling, General and Administrative Expenses

     Selling, general and administrative expense increased slightly by (euro)1
million to (euro)154 million for the nine months ended September 30, 2004
compared to the same period in 2003. This increase was primarily due higher
employee benefit related costs including severance and employee incentives which
were partially offset by favorable currency movements and (euro)13 million of
lower stock appreciation rights expense.

     Special Charges

     The components of special charges for the nine months ended September 30,
2004 and 2003 were as follows:

                                             NINE MONTHS         NINE MONTHS
                                                ENDED                ENDED
                                         SEPTEMBER 30, 2004   SEPTEMBER 30, 2003
                                         ------------------   ------------------
                                                                  (UNAUDITED)
                                                   (IN (EURO) MILLIONS)
Employee termination benefits.........             5                    4
Plant/office closures.................            --                   --
Restructuring adjustments.............             1                    1
                                                 ---                  ---
   Total Restructuring................             6                    5
Sorbates antitrust matters............            --                   84
Third-party reimbursements of
   restructuring charges..............            --                   --
Other.................................            20                   --
                                                 ---                  ---
   Total Special Charges..............            26                   89
                                                 ---                  ---

     Special charges decreased to (euro)26 million for the nine months ended
September 30, 2004 as compared to (euro)89 million for the same period last
year. Special charges for the nine months ended September 30, 2004 largely
consisted of advisory services associated with the tender offer of CAG shares in
the amount of (euro)20 million, while special charges for the same period in
2003 resulted mainly from expenses of (euro)84 million associated with antitrust
matters in the sorbates industry.

     Operating Profit

     Operating profit increased by 160% to (euro)112 million compared to
(euro)43 million in the same period in 2003. Operating profit for the nine
months ended September 30, 2004 benefited from lower special charges and
(euro)13 million of lower expense for stock appreciation rights.

     Equity in Net Earnings of Affiliates

     Equity in net earnings of affiliates rose by (euro)3 million to (euro)15
million for the nine months ended September 30, 2004 compared to the same period
last year. This increase primarily consisted of improved equity earnings from
Asian and European affiliates, due to increased sales volumes. Cash
distributions received from equity affiliates remained unchanged at (euro)14
million for the nine months ended September 30, 2004 and 2003.


                                       58



     Interest Expense

     Interest expense increased slightly to (euro)11 million for the nine months
ended September 30, 2004 from (euro)10 million in the same period last year,
primarily due to average debt levels remaining unchanged.

     Interest and other income, net

     Interest and other income rose slightly to (euro)41 million during the nine
months ended September 30, 2004 from (euro)38 million during the nine months
ended September 30, 2003. Dividend income from investments for the nine months
ended September 30, 2004 accounted for under the cost method remained flat at
(euro)24 million compared to the same period in 2003.

     Income Taxes

     Celanese recognized income tax expense of (euro)39 million for the nine
months ended September 30, 2004 compared to (euro)24 million for the same period
in 2003.

     The effective tax rate for Celanese for the nine months ended September 30,
2004 was 25 percent compared to 32 percent for the same period a year ago.

     Discontinued Operations

     In October 2004, the parent of the Purchaser completed an organizational
restructuring ("Restructuring"). As part of the Restructuring, CAC was
transferred to the Purchaser. See discussion at Summary of Consolidated Results
- Twelve Months Ended September 30, 2005 Compared with Twelve Months Ended
September 30, 2004 - Discontinued Operations.

     The Company recorded a tax expense of (euro)139 million associated with
discontinued operations for the nine months ended September 30, 2004, primarily
due to US tax laws which restict the utilization of net operating loss
carryforwards upon a more than 50% change in ownership. .

     The following table summarizes the results of the discontinued operations
of CAC as well as the Company's Acrylates and Vinnolit businesses for the nine
months ended September 30, 2004 and 2003.

                                           NINE MONTHS ENDED
                                             SEPTEMBER 30,
                                         --------------------
                                            2004     2003
                                           ------   ------
                                         (IN (EURO) MILLIONS)
Net sales                                   1,888    2,053
Cost of sales                              (1,646)  (1,853)
Gross profit                                  242      200
Operating profit                              (61)      64
Gain(loss) on disposal of discontinued
   operations                                  --       (1)
Earnings (loss) from discontinued
   operations                                (170)      64

     Net Earnings (Loss)

     As a result of the factors mentioned above, the net earnings (loss) of
Celanese declined to a net loss of (euro)70 million or (euro)1.42 per, basic and
diluted, share for the nine months ended September 30, 2004 from net earnings of
(euro)116 million or (euro)2.34 per, basic and diluted, share for the same
period last year.


                                       59



LIQUIDITY AND CAPITAL RESOURCES

Cash Flows

     Cash Provided by Operating Activities

     Cash from operating activities increased to a cash inflow of (euro)389
million for the twelve months ended September 30, 2005 compared to a cash inflow
of (euro)151 million for the same period in 2004. This increase primarily
resulted from an increase in earnings from continuing operations in 2005 of
(euro)141 million, the reduction of pension contributions of (euro)85 million
and an increase dividends from affiliates of (euro)8 million.

     Cash from operating activities increased to a cash inflow of (euro)110
million for the nine months ended September 30, 2004 compared to a cash inflow
of (euro)87 million for the same period in 2003. This increase primarily
resulted from an increase in net earnings from continuing operations in the nine
month period ended September 30, 2004 of (euro)48 million and a reduction in
taxes paid of (euro)109 million. Other factors increasing cash in the nine
months ended September 30, 2004 include a decline in payments associated with
bonuses and restructuring as well as lower cash consumed through changes in
inventory and trade payables. The increase in cash was partially offset by a
(euro)76 million payment of an obligation to third party, an increase in pension
contributions of (euro)36 million and payments of (euro)48 million associated
with the exercising of stock appreciation rights. The hedging of foreign
currency net receivables, primarily related entities, resulted in a (euro)13
million cash inflow in the first nine months of 2004 compared to a (euro)120
million cash inflow in the first nine months in 2003.

     Cash Used in Investing Activities

     Cash used in investing activities increased during the twelve months ended
September 30, 2005 by (euro)324 million to (euro)398 million from (euro)74
million during the twelve months ended September 30, 2004. The cash outflow was
primarily due to an increase in loans to related entities of (euro)384 million.
This increase was partially offset by (euro)21 million in net proceeds from the
sale of the powders business to ICI and the disposal of discontinued operations
of (euro)43 million.

     Cash used in investing activities decreased during the nine months ended
September 30, 2004 by (euro)27 million to (euro)38 million from (euro)65 million
during the nine months ended September 30, 2003. This decrease was primarily due
to a reduction in capital expenditures and acquisitions of businesses of
(euro)14 million and (euro)13 million respectively.

     Capital expenditures were (euro)76 million and (euro)73 million for the
twelve months ended September 30, 2005 and 2004, respectively, and were (euro)42
million and (euro)56 million for the nine months ended September 30, 2004 and
2003, respectively. Spending primarily related to major replacements of
equipment, capacity expansions, major investments to reduce future operating
costs, environmental, health and safety initiatives and the integration of a
company-wide SAP platform. In addition, 2004 and 2003 included spending related
to the completion of a production facility for synthesis gas, a primary raw
material at the Oberhausen site in Germany.

     Cash Provided by/Used in Financing Activities

     Cash provided by financing activities increased during the twelve months
ended September 30, 2005 by (euro)95 million to (euro)93 million compared to
cash used by financing activities of (euro)2 million during the twelve months
ended September 30, 2004. The increase is due to an (euro)85 million increase in
short-term borrowings, partially offset by a decrease in proceeds from long-term
debt of (euro)37 million. Also contributing to the increase was a decrease in
payments for long-term debt of (euro)52 million and the absence of a (euro)6
million dividend payment in 2005. The increase was partially offset by the
absence of proceeds for the issuance of preferred shares of (euro)14 million.

     Cash used for financing activities decreased during the nine months ended
September 30, 2004 by (euro)9 million to (euro)25 million from (euro)34 million
during the nine months ended September 20, 2003. The decrease was due to
proceeds from the sale of treasury stock of (euro)27 million, proceeds for the
issuance of preferred shares of (euro)14 million and a decrease in dividend
payments of (euro)16 million, partially offset by an increase in payments of
long-term debt of (euro)48 million.

     Liquidity

     Historically and in the near future, the primary source of liquidity has
been and is expected to be cash generated from operations, which includes cash
inflows from currency hedging activities. The primary liquidity


                                       60



requirements were for capital expenditures, working capital, pension
contributions and investments. We believe we will have available resources to
meet both our short-term and long-term liquidity requirements. If our cash flow
from operations is insufficient to fund our obligations, we may be forced to use
other means available to us, such as reducing or delaying capital expenditures,
seeking additional capital from Celanese Corporation, our ultimate parent, or
related entities and affiliates or seeking prepayment of related entity and
affiliate notes.

     As of September 30, 2005, Celanese had a total debt of (euro)332 million
and cash and cash equivalents of (euro)176 million. (euro)252 million of the
total debt is due in one year. Several non-consolidated affiliates pool their
excess cash with Celanese, and the excess cash is loaned to Celanese under a
revolving credit agreement. The outstanding payables for these agreements from
Celanese to its affiliates of (euro)228 million and (euro)165 million at
September 30, 2005 and 2004, respectively, are included within short-term
borrowings. Celanese expects to continue these arrangements at a comparable
level in the next fiscal year, depending on the level of liquidity of the
non-consolidated affiliates.

     As a result of the Purchaser's acquisition of Celanese AG, Celanese
canceled its previously existing revolving credit lines and, thus, the Company
has no availability or access to committed credit facilities. Additionally,
Celanese no longer has a commercial paper program.

     Subsidiaries of Celanese's ultimate parent, Celanese Corporation, have
incurred significant debt and do not have substantial operating activities from
which to generate operating cash flows. Consequently, these related entities may
be reliant in part on Celanese for funds to service their debt.

     The Domination Agreement entitles the Purchaser to give instructions
directly to the management board of Celanese, including, but not limited to,
instructions that are disadvantageous to Celanese, as long as such
disadvantageous instructions benefit the Purchaser or the companies affiliated
with either the Purchaser or Celanese. As a dominated company, Celanese may be
affected by risks that affect the Purchaser and its affiliates, including but
not limited to risks arising out of the debt levels of these companies.

     While the Domination Agreement is operative, the Purchaser is required to
compensate Celanese for any statutory annual loss incurred by Celanese, on a
non-consolidated basis, at the end of its fiscal year when the loss was
incurred. This compensation is contingent upon the Purchaser having adequate
liquidity. If the Purchaser were obligated to make cash payments to Celanese to
cover an annual loss, the Purchaser may not have sufficient funds to pay
interest when due on notes due to Celanese and, unless the Purchaser is able to
obtain funds from a source other than annual profits of Celanese, the Purchaser
may not be able to satisfy its obligation to fund such shortfall. The Domination
Agreement cannot be terminated by the Purchaser until September 30, 2009.

     For fiscal years ending subsequent to September 30, 2004, the remaining
minority shareholders of CAG shares are entitled to a guaranteed fixed annual
payment in lieu of dividends. The guaranteed fixed annual payment is not an
obligation of Celanese. For the fiscal years ended on September 30, 2004,
Celanese was not able to pay a dividend to its shareholders due to losses
incurred in the Celanese statutory accounts. As the Domination Agreement did not
become effective until October 1, 2004, the Purchaser has no obligation to
compensate Celanese for the statutory loss incurred prior to October 1, 2004.

     CONTRACTUAL OBLIGATIONS: The following table sets forth our fixed
contractual cash obligations as of September 30, 2005.



                                                     LESS THAN 1    1-3     4-5    AFTER 5
FIXED CONTRACTUAL CASH OBLIGATIONS           TOTAL       YEAR      YEARS   YEARS    YEARS
------------------------------------------   -----   -----------   -----   -----   -------
                                                         (IN (EURO) MILLIONS)

Total Debt................................     332        252         --      60      20
   of which Capital Lease Obligations
   and Other Secured Borrowings...........      24         23         --      --       1
Operating Leases..........................      94         23         23      15      33
Unconditional Purchase Obligations........     650         48        105     106     391
Other Contractual Obligations.............     133        132          1      --      --
                                             -----        ---        ---     ---     ---
   Fixed Contractual Cash Obligations-....   1,233        478        129     181     445
                                             =====        ===        ===     ===     ===



                                       61



     Unconditional Purchase Obligations include take or pay contracts and fixed
price forward contracts. Celanese does not expect to incur any material losses
under these contractual arrangements. In addition, these contracts may include
variable price components.

     Other Contractual Obligations primarily includes committed capital spending
and fines associated with the antitrust matter described in Note 26 to the
Consolidated Financial Statements. Included in Other Contractual Obligations is
a (euro)99 million fine from the European Commission related to antitrust
matters in the sorbates industry, which is pending an appeal. Celanese is
indemnified by a third party for 80% of the expenses relating to these matters,
which is not reflected in the amount above.

     At September 30, 2005, Celanese has contractual guarantees and commitments
as follows:



                                                    EXPIRATION PER PERIOD
                                          ---------------------------------------------
                                                  LESS THAN 1    1-3     4-5    AFTER 5
CONTRACTUAL GUARANTEES AND COMMITMENTS    TOTAL       YEAR      YEARS   YEARS    YEARS
---------------------------------------   -----   -----------   -----   -----   -------
                                                      (IN (EURO) MILLIONS)

Standby Letters of Credit..............     29         29         --      --       --
                                           ---        ---        ---     ---      ---
   Contractual Guarantees and
      Commitments......................     29         29         --      --       --
                                           ===        ===        ===     ===      ===


     Standby letters of credit of (euro)29 million at September 30, 2005 are
irrevocable obligations of an issuing bank that ensure payment to third parties
in the event that certain Celanese subsidiaries fail to perform in accordance
with specified contractual obligations. The likelihood is remote that material
payments will be required under these agreements. Of these standby letters of
credit and bank guarantees, approximately (euro)21 million relates to
obligations associated with the sorbates antitrust matters as described in the
"Other Contractual Obligations" above.

     For additional commitments and contingences, see Note 26 to the
Consolidated Financial Statements.

     Celanese expects to continue to incur costs for the following significant
obligations. Although Celanese cannot predict with certainty the annual
spending for these matters, such matters will affect future cash flows of
Celanese.

                                                         2006
                                         2005 ACTUAL   PROJECTED
OTHER OBLIGATIONS                         SPENDING     SPENDING
--------------------------------------   -----------   ---------
                                           (IN (EURO) MILLIONS)
Environmental Matters.................         24          20
Benefit Obligations...................          4           2
                                              ---         ---
Other Obligations.....................         28          22
                                              ===         ===

     Environmental Matters

     For the combined periods October 1, 2004 to August 24, 2005 and August 25
to September 30, 2005, the nine months ended September 30, 2004 and the year
ended December 31, 2003, Celanese's worldwide expenditures, including
expenditures for legal compliance, internal environmental initiatives and
remediation of active, orphan, and divested sites, were (euro)24 million,
(euro)20 million and (euro)25 million, respectively. Capital project related
environmental expenditures, included in worldwide expenditures, were (euro)1
million, (euro)1 million and (euro)2 million, respectively. Environmental
reserves for remediation matters were (euro)6 million as of September 30, 2005
and 2004, respectively. (See Note 27 to the Consolidated Financial Statements.)

     It is anticipated that stringent environmental regulations will continue to
be imposed on the chemical industry in general. Celanese cannot predict with
certainty future environmental expenditures, especially expenditures beyond
2006. A recent European Union directive that required a trading system for
carbon dioxide emissions took effect on January 1, 2005. Accordingly, Emission
Trading Systems could affect Celanese's power plants at the Kelsterbach and
Oberhausen sites in Germany, as well as power plants operated by InfraServ
entities on sites at which we operate. We and the InfraServ entities may be
required to purchase carbon dioxide credits, which could result in increased
operating costs, or may be required to develop additional cost-effective methods
to reduce carbon dioxide emissions further, which could result in increased
capital expenditures. Additionally, the new regulation indirectly affects our
other operations in the European Union, which may experience higher energy costs
from third party providers.


                                       62



     Due to its industrial history, Celanese has the obligation to remediate
specific areas on its active sites as well as on divested and orphan sites. In
addition, as part of the demerger agreement with Hoechst, a specified proportion
of the responsibility for environmental liabilities from a number of
pre-demerger divestitures was transferred to Celanese. Celanese has provided for
such obligations when the event of loss is probable and reasonably estimable.
Management believes that the environmental costs will not have a material
adverse effect on the financial position of Celanese, but they may have a
material adverse effect on the results of operations or cash flows in any given
accounting period. (See Note 27 to the Consolidated Financial Statements.)

     Benefit Obligations

     Celanese's funding policy for pension plans is to accumulate plan assets
that, over the long run, will approximate the present value of projected benefit
obligations. For the combined periods October 1, 2004 to August 24, 2005 and
August 25 to September 30, 2005 and the nine months ended September 30, 2004,
contributions to the pension plans amounted to (euro)4 million and (euro)85
million, respectively.

     Sorbates Litigation

     For the combined periods October 1, 2004 to August 24, 2005 and August 25
to September 30, 2005 and the nine months ended September 30, 2004, the Company
paid less than (euro)1 million and approximately (euro)1 million, respectively,
in connection with the sorbates litigation. As of September 30, 2005 and 2004
Celanese had remaining accruals of (euro)108 million and (euro)105 million,
respectively, included in current liabilities for the estimated loss relative to
this matter. In addition, Celanese had receivables from Hoechst in connection
with the sorbates matter of (euro)87 million and (euro)84 million as of
September 30, 2005 and 2004, respectively.

     Although it is impossible at this time to determine with certainty the
ultimate outcome of this matter, management believes, based on the advice of
legal counsel, that adequate provisions have been made and that the ultimate
outcome will not have a material adverse effect on the financial position of
Celanese, but could have a material adverse effect on the results of operations
or cash flows in any given accounting period. (See Note 26 to the Consolidated
Financial Statements.)

     Other Matters

     From time to time, certain of Celanese Corporation's foreign subsidiaries
have made sales of acetate, sweeteners and polymer products to countries that
are or have previously been subject to sanctions and embargoes imposed by the US
government. These countries include Iran, Sudan and Syria, three countries
currently identified by the U.S. State Department as terrorist-sponsoring states
and other countries that previously have been identified by the U.S. State
Department as terrorist-sponsoring states, or countries to which sales have been
regulated in connnection with other foreign policy concerns. Approximately
(euro)9 million of these sales by Celanese Corporation's foreign subsidiaries
over a five year period may be in violation of regulations of the United States
Treasury Department's Office of Foreign Assets Control, or OFAC, or the United
States Department of Commerce's Bureau of Industry and Security. Approximately
(euro)5 million of these sales were made by the Company or its subsidiaries. In
addition, Celanese Corporation has discovered that the Company made
approximately (euro)150,000 of sales of emulsions to Cuba which were apparently
in violation of OFAC regulations. Cuba is also currently identified by the U.S.
State Department as a terrorist-sponsoring state. Celanese Corporation has
informed the U.S. Treasury Department and the U.S. Department of Commerce of
both of these matters and is currently engaged in discussions with the
Departments. The inquiry into these transactions is continuing. None of the
aforementioned sales were in violation of German law. To the extent Celanese
Corporation or the Company violated any regulations with respect to the above or
other transactions, Celanese Corporation or the Company may be subject to fines
or other sanctions, including possible criminal penalties, which may result in
adverse business consequences. Neither the Company nor Celanese Corporation
expect these matters to have a material adverse effect on their respective
financial position, results of operations and cash flows.

     Capital Expenditures

     Celanese's combined capital expenditures were (euro)76 million for the
periods October 1, 2004 to August 24, 2005 and August 25 to September 30, 2005.
Capital expenditures primarily related to major replacements of equipment,
capacity expansions, major investments to reduce future operating costs,
environmental, health and safety initiatives and the integration of a
company-wide SAP platform.

     Capital expenditures were financed principally with cash from operations.
Celanese anticipates spending for the 2006 fiscal year to be approximately 2% of
combined net sales for the periods October 1, 2004 to August 24,


                                       63



2005 and August 25 to September 30, 2005. At September 30, 2005, there were
approximately (euro)25 million of outstanding commitments related to capital
projects, which are included within the fixed contractual cash obligations table
above.

     Total Shareholders' Equity

     At September 30, 2005, shareholders' equity amounted to (euro)2,456
million, compared to (euro)1,888 million at September 30, 2004. The increase was
primarily attributable to the removal of accumulated other comprehensive loss
components totalling (euro)577 million related to the transfer out of CAC,
exercise of stock options funded by treasury stock of (euro)16 million, change
in foreign currency translation and current year net earnings of (euro)235
million for the combined periods August 25 to September 30, 2005 and October 1,
2004 to August 24, 2005, respectively partially offset by the deemed
distribution related to the transfer of CAC of (euro)227 million, net push down
adjustments of (euro)64 million and the recognition of an additional minimum
liability adjustment for pensions of approximately (euro)13 million.

     As of September 30, 2005, Celanese had 20,850 stock appreciation rights
outstanding. There were 3,800 stock appreciation rights exercised during the
period October 1, 2004 to August 24, 2005 and August 25 to September 30, 2005.
There were no payments in 2005 related to the exercise of stock appreciation
rights.

     There were 50,365,018 and 49,881,618 CAG shares outstanding as of September
30, 2005 and 2004, respectively. As of September 30, 2005, Celanese had zero
stock options outstanding. As of September 30, 2004, and December 31, 2003,
Celanese had 544,750 and 1,151,600 stock options outstanding, respectively. The
combined expense associated with stock options was approximately (euro)2
million, (euro)2 million, and (euro)5 million for the period August 25 to
September 30, 2005 and October 1, 2004 to August 24, 2005, nine months ended
September 30, 2004 and the year ended December 31, 2003, respectively.

Market Risks

     Celanese is exposed to market risk through commercial and financial
operations. Celanese's market risk consists principally of exposure to currency
exchange rates, interest rates and commodity prices. Celanese has in place
policies of hedging against changes in currency exchange rates, interest rates
and commodity prices as described below. These contracts are accounted for under
SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities
amended by SFAS No. 138, Accounting for Certain Derivative Instruments and
Certain Hedging Activities and SFAS No. 148, Amendment of Statement 133 on
Derivative Instruments and Hedging Activities. (See Note 25 to the Consolidated
Financial Statements.)

     Foreign Exchange Risk Management

     Celanese's reporting currency is the euro. Certain Celanese entities have
receivables and payables denominated in currencies other than their functional
currencies, which creates foreign exchange risk. With the introduction of the
euro on January 1, 1999, the exposure to exchange rate fluctuations is
eliminated in relation to the euro zone countries that have adopted the euro as
their common currency, leaving the U.S. dollar, Japanese yen, British pound
sterling, and Canadian dollar as the most significant potential sources of
currency risk. Accordingly, Celanese enters into foreign currency forwards and
options to minimize its exposure to foreign currency fluctuations. The foreign
currency contracts are designated for recognized assets and liabilities and
forecasted transactions. The terms of these contracts are generally less than
one year. Celanese's centralized hedging strategy states that foreign currency
denominated receivables or liabilities recorded by the operating entities will
be used to hedge the exposure on a consolidated basis. As a result, Celanese's
foreign currency forward contracts relating to this centralized strategy did not
meet the criteria of SFAS No. 133 to qualify for hedge accounting. Net foreign
currency transaction gains or losses are recognized on the underlying
transactions, which are offset by losses and gains related to foreign currency
forward contracts.

     Contracts with notional amounts totaling approximately (euro)420 million,
(euro)498 million and (euro)606 million at September 30, 2005 and 2004 and
December 31, 2003, respectively, are predominately in U.S. dollars, British
pound sterling, Japanese yen, and Canadian dollars. For the period October 1,
2004 to August 24, 2005 and August 25 to September 30, 2005, Celanese's foreign
currency forward contracts, designated as fair value hedges, resulted in a
decrease in total assets and total liabilities of (euro)8 million and (euro)1
million, respectively. As of September 30, 2005, these contracts hedged a
portion (approximately 50%) of Celanese's U.S. dollar denominated related entity
deposits done by USD denominated entities with euro denominated entities.
Related to the unhedged portion, a net loss of approximately (euro)5 million
from foreign exchange gains or losses was


                                       64



recorded to interest and other income, net for the combined period October 1,
2004 to August 24, 2005 and August 25 to September 30, 2005. For the nine months
ended September 30, 2004, Celanese's foreign currency forward contracts,
designated as fair value hedges, resulted in a decrease in total assets and
total liabilities of (euro)26 million and (euro)2 million, respectively. During
2003, Celanese's foreign currency forward contracts, designated as fair value
hedges, resulted in a decrease in total assets of (euro)7 million and an
increase in total liabilities of (euro)1 million. As of September 30, 2004 these
contracts hedged a portion (approximately 81%) of Celanese's U.S. dollar
denominated related entity net receivables held by euro denominated entities.
Related to the unhedged portion, a net gain of approximately (euro)2 million
from foreign exchange gains or losses was recorded to interest and other income,
net for the nine months ended September 30, 2004. As of December 31, 2003, these
contracts hedged a portion (approximately 85%) of Celanese's U.S. dollar
denominated related entity net receivables held by euro denominated entities.
Related to the unhedged portion, a net loss of approximately (euro)12 million
from foreign exchange gains or losses was recorded to interest and other income,
net in 2003. Hedging activities with related entities and intercompany net
receivables yielded total cash flows from operating activities of approximately
(euro)23 million for the combined periods August 25, 2005 to September 30, 2005
and October 1, 2004 to August 24, 2005. Hedging activities with related entities
and intercompany net receivables yielded cash flows from operating activities of
approximately (euro)13 million and (euro)160 million for the nine months ended
September 30, 2004 and the year ended December 31, 2003, respectively.

     A substantial portion of Celanese's assets, liabilities, revenues and
expenses are denominated in currencies other than the euro, principally the U.S.
dollar. Fluctuations in the value of these currencies against the euro,
particularly the value of the U.S. dollar, can have, and in the past have had, a
direct and material impact on Celanese's business and financial results. For
example, a decline in the value of the U.S. dollar versus the euro, results in a
decline in the euro value of Celanese's sales denominated in U.S. dollars and
earnings due to translation effects. Likewise, an increase in the value of the
U.S. dollar versus the euro would result in an opposite effect. Celanese
estimates that the translation effects of changes in the value of other
currencies against the euro decreased net sales by less than 1% for the period
October 1, 2004 to August 24, 2005 and August 25 to September 30, 2005, 6% the
nine months ended September 30, 2004 and approximately 13% in 2003. Celanese
estimates that the translation effects of changes in the value of other
currencies against the euro increased total assets by approximately 2% and 1% in
2005 and 2004 respectively and decreased total assets by approximately 13% in
2003. Celanese's exposure to transactional effects is further reduced by a high
degree of overlap between the currencies in which sales are denominated and the
currencies in which the raw material and other costs of goods sold are
denominated.

     Interest Rate Risk Management

     From time to time Celanese enters into interest rate swap agreements to
reduce the exposure of interest rate risk inherent in Celanese's outstanding
debt by locking in borrowing rates to achieve a desired level of fixed/floating
rate debt depending on market conditions. At September 30, 2005 and 2004,
Celanese had no interest rate swap agreements in place.

     Commodity Risk Management

     Celanese's policy for the majority of its natural gas and butane
requirements allows entering into supply agreements and forward purchase or
cash-settled swap contracts. During the twelve monthes ended September 30, 2005
and the nine months ended September 30, 2004, there were no forward contracts
for our butane and natural gas requirements. In the future, we may modify our
practice of purchasing a portion of our commodity requirements, and consider
utilizing a variety of other raw material hedging instruments in addition to
forward purchase contracts based on changes in market conditions. The fixed
price natural gas forward contracts are principally settled through actual
delivery of the physical commodity. The maturities of the cash-settled swap
contracts correlate to the actual purchases of the commodity and have the effect
of securing predetermined prices for the underlying commodity. Although these
contracts are structured to limit Celanese's exposure to increases in commodity
prices, they can also limit the potential benefit Celanese might have otherwise
received from decreases in commodity prices. These cash-settled swap contracts
are accounted for as cash flow hedges. Realized gains and losses on these
contracts are included in the cost of the commodity upon settlement of the
contract.


                                       65



RECENT ACCOUNTING PRONOUNCEMENTS

     See Note 5 to the Consolidated Financial Statements included in this Form
20-F for discussion of recent accounting pronouncements.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

     Our Consolidated Financial Statements are based on the selection and
application of significant accounting policies. The preparation of these
financial statements and application of these policies requires management to
make estimates and assumptions that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and liabilities at the date
of the financial statements as well as the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those
estimates. However, Celanese is not currently aware of any reasonably likely
events or circumstances that would result in materially different results.

     Celanese believes the following accounting polices and estimates are
critical to understanding the financial reporting risks present in the current
economic environment. These matters, and the judgments and uncertainties
affecting them, are also essential to understanding our reported and future
operating results. See Note 4 to the Consolidated Financial Statements for a
more comprehensive discussion of Celanese's significant accounting policies.

     Recoverability of Long-Lived Assets

     Our business is capital intensive and has required, and will continue to
require, significant investments in property, plant and equipment. At September
30, 2005 and 2004, the carrying amount of property, plant and equipment was
(euro)584 million and (euro)566 million, respectively. As discussed in Note 4 to
the Consolidated Financial Statements, Celanese assesses the recoverability of
property, plant and equipment to be held and used by a comparison of the
carrying amount of an asset or group of assets to the future net undiscounted
cash flows expected to be generated by the asset or group of assets. If such
assets are considered impaired, the impairment recognized is measured as the
amount by which the carrying amount of the assets exceeds the fair value of the
assets.

     In December 2004, we approved a plan to dispose of the COC business
included within the Ticona segment. This decision resulted in (euro)45 million
of asset impairment charges recorded as a special charge related to the COC
business in the combined periods October 1, 2004 to August 24, 2005 and August
25 to September 30, 2005. The transaction to dispose of COC in December 2005
will result in a loss of approximately (euro)30 million.

     Celanese assesses the recoverability of the carrying value of its goodwill
and other intangible assets with indefinite useful lives at least annually or
whenever events or changes in circumstances indicate that the carrying amount of
the asset may not be fully recoverable. Recoverability of goodwill is measured
at the reporting unit level based on a two-step approach. First, the carrying
amount of the reporting unit is compared to the fair value as estimated by the
future net discounted cash flows expected to be generated by the reporting unit.
To the extent that the carrying value of the reporting unit exceeds the fair
value of the reporting unit, a second step is performed, wherein the reporting
unit's assets and liabilities are fair valued. The implied fair value of
goodwill is calculated as the fair value of the reporting unit in excess of the
fair value of all non-goodwill assets and liabilities allocated to the reporting
unit. To the extent that the reporting unit's carrying value of goodwill exceeds
its implied fair value, impairment exists and must be recognized. As of
September 30, 2005 and 2004, the Company had (euro)448 million and (euro)464
million, respectively, of goodwill and other intangible assets.

     During 2003, Celanese performed the annual impairment test of goodwill and
determined that there was no impairment. As a result of the tender offer price
of (euro)32.50 per share announced on December 16, 2003, which would place an
implicit value on Celanese at an amount below book value of the net assets,
management initiated an impairment analysis in accordance with SFAS No. 142. The
impairment analysis was prepared on a reporting unit level and utilized the most
recent cash flow, discount rate and growth rate assumptions. Based on the
resulting analysis, management concluded that goodwill was not impaired as of
December 31, 2003.

     During 2005 there were significant changes to the underlying business.
These changes include the sale of CAC to the Purchaser, which reduced goodwill.
Further the application of push down accounting changed the amounts previously
recorded for assets and liabilities. As of September 30, 2004, there were no
significant changes in the underlying business assumptions or circumstances that
would drive the impairment analysis led


                                       66



management to believe goodwill might have been impaired. We will continue to
evaluate the need for impairment if changes in circumstances or available
information indicate that impairment may have occurred. We perform the required
impairment tests at least annually as of June 30 unless circumstances dictate
more frequent testing. During 2005 and 2004, we performed an impairment test at
each level and determined that goodwill was not impaired.

     A prolonged general economic downturn and, specifically, a continued
downturn in the chemical industry as well as other market factors could
intensify competitive pricing pressure, create an imbalance of industry supply
and demand, or otherwise diminish volumes or profits. Such events, combined with
changes in interest rates, could adversely affect our estimates of future net
cash flows to be generated by our long-lived assets. Consequently, it is
possible that our future operating results could be materially and adversely
affected by additional impairment charges related to the recoverability of our
long-lived assets.

     Push Down Accounting

     As described in Note 1 to the Consolidated Financial Statements, because
the Purchaser acquired more than a 95% ownership percentage in Celanese,
Celanese was required to follow push down accounting. Under push down
accounting, the Company's assets and liabilities are adjusted to fair value, as
determined by the Purchaser. Given the time it takes to obtain pertinent
information to finalize the fair value of assets and liabilities acquired,
(frequently with implications to the push down allocation of fair value), it is
often several quarters before the Purchaser is able to finalize those initial
fair value estimates. Accordingly, it is not uncommon for the initial estimates
to be subsequently revised. The judgments made in determining the estimated fair
value assigned to each class of assets acquired and liabilities assumed, as well
as asset lives, can materially impact net earnings (loss).

     Restructuring and Special Charges

     Special charges include provisions for restructuring and other expenses and
income incurred outside the normal ongoing course of operations. Restructuring
provisions represent costs related to severance and other benefit programs
related to major activities undertaken to fundamentally redesign our operations
as well as costs incurred in connection with a decision to exit non-strategic
businesses. These measures are based on formal management decisions,
establishment of agreements with the employees' representatives or individual
agreements with the affected employees as well as the public announcement of the
restructuring plan. The related reserves reflect certain estimates, including
those pertaining to separation costs, settlements of contractual obligations and
other closure costs. We reassess the reserve requirements to complete each
individual plan under our restructuring program at the end of each reporting
period. Actual experience has been and may continue to be different from these
estimates. (See Note 28 to the Consolidated Financial Statements.)

     Environmental Liabilities

     Celanese manufactures and sells a diverse line of chemical products
throughout the world. Accordingly, Celanese's operations are subject to various
hazards incidental to the production of industrial chemicals including the use,
handling, processing, storage and transportation of hazardous materials.
Celanese recognizes losses and accrues liabilities relating to environmental
matters if available information indicates that it is probable that a liability
has been incurred and the amount of loss is reasonably estimated. If the event
of loss is neither probable nor reasonably estimable, but is reasonably
possible, Celanese provides appropriate disclosure in the notes to its
Consolidated Financial Statements if the contingency is material.

     Total reserves for environmental liabilities were (euro)6 million at both
September 30, 2005 and 2004. Measurement of environmental reserves is based on
the evaluation of currently available information with respect to each
individual site and considers factors such as existing technology, presently
enacted laws and regulations and prior experience in remediation of contaminated
sites. An environmental reserve related to cleanup of a contaminated site might
include, for example, provision for one or more of the following types of costs:
site investigation and testing costs, cleanup costs, costs related to soil and
water contamination resulting from tank ruptures and post-remediation monitoring
costs. These reserves do not take into account any claims or recoveries from
insurance. The measurement of environmental liabilities is based on a range of
management's periodic estimate of what it will cost to perform each of the
elements of the remediation effort. Celanese uses its best estimate within the
range to establish its environmental reserves. Celanese utilizes third parties
to assist in the management and the development of its cost estimates for its
sites. Changes to environmental regulations or other factors affecting
environmental liabilities are reflected in the Consolidated Financial Statements
in the period in


                                       67



which they occur. Celanese accrues for legal fees related to litigation matters
when the costs associated with defense can be reasonably estimated and are
probable to occur. All other fees are expensed as incurred. (See Note 27 to the
Consolidated Financial Statements.)

     Asset Retirement Obligations

     SFAS No. 143 requires that the fair value of a liability for an asset
retirement obligation be recognized in the period in which it is incurred. The
liability is measured at the discounted fair value and is adjusted to its
present value in subsequent periods as accretion expense is recorded. The
corresponding asset retirement costs are capitalized as part of the carrying
amount of the related long-lived asset and depreciated over the asset's useful
life. We have identified but not recognized asset retirement obligations related
to substantially all our existing operating facilities. Examples of these types
of obligations include demolition, decommissioning, disposal and restoration
activities. Legal obligations exist in connection with the retirement of these
assets upon closure of the facilities or abandonment of the existing operations.
However, operations at these facilities are expected to continue indefinitely
and therefore a reasonable estimate of fair value cannot be determined at this
time. In the future, we will assess strategies of the businesses acquired and
may support decisions that differ from past decisions of management regarding
the continuing operations of existing facilities. Asset retirement obligations
will be recorded if these strategies are changed and probabilities of closure
are assigned to existing facilities. If certain operating facilities were to
close, the related asset retirement obligations could significantly affect our
results of operations and cash flows. In March 2005, FASB issued Interpretation
No.47, Accounting for Conditional Asset Retirement Obligations - an
interpretation of FASB No.143 ("FIN No. 47"). FIN 47 is effective no later than
the end of fiscal years ending after December 15, 2005. The Company is still
assessing the impact of FIN No. 47 on its future results of operations and
financial position.

     Realization of Deferred Tax Assets and Liabilities

     Total net deferred tax liabilities were (euro)143 million and (euro)12
million at September 30, 2005 and 2004, respectively. Celanese regularly reviews
its deferred tax assets for recoverability and establishes a valuation allowance
based on historical taxable income, projected future taxable income, applicable
tax strategies, and the expected timing of the reversals of existing temporary
differences. A valuation allowance is provided when it is more likely than not
that some portion or all of the deferred tax assets will not be realized. Such
evaluations require significant management judgments. During the combined
periods October 1, 2004 to August 24, 2005 and August 25 to September 30, 2005
valuation allowances have been recorded for certain German entities' deferred
tax assets. The primary deferred tax asset recorded on the Company's books
relates to Net operating loss carryforwards. These Net operating loss
carryforwards do not have expiration dates. The primary deferred tax liabilities
relate to purchase accounting basis adjustments for property plant and equipment
and intangible assets. (See Note 14 to the Consolidated Financial Statements.)

     Benefit Obligations

     Celanese sponsors pension plans covering substantially all employees who
meet eligibility requirements. Contributions to the pension plans for the
combined period October 1, 2004 to August 24, 2005 and August 25 to September
30, 2005 were (euro)4 million. Contributions to the German plans for the nine
months ended September 30, 2004 were (euro)85 million, respectively. Benefits
are generally based on years of service and/or compensation. Various assumptions
are used in the calculation of the actuarial valuation of Celanese -sponsored
plans. These assumptions include the weighted average discount rate, rates of
increase in compensation levels and expected long-term rates of return on plan
assets. In addition to the above mentioned assumptions, Celanese's actuarial
consultants use subjective factors such as withdrawal and mortality rates to
estimate the projected benefit obligation. The actuarial assumptions used by
Celanese may differ materially from actual results due to changing market and
economic conditions, higher or lower withdrawal rates or longer or shorter life
spans of participants. These differences may result in a significant impact to
the amount of pension expense recorded by Celanese in future periods.

     The amounts recognized in the Consolidated Financial Statements related to
pension and other postretirement benefits are determined on an actuarial basis.
A significant assumption used in determining our pension expense is the expected
long-term rate of return on plan assets. At September 30, 2005, our expected
long-term rate of return on plan assets was 4.5% for the German defined benefit
pension plans.

     For the combined period October 1, 2004 to August 24, 2005 and August 25 to
September 30, 2005, our expected long-term rate of return assumption for our
plan assets was 5.55%, reflecting the generally expected


                                       68



moderation of long-term rates of return in the financial markets. We estimate a
25 basis point decline in the expected long-term rate of return for our
qualified defined benefit pension plan to increase pension expense by an
estimate of less than (euro)1 million in 2006. Another estimate that affects our
pension expense is the discount rate used in the annual actuarial valuations of
pension plan obligations. At the end of each year, we determine the appropriate
discount rate, which represents the interest rate that should be used to
determine the present value of future cash flows currently expected to be
required to settle the pension obligation. The discount rate is generally based
on the yield on high-quality corporate fixed-income securities. At September 30,
2005, the discount rate was 4.07%.

     Accounting for Commitments & Contingencies

     Celanese is subject to a number of lawsuits, claims, and investigations,
incidental to the normal conduct of its business, relating to and including
product liability, patent and intellectual property, commercial, contract,
antitrust, and employment matters, which are handled and defended in the
ordinary course of business. (See Note 26 to the Consolidated Financial
Statements.) Celanese routinely assesses the likelihood of any adverse judgments
or outcomes to these matters as well as ranges of probable and reasonably
estimable losses. Reasonable estimates involve judgments made by management
after considering a broad range of information including: notifications,
demands, settlements which have been received from a regulatory authority or
private party, estimates performed by independent companies and outside counsel,
available facts, identification of other potentially responsible parties and
their ability to contribute, as well as prior experience. A determination of the
amount of loss contingency required, if any, is assessed in accordance with SFAS
No. 5 "Contingencies and Commitments" and recorded if probable and estimable
after careful analysis of each individual matter. The required reserves may
change in the future due to new developments in each matter and as additional
information becomes available.

     Nutrinova Inc., a U.S. subsidiary of Nutrinova Nutrition Specialties & Food
Ingredients GmbH, a wholly-owned subsidiary of Celanese, is party to various
legal proceedings in the United States, Canada and Europe alleging Nutrinova
Inc. engaged in unlawful, anticompetitive behavior which affected the sorbates
markets while it was a wholly-owned subsidiary of Hoechst. In accordance with
the demerger agreement between Hoechst and Celanese, which became effective
October 1999, Celanese, the new owner to Hoechst's sorbates business, was
assigned the obligation related to these matters. However, Hoechst agreed to
indemnify Celanese for 80 percent of payments for such obligations. Expenses
related to this matter are recorded gross of any such recoveries from Hoechst
while the recoveries from Hoechst, which represents 80 percent of such expenses,
are recorded directly to shareholders' equity, net of tax, as a contribution of
capital.

     Based on the advice of external counsel and a review of the existing facts
and circumstances relating to the sorbates matter, including the status of
governmental investigations, as well as civil claims filed and settled, Celanese
has remaining accruals of (euro)108 million, and (euro)105 million at September
30, 2005 and 2004, respectively, included in current liabilities for the
estimated loss relative to this matter. Although the outcome of this matter
cannot be predicted with certainty, management's best estimate of the range of
possible additional future losses and fines, including any that may result from
governmental proceedings, as of September 30, 2005 is between (euro)0 and
(euro)7 million. The estimated range of such possible future losses is
management's best estimate based on the advice of external counsel taking into
consideration potential fines and claims, both civil and criminal, that may be
imposed or made in other jurisdictions. At September 30, 2005 and 2004, Celanese
has receivables, recorded within current assets, relating to the sorbates
indemnification from Hoechst, of (euro)87 million and (euro)84 million,
respectively. (See Note 26 to the Consolidated Financial Statements).

OUTLOOK

     In the first quarter of our 2006 fiscal year, our Chemical Products segment
benefited from higher pricing while our Ticona and Performance Products segments
experienced volume increases year over year. As we begin the second quarter of
our 2006 fiscal year, demand for our products in Europe is mixed. We remain
cautious about economic conditions as pricing for our hydrocarbon-based raw
materials and energy are expected to remain at high levels. As a dominated
company, we will not offer guidance on operating profit, which can be influenced
by unilateral decisions of our parent. Should those decisions result in a loss
for Celanese AG on a stand alone statutory reporting basis, then Celanese AG
must be compensated.

     To increase the productivity and profitability of our operations and those
of our affiliates, we sold our cyclo-olefin copolymer ("COC") business included
within the Technical Polymers Ticona segment and part of our


                                       69



interest in Pemeas GmbH, the fuel cell venture included in Other Activities in
December 2005. See Note 30 to the Consolidated Financial Statements for details.

Risks of Future Development

     Celanese's business activity is subject to general economic and political
risks in the countries and regions in which it does business. As a result of the
transfers of CAC and CPO, Celanese now serves primarily as the holding company
for the European business and certain Asian businesses of Celanese Corporation,
the ultimate parent of the Purchaser and Celanese. In addition, changes in the
economic conditions in many of its markets (e.g. automotive,
electrical/electronic, and construction industries), as well as cyclicality in
the basic chemicals industry could have an effect on the Company's economic
performance. In particular, the markets for basic chemicals are characterized by
significant economic swings, during which periods of low prices and overcapacity
could lead to reduced profit margins and lower operating profits.

     Celanese is subject to risks associated with the increased volatility in
raw materials prices and the availability of key raw materials such as natural
gas, propylene, ethylene and butane, as well as the Company's ability to pass on
increased raw materials costs to its customers by increasing the prices of its
products, or to offset such increased raw materials costs by reducing costs. It
is the Company's policy to lock in prices for certain important raw materials by
entering into hedging arrangements, which are customary in the industry. This
practice could also lead to negative effects, should unforeseen developments
occur with respect to raw material prices.

     The safe operation of Celanese's plants is subject to risks associated with
the production of chemicals, including the storage and transport of raw
materials, products and wastes, and in particular environmental risks. The
Company carries appropriate property, business interruption and casualty
insurance in accordance with customary industry practice. The environmental,
health and safety regulations pertaining to Celanese's business are subject to
continuous legislative review, which could result in stricter regulations and
trigger increased costs for the Company. In addition, Celanese's plants may be
negatively affected by infrastructure projects such as the planned expansion of
the Frankfurt international airport. The expansion, which is not expected to be
approved until 2007, with operations starting in 2009-2010 could, depending on
the outcome, have a negative effect on the current production capacity at and
the future development of Celanese's Kelsterbach plant.

     Moreover, in connection with the demerger, certain environmental
liabilities, including those resulting from the former business activities of
the Hoechst Group at various sites, were allocated between Celanese and Hoechst
AG, regardless of the responsibility for the cause of such environmental
liabilities. In some instances this could lead to Celanese having to compensate
third parties, as well as to indemnification payments between Celanese and
Hoechst, the amounts of which cannot at present be determined. Celanese
established reserves for this contingency as required.

     Depending on their categorization as to their dangerousness resulting from
risk assessment by the relevant authorities, the products of the chemicals
industry are subject to restrictions regarding production, handling and use. The
applicable regulations and the resulting restrictions are under constant review
by the relevant authorities. Therefore, a change in the risk assessment of
Celanese's products can affect demand for these products. Currently, the
European Union evaluates potential health risks associated with a number of
chemical products including vinyl acetate monomer. Similarly, the International
Agency for Research on Cancer ("IARC") has reclassified formaldehyde as a known
human carcinogen based on studies linking formaldehyde exposure to
nasopharyngeal cancer, a rare cancer in humans. The results of the IARC's review
will be examined by government agencies responsible for setting worker and
environmental exposure standards and labeling requirements. Although the final
effect cannot be predicted at this time, the IARC's reclassification could
adversely affect the demand for this product.

     Additionally, fluctuations in market rates of return and interest rates
affect the value of Celanese's pension assets and liabilities. An extended
period of decline in rates of return and interest rates could cause a material
financial impact on Celanese's financial position or cash flows in any given
year. (See "Critical Accounting Policies" and Note 4 to the Consolidated
Financial Statements).

     Under the domination and profit and loss transfer agreement (the
"Domination Agreement") that Celanese entered into with its majority shareholder
the Purchaser, the Purchaser is entitled to give instructions directly to the
management board of Celanese, including, but not limited to, instructions that
are disadvantageous to Celanese, as long as such disadvantageous instructions
benefit the Purchaser or the companies affiliated with


                                       70



either the Purchaser or Celanese. In addition, Celanese is, under the Domination
Agreement, obligated to transfer its entire annual statutory profits, subject to
certain deductions, to the Purchaser while the Domination Agreement requires the
Purchaser to compensate Celanese for any annual statutory loss
(Jahresfehlbetrag) incurred on a non-consolidated basis. Furthermore, the net
amount of the guaranteed fixed annual payment (Ausgleich) guaranteed by the
Purchaser vis-a-vis the minority shareholders of Celanese in lieu of any future
dividend as long as the Domination Agreement is effective, which, at the time of
the entering into of the Domination Agreement, amounted to (euro)2.89 per share
for a full fiscal year, may, depending on applicable corporate tax rates, in the
future be higher, lower or the same as (euro)2.89. As a dominated company,
Celanese may be affected by risks that affect the Purchaser and its affiliates,
including but not limited to risks arising out of the debt levels of these
companies.

     As a result of the Restructuring and pursuant to instructions issued by the
Purchaser under the Domination Agreement, Celanese entered into long term notes
with the Purchaser for approximately (euro)1,034 million. Celanese Corporation
has provided letters of support for the repayment of these notes. The repayment
of these notes will depend upon sufficient liquidity of the Purchaser and
Celanese Corporation and its other subsidiaries.

     Management is not currently aware of any risks that jeopardize the
existence of Celanese.

Forward-looking Statements May Prove Inaccurate

     This annual report contains certain forward-looking statements and
information relating to us that are based on the beliefs of our management as
well as assumptions made by, and information currently available to, us. These
statements include, but are not limited to, statements about our strategies,
plans, objectives, expectations, intentions, expenditures, and assumptions and
other statements contained in this prospectus that are not historical facts.
When used in this document, words such as "anticipate," "believe," "estimate,"
"expect," "intend," "plan" and "project" and similar expressions, as they relate
to us are intended to identify forward-looking statements. These statements
reflect our current views with respect to future events, are not guarantees of
future performance and involve risks and uncertainties that are difficult to
predict. Further, certain forward-looking statements are based upon assumptions
as to future events that may not prove to be accurate.

     Many factors could cause our actual results, performance or achievements to
be materially different from any future results, performance or achievements
that may be expressed or implied by such forward-looking statements. These
factors include, among other things:

     o    changes in general economic, business, political and regulatory
          conditions in the countries or regions in which we operate;

     o    the length and depth of product and industry business cycles
          particularly in the automotive, electrical, electronics and
          construction industries;

     o    changes in the price and availability of raw materials, particularly
          changes in the demand for, supply of, and market prices of fuel oil,
          natural gas, coal, electricity and petrochemicals such as ethylene,
          propylene and butane, including changes in production quotas in OPEC
          countries and the deregulation of the natural gas transmission
          industry in Europe;

     o    the ability to pass increases in raw material prices on to customers
          or otherwise improve margins through price increases;

     o    the ability to maintain plant utilization rates and to implement
          planned capacity additions and expansions;

     o    the ability to reduce production costs and improve productivity by
          implementing technological improvements to existing plants;

     o    the existence of temporary industry surplus production capacity
          resulting from the integration and start-up of new world-scale plants;

     o    increased price competition and the introduction of competing products
          by other companies;

     o    the ability to develop, introduce and market innovative products,
          product grades and applications, particularly in the Technical
          Polymers Ticona and Performance Products segments of our business;

     o    changes in the degree of patent and other legal protection afforded to
          our products;


                                       71



     o    compliance costs and potential disruption or interruption of
          production due to accidents or other unforeseen events or delays in
          construction of facilities;

     o    potential liability for remedial actions under existing or future
          environmental regulations;

     o    potential liability resulting from pending or future litigation, or
          from changes in the laws, regulations or policies of governments or
          other governmental activities in the countries in which we operate;

     o    changes in currency exchange rates and interest rates;

     o    changes in the composition or restructuring of us or our subsidiaries
          and the successful completion of acquisitions, divestitures and
          venture activities;

     o    pending or future challenges to the Domination Agreement; and

     o    various other factors, both referenced and not referenced in this
          report.

     Many of these factors are macroeconomic in nature and are, therefore,
beyond our control. Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect, our actual
results, performance or achievements may vary materially from those described in
this annual report as anticipated, believed, estimated, expected, intended,
planned or projected. We neither intend nor assume any obligation to update
these forward-looking statements, which speak only as of their dates.

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

DIRECTORS AND SENIOR MANAGEMENT

     The current members of the Celanese board of management, their respective
ages as of March 15, 2006 and their functions are as follows:



Andreas Pohlmann..................   Age:                         48
                                     First Elected:               2002
                                     Function:                    Chairman of the Celanese Board of Management and
                                                                  Director of Personnel of Celanese
                                     Supervisory Board
                                     Memberships/Directorships:   Executive Vice President, Chief Administrative
                                                                  Officer and Secretary of Celanese Corporation,
                                                                  Managing Director of BCP Holdings GmbH, Managing
                                                                  Director of Celanese Europe Management GmbH,
                                                                  Pensionskasse der Mitarbeiter der Hoechst-Gruppe VvaG
                                                                  (German pension fund for former employees of the Hoechst
                                                                  Group)
                                     Term Expires                 October 31, 2007
Lyndon Cole.......................   Age:                         53
                                     First Elected:               2003
                                     Function                     Vice-Chairman of the Celanese AG Board of Management,
                                                                  Responsible for the operating businesses and
                                                                  President of Ticona
                                     Supervisory Board
                                     Memberships/Directorships:   Executive Vice President of Celanese Corporation,
                                                                  Managing Director of BCP Holdings GmbH, Managing
                                                                  Director of Celanese Europe Management GmbH
                                     Term Expires                 October 31, 2006



                                       72





Peter Jakobsmeier.................   Age:                         61
                                     First Elected:               2004
                                     Function:                    Chief Financial Officer of Celanese
                                     Term Expires                 October 31, 2006
                                     Supervisory Board
                                     Memberships/Directorships:   Managing Director of BCP Holdings GmbH, Managing
                                                                  Director of Celanese Europe Management GmbH


     Andreas Pohlmann was appointed to the Celanese AG board of management on
October 22, 2002 and became chairman on November 1, 2004. He had served as
Celanese AG's vice president and corporate secretary since October 1999, as well
as managing director of Celanese Ventures since February 2002. In his ten years
at Hoechst, Dr. Pohlmann, an attorney, held various positions of increasing
responsibility in the Corporate Law, Corporate Public and Governmental Affairs,
and Corporate Controlling and Development departments, ultimately serving as
Hoechst AG's corporate secretary from 1996 to 1999. Dr. Pohlmann is currently
the executive vice president and chief administrative officer of Celanese
Corporation.

     Lyndon Cole became Ticona's president and the head of the Celanese Growth
and Excellence Council on April 1, 2003. He was named to Celanese AG's board of
management on September 23, 2003 and became vice-chairman on November 1, 2004.
Dr. Cole joined Celanese in March 2002 as president of Celanese Chemicals. From
1998 to 2001 he had been chief executive officer of United Kingdom based
Elementis PLC, a global specialty chemicals company. Prior to joining Elementis,
he was general manager-Global Structured Products for GE Plastics from 1990 to
1998 and previously held general management and commercial positions with GE
Plastics, Dow Chemicals Europe and ICI. Dr. Cole is currently an executive vice
president of Celanese Corporation.

     Peter Jakobsmeier was named a member of the Celanese AG board of management
and became its chief financial officer on November 1, 2004. He was Celanese AG's
vice president and treasurer from 2000 to 2004 and its vice president and
controller from 1999 to 2000. In his 29 years at Hoechst AG, Mr. Jakobsmeier
held increasing positions of responsibility, ultimately serving as the head of
corporate controlling.

     The incumbent members of the supervisory board of Celanese, their
respective ages as of March 15, 2006 and their principal occupations are as
follows:




Bernd Thiemann(3)(4)(5)...........   Age:                         62
   Chairman.......................   First Elected:               2004
                                     Principal Occupation:        Managing Partner of Drueker & Co. GmbH & Co. KG
                                     Supervisory Board
                                     Memberships/Directorships:   Bankhaus Hallbaum AG & Co. KG, DES AG, EM.TV AG
                                                                  (Chairman), ThyssenKrupp Steel AG, VHV Vereinigte
                                                                  Hannoversche Versicherung a.G., VHV Lebensversicherung
                                                                  AG, M.M. Warburg & Co. KGaA Holding (Deputy Chairman)
                                     Term Expires:                2009
Gerald Mosel(1)(4)(5).............   Age:                         45
   Deputy Chairman................   First Elected:               2005
                                     Principal Occupation:        Head of Training, Lean Leader Celanese Chemicals
                                                                  Europe GmbH and Workers' Council, Oberhausen, Chairman
                                                                  of the General Workers' Council of Celanese, Pensionskasse
                                                                  der Mitarbeiter der Hoechst-Gruppe VvaG (German pension
                                                                  fund for former employees of the Hoechst Group)
                                     Term Expires:                2009
Ralf Becker(1)....................   Age:                         40



                                       73





                                     First Elected:               2003(2)
                                     Principal Occupation:        Board Secretary, of IG BCE Hannover
                                     Supervisory Board
                                     Memberships/Directorships:   RAG Bildung GmbH (Advisory Board
                                     Term Expires:                2010
Chinh E. Chu......................   Age:                         39
                                     First Elected:               2004
                                     Principal Occupation:        Senior Managing Director of The
                                                                  Blackstone Group, USA
                                     Supervisory Board
                                     Memberships/Directorships:   Celanese Corporation (Chairman of the Board of
                                                                  Directors), Graham Packaging Holdings Company (also a
                                                                  member of the Advisory Committee), Nalco Holdings LLC,
                                                                  FGIC and SunGard
                                     Term Expires:                2009
Armin Droth(1)....................   Age:                         51
                                     First Elected:               2000
                                     Principal Occupation:        Electrical Engineer, representative of the German
                                                                  association of management and professional staff
                                                                  (Verband angestellter Akademiker), member of the
                                                                  Celanese joint workers' council, Hochst site
                                     Term Expires:                2010
Cornelius Geber(3)................   Age:                         53
                                     First Elected:               2004
                                     Principal Occupation:        Managing Director of BCP Holdings GmbH, Celanese
                                                                  Europe Management GmbH, and CG Beteiligungs- &
                                                                  Management GmbH
                                     Supervisory Board
                                      Memberships/Directorships:  Barkawi & Partner GmbH (Advisory Board), Inconso AG
                                                                  (Deputy Chairman), Kiala S.A., Neopost S.A.
                                     Term Expires:                2009
Bernd Hupfer(1)(5)................   Age:                         52
                                     First Elected:               2005
                                     Principal Occupation:        Chemical Engineer, Head of Intellectual Property of
                                                                  Ticona GmbH; Member of the Group Senior Executives'
                                                                  Committee of Celanese
                                     Term Expires:                2010
Benjamin J. Jenkins...............   Age:                         35
                                     First Elected:               2004
                                     Principal Occupation:        Principal in the Private Equity Group at The
                                                                  Blackstone Group, USA
                                     Supervisory Board
                                      Memberships/Directorships:  Celanese Corporation, Global Tower Partners, Axtel
                                                                  S.A. de C.V., Vanguard Health Systems LLC, Team Health Inc.
                                     Term Expires:                2009



                                       74





Johannes Lehn(1)(3)...............   Age:                         52
                                     First Elected:               2005
                                     Principal Occupation:        Plant Mechanic, Chairman of the Group Workers' Council
                                                                  of Celanese
                                     Term Expires:                2010
Hanns Ostmeier(3)(4)(5)...........   Age:                         45
                                     First Elected:               2004
                                     Principal Occupation:        Senior Managing Director at The Blackstone Group, USA,
                                                                  and Managing Director of The Blackstone Group
                                                                  Deutschland GmbH
                                     Supervisory Board
                                     Memberships/Directorships:   Celanese Corporation, Gerresheimer Group GmbH
                                                                  (Chairman), SULO Group (Advisory Board)
                                     Term Expires:                2009
Ron Sommer(3).....................   Age:                         56
                                     First Elected:               2004
                                     Principal Occupation:        Former Chairman of the Board of Deutsche Telekom AG

                                     Supervisory Board
                                     Memberships/Directorships:   AFK Sistema, Munchener Ruckversicherungs-Gesellschaft
                                                                  Aktiengesellschaft, Motorola Inc.
                                     Term Expires:                2009
Axel Weidner(1)(3)................   Age:                         52
                                     First Elected:               2005
                                     Principal Occupation:        Chemistry Lab Technician, Chairman of the European
                                                                  Workers' Council of Celanese
                                     Term Expires:                2010


----------
(1)  Representative of the employees

(2)  Appointed by the local court (Amtsgericht) in Koenigstein on September 30,
     2003 to replace Ralf Sikorski, who resigned on September 15, 2003.

(3)  Finance and Audit Committee

(4)  Personnel and Compensation Committee

(5)  Squeeze-Out Committee

COMPENSATION OF DIRECTORS AND OFFICERS

Supervisory Board

     Members of the Celanese supervisory board receive, in addition to
reimbursement of out-of-pocket expenses, a fixed annual payment which, for
fiscal year 2005, amounted to (euro)120,904 for the Chairman, (euro)90,678 for
the Deputy Chairman and (euro)60,452 for all other members of the Celanese
supervisory board. In addition, for each Celanese supervisory board meeting
attended, members receive a meeting fee of (euro)4,000 for the Chairman,
(euro)3,000 for the Deputy Chairman and (euro)2,000 for all other members of the
Celanese supervisory board. Also, each member of the Celanese supervisory board
receives a committee retainer for each membership in a committee of the Celanese
supervisory board. The committee retainer amounts to (euro)4,000 for the
chairman of the committee and (euro)2,000 for all other members of the
committee. All members of the Celanese supervisory board are also reimbursed for
value added tax on these amounts.

     For the year ended September 30, 2005, the aggregate compensation of the
members of the supervisory board amounted to approximately (euro)0.8 million.
According to German law, compensation of supervisory board members requires
shareholder approval. Compensation for the Celanese supervisory board was
approved at the June 15, 2004 annual general meeting of shareholders and remains
in effect on the date of this annual report.


                                       75



     The following table shows the compensation paid to individual members of
the supervisory board who were active on the board during the year ended
September 30, 2005.

                        COMPENSATION OF SUPERVISORY BOARD

                            FIXED ANNUAL    OTHER CASH        TOTAL
                            REMUNERATION   REMUNERATION   REMUNERATION
NAME                           (EURO)        (EURO) (1)      (EURO)
-------------------------   ------------   ------------   ------------
Dr. Bernd Thiemann
   Chairman..............      120,904         40,000       160,904
Gerald Mosel**
   Deputy Chairman.......       33,290          7,000        40,290
Reiner Nause*
   Deputy Chairman.......       57,636         23,000        80,636
Dr. Hanswilhelm Bach*....       38,424         12,000        50,424
Ralf Becker..............       60,452         14,000        74,452
Hans-Juergen Brinkmann*..       38,424         12,000        50,424
Chinh E. Chu***..........            0          4,000         4,000
Armin Droth..............       60,452         14,000        74,452
Cornelius Geber..........       60,452         14,000        74,452
Dr. Bernd Hupfer**              22,193          4,000        26,193
Benjamin J. Jenkins***...            0         10,000        10,000
Johannes Lehn**                 22,193          4,000        26,193
Dr. Hanns Ostmeier***....            0         10,000        10,000
Herbert Schmalz*.........       38,424         12,000        50,424
Dr. Ron Sommer...........       60,452         14,000        74,452
Axel Weidner**...........       22,193          4,000        26,193
                               -------        -------       -------
                               635,489        198,000       833,489
                               =======        =======       =======

----------
(1)  Compensation for supervisory board meetings and committee memberships for
     October 1, 2004 to September 30, 2005.

*    Supervisory Board member until May 20, 2005

**   Employee representative appointed to the supervisory board after May 20,
     2005

***  Waived remuneration (other than Other Cash Compensation up to May 2005)
     pursuant to letter dated June 22, 2005

Board of Management

     The aggregate amount of compensation paid during the year ended September
30, 2005 to the members of the Celanese board of management was (euro)2.5
million. The aggregate amount accrued by Celanese during the fiscal year ended
September 30, 2005 to provide pension, retirement and similar benefits for the
members of the board of management was (euro)24.1 million.


                                       76



     The following table shows the compensation expense for the individual
members of the board of management who were active on the board as of September
30, 2005.
                      TOTAL COMPENSATION EXPENSE TABLE (1)



                                                                                                                     TOTAL CASH
                                                                                                                    COMPENSATION
NAME AND PRINCIPAL POSITION                                                    FIXED SALARY (EURO)   BONUS (EURO)      (EURO)
----------------------------------------------------------------------------   ------------------    ------------   ------------

Claudio Sonder
   Chairman of the Board of Management until October 31, 2004 ..............           89,167           90,019          179,186
Andreas Pohlmann
   Chairman of the Board of Management from November 1, 2004 (2) ...........          177,083          218,773          395,856
David N. Weidman
   Deputy Chairman of the Board of Management until October 31, 2004 (2) ...           43,750           55,373           99,123
Lyndon Cole
   Vice-Chairman of the Board of Management from November 1, 2004 (2) ......          293,705          360,181          653,886
Perry W. Premdas
   Member of the Board of Management and Chief Financial Officer until
      October 31, 2004 (2) .................................................           32,788           40,851           73,639
Peter Jakobsmeier
   Member of the Board of Management and Chief Financial Officer
      from November 1, 2004 ................................................          320,833          390,206          711,039
                                                                                      -------        ---------        ---------
                                                                                      957,326        1,155,403        2,112,729
                                                                                      =======        =========        =========


----------
(1)  Determination of compensation in accordance with German Commercial Code

(2)  Former board of managment members Premdas and Weidman received part of
     their salaries from the US entity. Board of management members Cole and
     Pohlmann receive part of their compensation from Celanese Corporation.


                                       77



     The table below shows the number of stock options exercised by the board of
management during the year ended September 30, 2005. No stock options were
granted to the board of management during 2005 and no stock options were held as
of September 30, 2005.

                          INCENTIVE COMPENSATION TABLE



                                                                                STOCK OPTIONS
                                                              -----------------------------------------------------
                                                                                         NUMBER OF
                                                                                       STOCK OPTIONS
                                                                                         EXERCISED       EARNINGS
                                                                                      DURING THE YEAR      FROM
                                                                                           ENDED        EXERCISE OF
                                                              NUMBER                    SEPTEMBER 30,     STOCK
NAME AND PRINCIPAL POSITION                                    HELD    VALUE (EURO)         2005         OPTIONS
-----------------------------------------------------------   ------   ------------   ---------------   -----------

Claudio Sonder
   Chairman of the Board of Management until October 31,
      2004.................................................      0           0             90,000        2,030,400
Andreas Pohlmann
   Chairman of the Board of Management from November 1,
      2004.................................................      0           0             13,000          276,640
David N. Weidman
   Deputy Chairman of the Board of Management until
      October 31, 2004.....................................      0           0             55,000        1,207,250
Perry W. Premdas
   Member of the Board of Management and Chief Financial
      Officer until October 31, 2004.......................      0           0                  0                0
Peter Jakobsmeier
   Member of the Board of Management and Chief Financial
      Officer from October 31, 2004........................      0           0             13,000          293,150
Lyndon Cole
   Vice-Chairman of the Board of Management................      0           0             15,000          318,900
                                                               ---         ---            -------        ---------
                                                                 0           0            186,000        4,126,340
                                                               ===         ===            =======        =========


     Board Service Agreements

     Celanese AG has entered into service agreements with the members of its
board of management as follows:

     Mr. Jakobsmeier has entered into a service agreement with Celanese AG,
pursuant to which he receives (i) a base salary of (euro)350,000 that is
established based on a comparative analysis of base salaries paid within a
selected peer group of international companies; and (ii) an annual bonus
dependent on achieving the economic and personal objectives he agrees upon with
the personnel and compensation committee of the supervisory board. At present,
such objectives pertain to EBIDTA and trade working capital of Celanese on a
consolidated basis. Bonuses are expressed as a percentage of base salary and may
be adjusted, upward or downward, based on the degree to which the targets are
achieved and could account for up to 80 percent of base salary, or up to 160
percent of base salary if all targets were significantly exceeded.

     Drs. Cole and Pohlmann have each entered into a service agreement with
Celanese AG and an employment agreement with Celanese Corporation. The service
agreements with Celanese AG cover their duties as members of the Celanese board
of management; however, their compensation is governed by their employment
agreements with Celanese Corporation. Pursuant to their agreements with Celanese
Corporation, effective January 1, 2005, Drs. Cole and Pohlmann are each entitled
to an annual base salary of $650,000 for Dr. Pohlmann and $700,000 for Dr. Cole.
In addition, they are each eligible to earn an annual bonus targeted at 80
percent of base salary. Seventy percent of Dr. Pohlmann's and sixty percent of
Dr. Cole's base salary and annual bonus and paid by


                                       78



Celanese Corporation. The remainder is paid by Celanese AG and is included in
the amounts in the table above. In the event that either of these persons is
terminated without cause (as defined in the agreement) or if he resigns for good
reason (as defined in the agreement) he will be entitled to, subject to
continued compliance with the restrictive covenants described below, (i)
continued payment of base salary and target bonus for one year and (ii) a pro
rata bonus for the year of termination, based on actual Company performance. The
executives will be subject to customary confidentiality, intellectual property
and non-disclosure covenants. In addition, the executives will be subject to
noncompetition and nonsolicitation provisions during the term of employment and
for a period of one year thereafter.

     Drs. Pohlmann and Cole are also entitled to an alignment bonus from
Celanese Corporation. Fifty percent of this bonus was paid in January 2005 and
twenty-five percent was paid in January 2006. The remainder will be paid in
January 2007, provided Drs. Pohlmann and Cole are still employeed by Celanese
Corporation on these dates. The table below shows the alignment bonuses paid or
to be paid to Drs. Pohlmann and Cole.



                                      50% PAID IN   25% TO BE PAID IN   25% TO BE PAID IN
                           TOTAL     JANUARY 2005      JANUARY 2006        JANUARY 2007
                           (US$)         (US$)            (US$)               (US$)
                         ---------   ------------   -----------------   -----------------

Andreas Pohlmann......   3,710,000     1,855,000         927,500             927,500
Lyndon Cole...........   3,960,000     1,980,000         990,000             990,000


     Furthermore Messrs. Cole, Jakobsmeier and Pohlmann participate in Celanese
Corporation's Management Incentive Program, which under certain conditions, will
provide cash payments and stock options and requires an investment in Celanese
Corporation shares. Members of the Celanese AG board of management and
approximately nine other executives of Celanese AG participate in this program.
The table below sets forth the benefits Messrs. Cole, Jakobsmeier and Pohlmann
receive under this program.



                                          PAYMENT
                           DEFERRED       MADE IN                   IPO    DISCOUNTED
                         CASH AMOUNT   JANUARY 2005     STOCK     SHARES     SHARES
                            (US$)         (US$)        OPTIONS    (US$16)   (US$7.20)
                         -----------   ------------   ---------   ------   ----------

Andreas Pohlmann......    19,989,966     2,987,338    1,013,847   51,471     148,007
Lyndon Cole...........    20,397,924     3,048,304    1,231,000   62,500     179,722
Peter Jakobsmeier.....     3,999,593       597,707      217,253   11,029      31,716


     The deferred cash amount is paid once certain conditions are met. The
initial component of the deferred cash vested in 2004 and was paid in January
2005. The remainder is subject to downward adjustment if the price of Celanese
Corporation's common stock is below the initial offering price of US$16.00 on
the distribution date and vests subject to both (1) continued employment or the
achievement of certain performance criteria and (2) the disposition by The
Blackstone Group of at least 90 percent of its equity interest of Celanese
Corporation with at least a 25 percent cash internal rate of return on their
equity interest. The vesting of stock options must also meet certain conditions
and can be exercised the earliest 2.5 years after the initial public offering.
Celanese Corporation shares under the requested investment had to be purchased
partly at the IPO-price of US $16.00 per share and partly with a discount of
US$8.80 per share.

     Members of Celanese's supervisory board are not entitled to severance nor
to change in control payments.

INCENTIVE PLANS

     Prior to the Restructuring, Celanese had, at various times, provided three
stock appreciation rights plans to its board of management and executives. All
three plans gave the participants a right to receive the cash difference between
the base price and the price of CAG Shares on the day of exercise. The equity
participation plan required the invesment of a defined amount of money over a
one to two year period. The 1999 and 2000 long term participation plans did not
require an investment and were open only to board of management members and
senior executives. Under all three plans, every right entitled the eligible
person to participate in the long-term appreciation in the price of one share of
Celanese. Stock appreciation rights granted under these plans have a ten year
term and are generally exercisable in whole or in part, subject to limitations,
at any time during a period defined for each plan, provided at the time of
exercise, the performance of an ordinary share of Celanese on the


                                       79



Frankfurt Stock Exchange exceeds the median of the performance of the share
prices of Celanese's peer group companies as defined by Celanese's board of
management*. Following a change in control of Celanese, the stock appreciation
rights were able to be exercised during a period of six months irrespective of
whether Celanese's share price outperformed the median of the performance of the
share prices of the peer group. As Celanese Europe Holdings' acquisition of
Celanese constituted a change in control under the plans, the performance
hurdles described in this paragraph were waived from April 6 to October 5, 2004.
During this period, a combined 16,050 stock appreciation rights were exercised
under the three plans. Thereafter, the stock appreciation rights can be
exercised provided that the performance hurdles are reached and the shares are
still traded on the Frankfurt Stock Exchange.

     The table below describes the number of stock appreciation rights still
outstanding as of September 30, 2005:



                                            STOCK
                                        APPRECIATION
                                           RIGHTS                        STOCK APPRECIATION
                                           GRANTED                    RIGHTS OUTSTANDING AS OF
                 PLAN                   (IN MILLIONS)    BASE PRICE       SEPTEMBER 30, 2005
-------------------------------------   -------------   ------------   ------------------------

Equity Participation Plan............        2.6        Market Price             3,700
1999 Long Term Participation Plan....        2.4         (euro)16.37             8,650
2000 Long Term Participation Plan....        2.0         (euro)19.56             8,500


     Members of the Celanese board of management and senior executives were also
eligible to participate in the 2002 Celanese Stock Option Plan (the "2002
Plan"). The 2002 Plan authorized the issuance of up to 1.25 million options to
purchase shares of common stock. Options were granted at an exercise price
reflecting the reference price (twenty day average of market price prior to
grant date) plus a 20 percent premium and become exercisable five years from the
date of grant. Two year vesting was possible, if the market price per share
outperformed the median performance of Celanese's competitors as defined in the
plan over the holding period. All unexercised options expire ten years from the
date of grant. If the market price per Celanese share of common stock on the
date of exercise is at least 20 percent higher than the reference price at the
time of the grant, the holder is entitled to receive a cash payment equal to the
original exercise premium of 20 percent. The plan documents governing the 2002
Plan do not contain any provisions dealing with a change in control of Celanese.
Therefore the legal terms of the stock options were not affected by the
successful consummation of the Tender Offer.

     The table below describes the number of stock options still outstanding as
of September 30, 2005:



                                                      STOCK OPTIONS                                  STOCK OPTIONS
                                                         GRANTED       REFERENCE      EXERCISE     OUTSTANDING AS OF
          DATE GRANTED                DATE VESTED     (IN MILLIONS)      PRICE         PRICE      SEPTEMBER 30, 2005
--------------------------------   ----------------   -------------   -----------   -----------   ------------------

July 8, 2002....................     July 8, 2004          1.1        (euro)22.95   (euro)27.54            0
January 31, 2003(1).............   January 31, 2005        0.1        (euro)19.82   (euro)23.78            0


(1) 86,800 stock options were granted on January 31, 2003, 28,000 of which were
exercised, 58,800 of which were forfeited and 48,800 of which were cashed out.

     For additional information related to incentive plans, see Note 20 to the
Consolidated Financial Statements.

BOARD PRACTICES

     As required by the German Stock Corporation Act (Aktiengesetz), Celanese
has a two-tier board system consisting of a board of management (Vorstand) and a
supervisory board (Aufsichtsrat). The Celanese board of management as a
collective body is responsible for managing Celanese and representing Celanese
in its dealings

----------
* The peer group consists of Dow, DSM, Eastman, Georgia Gulf Corp. (Solutia,
Inc. is substituted for Georgia Gulf Corp. in the peer group for the 2000
long-term incentive plan and for the 2002 Stock Option Program), ICI, Lyondell
Chemical Co., Methanex, Millennium and Rhodia.



                                       80



with third parties, while the Celanese supervisory board appoints and removes
the members of the Celanese board of management and oversees the management of
Celanese. Under the German Stock Corporation Act, the Celanese supervisory board
is not permitted to make management decisions. Pursuant to the rules of
procedure of the Celanese management and supervisory boards, the Celanese board
of management must obtain the prior consent of the Celanese supervisory board
for specific matters such as acquisitions and divestitures, ventures, entry into
new business areas, the incurrence of indebtedness, issuance of guarantees and
creation of mortgages on real estate, if the specific matter is considered to be
of substantial economic importance to Celanese. The supervisory board is also
authorized to subject other actions of the board of management to its prior
consent. The German Stock Corporation Act prohibits simultaneous membership on
the board of management and the supervisory board of a company.

     Under the Domination Agreement, Celanese Europe Holding has the right to
instruct the board of management to take actions and transact business, even if
such actions or transactions are disadvantageous to Celanese, provided they are
in the interest of Celanese Europe Holding or companies affiliated with Celanese
Europe Holding and Celanese. Although by law the supervisory board is not bound
by such instructions and is entitled to approve or reject any action requiring
its approval, Celanese Europe Holding can effectively overrule the supervisory
board's decision by issuing a second instruction. For additional information,
see Item 4. Information on the Company - Acquisition of Celanese.

Board of Management

     The members of the Celanese board of management may be appointed by the
Celanese supervisory board for a maximum term of five years. They may be
reappointed or have their term of office extended for one or more five year
terms. Under some circumstances, such as a serious breach of duty or a bona fide
vote of no confidence by a majority of the votes cast at a shareholders'
meeting, a member of the Celanese board of management may be removed by the
Celanese supervisory board prior to the expiration of such term of office. A
member of the Celanese board of management may not deal with, or vote on,
matters relating to proposals, arrangements or contracts between himself and
Celanese.

     Celanese board of management decisions are made by a simple majority vote.
In the event of a tie vote, the Chairman of the Celanese board of management has
the deciding vote.

     Under the Articles of Association (Satzung) of Celanese, any two members of
the Celanese board of management, or any member of the Celanese board of
management together with the holder of a special power of attorney (Prokurist)
granted by the Celanese board of management, may represent Celanese. The
Celanese board of management must report regularly to the Celanese supervisory
board, in particular, on proposed business policy and strategy, profitability,
the performance of the businesses of Celanese, environment, health and safety,
and corporate governance matters, including risk management and compliance as
well as on any matters of particular significance that may arise from time to
time.

     For information on service contracts between Celanese and the members of
its board of management, see "Compensation of Directors and Officers".

Supervisory Board

     Celanese has approximately 2,800 employees in Germany. Therefore, under the
German Stock Corporation Act, the German Co-Determination Law
(Mitbestimmungsgesetz) and the Articles of Association of Celanese, the Celanese
supervisory board consists of 12 members of whom six are elected by the
shareholders and six are elected by representatives of the German based
employees. Four of the Celanese supervisory board members representing the
employees must be employees of Celanese, whereas the remaining two must be union
representatives. Blue collar (Arbeiter) and white-collar (Angestellte) employees
must be represented in accordance with the ratio of employees who are entitled
to vote in the elections.

     Any member elected by the shareholders in a general meeting may be removed
by a majority of the votes cast by the shareholders in a general meeting. Any
member of the Celanese supervisory board elected by a particular class of
employees may be removed by three-quarters of the votes cast by the
representatives of that class of employees.

     The Celanese supervisory board appoints a chairman (Vorsitzender des
Aufsichtsrats) and a deputy chairman (Stellvertretende Vorsitzender des
Aufsichtsrats) from among its members. The chairman of the Celanese


                                       81



supervisory board must be elected by a majority of two-thirds of the members of
the Celanese supervisory board. If that majority is not reached in the first
vote, the chairman will be elected in a second vote solely by the
representatives of the shareholders. At least half the members of the Celanese
supervisory board must be present to constitute a quorum. Unless otherwise
provided for by law, resolutions are passed by a simple majority of the Celanese
supervisory board. In the event of a tie, another vote is held and the chairman
then has the deciding vote.

     Celanese supervisory board members are usually elected for five-year terms.
Supervisory board members may be re-elected. The remuneration of the members of
the Celanese supervisory board is determined by resolution at shareholder
meetings. For further information on supervisory board remuneration, see
"Compensation of Directors and Officers."

     The Koenigstein local court (Amtsgericht) appointed Messrs. Chu, Jenkins,
Thiemann, Ostmeier, Sommer and Geber as shareholder representatives, and
Celanese shareholders confirmed the court-appointed representatives at the
annual meeting held on June 15, 2004. Messrs. Chu, Jenkins and Ostmeier are all
employed by The Blackstone Group, the majority shareholder of Celanese
Corporation. The following members were elected by the employees for a term
commencing May 20, 2005: Messrs. Becker and Droth were reelected for a second
term and Messrs. Mosel, Hupfer, Lehn and Weidner replaced Messrs. Nause, Bach,
Brinkmann, and Schmalz.

     The supervisory board maintains the following standing committees, all of
which have their own written rules of procedure:

     Finance and Audit Committee. The finance and audit committee reviews in
advance the annual financial statements, the consolidated annual financial
statements, the management report, the consolidated management report and the
proposals to be made to the annual general shareholders' meeting for the
election of the external auditors. The committee uses its review of these issues
to prepare the corresponding resolutions of the supervisory board. The finance
and audit committee also reviews the external auditors' engagement letter,
including proposed fees, and monitors the external auditors and their work.
Furthermore, the committee reviews Celanese's significant accounting policies
and remains informed of the processes, organization and work product of the
Celanese's internal auditing function. It monitors Celanese's internal risk
management and its compliance with all applicable legal and regulatory
requirements. The finance and audit committee met four times during calendar
year 2005. The members of the finance and audit committee until May 20, 2005
were Hanns Ostmeier (Chairman), Hanswilhelm Bach, Hans-Juergen Brinkmann,
Cornelius Geber, and Bernd Thiemann. On May 21, 2005, Hanswilhelm Bach and
Hans-Jurgen Brinkmann were replaced by Johannes Lehn and Axel Weidner,
respectively. See also Item 16A. Audit Committee Financial Expert, and Item 16C.
Principal Accountant Fees and Services.

     Personnel and Compensation Committee. The task of the personnel and
compensation committee is to prepare resolutions of the supervisory board on
personnel matters, in particular regarding the appointment of new board of
management members. In addition the personnel and compensation committee
approves the adoption, amendment and termination of service agreements with the
members of the board of management, as well as any dealings or proceedings
between them and Celanese. The personnel and compensation committee also
approves contracts and acts of members of the management and supervisory boards
which, according to German law, require the approval of the supervisory board.
Furthermore, it has reviewed Celanese's incentive and equity based compensation
plans, and prepares the supervisory board's proposal to the annual general
meeting on the election of new members of the supervisory board. The members of
the personnel and compensation committee until May 20, 2005 were: Bernd Thiemann
(Chairman), Reiner Nause and Hanns Ostmeier. On May 21, 2005, Reiner Nause was
replaced by Gerald Mosel. The personnel and compensation committee met four
times during calendar year 2005.

     Squeeze-Out Committee. The supervisory board also established an ad hoc
squeeze out committee on December 20, 2005 to ensure that the supervisory board
was kept fully informed on a timely basis of all matters connected with the
Squeeze-Out. The members of this committee are Bernd Thiemann (Chairman), Gerald
Mosel, and Hanns Ostmeier.


                                       82



EMPLOYEES

     As of September 30, 2005, Celanese had approximately 3,550 employees
worldwide from continuing operations, substantially unchanged from the previous
year. Celanese had approximately 3,250 employees in Europe, 200 employees in
Asia and 20 employees in North America, and 60 employees in the rest of the
world. The following table sets forth the approximate number of employees on a
continuing basis as of September 30, 2005 and the nine months ended September
30, 2004.

                                EMPLOYEES AS OF   EMPLOYEES AS OF
                                 SEPTEMBER 30,     SEPTEMBER 30,
                                      2005              2004
                                ---------------   ---------------
North America                           19                22
Europe.......................        3,258             3,287
   thereof Germany...........        2,824             2,967
Asia.........................          191               164
Rest of World................           63                58
                                     -----             -----
Total Celanese Employees.....        3,531             3,531
                                     =====             =====

     Many of Celanese's employees are unionized, particularly in Germany,
Brazil, and France. Moreover, in Germany and France, wages and general working
conditions are often the subject of centrally negotiated collective bargaining
agreements. Within the limits established by these agreements, the various
subsidiaries of Celanese negotiate directly with the unions and other labor
organizations, such as workers' councils, representing the employees. Collective
bargaining agreements between the German chemical employers associations and
unions relating to remuneration typically have a term of one year. Celanese
offers comprehensive benefit plans for employees and their families and believes
its relations with employees are satisfactory.

SHARE OWNERSHIP

     As of September 30, 2005, members of the supervisory board and board of
management of Celanese did not own any shares of Celanese. All of the Celanese
shares held by members of the supervisory board and board of management were
either tendered into the Tender Offer or otherwise sold.

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

MAJOR SHAREHOLDERS

     The capital stock of Celanese consists of ordinary shares, no par value
(Stueckaktien), which are issued in registered form.

     Under the German Securities Trading Act (Wertpapierhandelsgesetz), holders
of voting securities of a German company listed on a stock exchange in the
European Union must notify the company and the German Federal Supervisory
Authority for Securities Trading (Bundesanstalt fur
Finanzdienstleistungsaufsicht) of the level of their holding whenever it
reaches, exceeds or falls below specified thresholds. These thresholds are 5
percent, 10 percent, 25 percent, 50 percent and 75 percent of a company's
outstanding voting rights.

     As of March 15, 2006, Celanese Europe Holding, with 49,439,911 shares or
approximately 98 percent of the outstanding shares of Celanese, was the only
shareholder that held more than 5 percent of Celanese ordinary shares.

     In August 2005, Celanese Europe Holding acquired approximately 5.9 million,
or approximately 12%, of the outstanding Celanese shares from two shareholders
for the aggregate consideration of approximately (euro)302 million. Celanese
Europe Holding also paid to such shareholders an additional purchase price of
approximately (euro)12 million in consideration for the settlement of certain
claims and for such shareholders agreeing to, among other things, (1) accept the
shareholders' resolutions passed at the extraordinary general meeting of
Celanese held on July 30-31, 2004 and the annual general meeting of Celanese
held on May 19-20, 2005, (2) acknowledge the legal effectiveness of the
Domination Agreement, (3) irrevocably withdraw and abandon all actions,
applications and appeals each brought or joined in legal proceedings related to,
among other things, challenging the effectiveness of the Domination Agreement
and amount of fair cash compensation offered by Celanese Europe Holding in the
Mandatory Offer required by Section 305(1) of the German Stock Corporation Act,
(4) refrain


                                       83



from acquiring any CAG shares or any other investment in Celanese, and (5)
refrain from taking any future legal action with respect to shareholder
resolutions or corporate actions of Celanese. Celanese Europe Holding also
increased its offer to purchase any remaining outstanding CAG shares to (euro)51
per share (plus interest on (euro)41.92 per share) for all minority shareholders
that would accept the increased offer on or prior to September 29, 2005 and
waive their rights to participate in an increase of the offer consideration as a
result of the pending award proceedings. In addition, all shareholders who
tendered their shares pursuant to the Mandatory Offer of (euro)41.92 per share
were entitled to claim the difference between the increased offer of (euro)51
per share and the Mandatory Offer of (euro)41.92 per share provided they did so
by September 29, 2005 (the "Limited Offer"). Any shareholder who accepted the
increased offer of (euro)51 per share, or claimed the difference between the
Mandatory Offer and the increased offer, was obligated to agree to waive its
rights to participate in any possible future increase of the offer consideration
as a result of the pending award proceedings. Celanese Europe Holding acquired
an additional 1,136,724 ordinary shares pursuant to the Limited Offer. For
minority shareholders who did not accept the Limited Offer on or prior to the
September 29, 2005 expiration date, the terms of the original (euro)41.92 per
share Mandatory Offer continue to apply. The Mandatory Offer will remain open
for two months following final resolution of the award proceedings
(Spruchverfahren) by the German courts.

     As of September 30, 2005, Celanese had approximately 8,100 shareholders.
Approximately 1,700 of these shareholders were U.S. holders. Based on the share
register, it is estimated that 0.1 percent of Celanese outstanding shares were
held by U.S. holders as of this date.

     On June 22, 2004, Celanese entered into the Domination Agreement with its
majority shareholder, Celanese Europe Holding, pursuant to which Celanese AG
agreed to submit itself to the direction of, and to transfer its entire profits
to, Celanese Europe Holding, and Celanese Europe Holding agreed to compensate
Celanese for any annual losses (Jahresfehlbetrag) incurred while the Domination
Agreement is in effect. The Domination Agreement was approved by shareholders at
an extraordinary general meeting held on July 30-31, 2004. The Domination
Agreement was registered in the commercial register on August 2, 2004 and became
operative on October 1, 2004. For more information see Domination and Profit and
Loss Transfer Agreement in Item 4. Information on the Company - Acquisition of
Celanese. In November 2005, Celanese Corporation caused Celanese Europe Holding
to require, as permitted under German law, the transfer to Celanese Europe
Holding of the shares owned by the then-outstanding minority shareholders of
Celanese in exchange for fair cash compensation (the "Squeeze-Out"). In March
2006, Celanese Europe Holding set the cash compensation at (euro)62.22. The
Squeeze-Out will require the approval by the affirmative vote of the majority of
the votes cast at Celanese's annual general meeting in May 2006. Once Celanese
Europe Holding effects the Squeeze-Out, Celanese Europe Holding must pay the
then remaining minority shareholders of Celanese fair cash compensation, as
described below, in exchange for their shares.

RELATED PARTY TRANSACTIONS

     As part of Celanese's cash management strategy, affiliates invest surplus
funds with Celanese AG. These balances were (euro)112 million and (euro)80
million at September 30, 2005 and 2004, respectively. As of March 15, 2006
short-term borrowings from affiliates were (euro)139 million. Interest rates on
these borrowings were adjusted on a short-term basis to reflect market
conditions. The weighted average annual interest rates on these borrowings was
two percent for the year ended September 30, 2005 as well as for the nine months
ended September 30, 2004.

     Other than the Domination Agreement and except as noted in this section,
Celanese has not entered into any material transactions in the last three years
in which any shareholder or member of its management or supervisory boards, or
any associate of any shareholder or member of its management or supervisory
boards has or had any interest. Except as noted in this section, no shareholder
or member of its management or supervisory boards or associate of any
shareholder or member of its management or supervisory boards is or was during
the last three years indebted to Celanese.

     As of March 15, 2006 Celanese holds three intercompany notes of Celanese
Europe Holding, the first having a principal amount of approximately (euro)291
million, representing the fair market value of CAC, the second having a
principal amount of approximately (euro)677 million, representing a receivable
for intercompany debt with CAC that was transferred from


                                       84



Celanese AG to Celanese Europe Holding, and the third having a principal amount
of approximately (euro)223 million, representing the amount of the equity
investment in a Canadian indirect subsidiary of Celanese Corporation in
connection with its acquisition of Acetex Corporation. Each of these notes bears
interest at the rate of 4.67 percent per annum. In addition, in November 2005,
Celanese extended intercompany loans to two French subsidiaries of Acetex
Corporation in the aggregate principal amount of (euro)213 million, each bearing
interest at the rate of 6.104 percent per annum. The principal amount represents
part of the funding used for the redemption of Acetex's 10-7/8% senior notes. In
December 2005, Celanese extended an intercompany loan to Celanese Emulisions
Ltd., a British subsidiary of CAC, in the principal amount of GBP 17 million,
bearing interest at 8.08 percent per annum, and Celanese Emulsions B.V., a Dutch
subsidiary of CAC, in the principal amount (EURO) 6 million, bearing interest at
6.174 percent per annum. The principal amounts of these loans represent part of
the net debt settlement in accordance with Celanese Corporation's purchase
agreement for these entities. Celanese also holds an intercompany note of BCP
Acquisition GmbH & Co. KG, the parent of Celanese Europe Holding, in the
principal amount of approximately (euro)66 million and bearing interest at the
rate of 5.5 percent per annum. This amount represents a receivable for
intercompany debt with CAC that was transferred from Celanese AG to BCP
Acquisition GmbH & Co. KG. All of the intercompany notes described above are
secured by letters of support from Celanese Corporation (See also Item 10.
Additional Information - Material Contracts).

     Celanese Corporation has entered into a sponsor services agreement with
Blackstone Management Partners IV L.L.C., an affiliate of The Blackstone Group
(the "Advisor"). Chinh Chu, Benjamin Jenkins, Anjan Mukherjee, and Hanns
Ostmeier, all members of Celanese's supervisory board, are all employed by The
Blackstone Group. Under the agreement, and in the absence of a separate
agreement regarding compensation for these types of additional services, the
Advisor is entitled to receive upon consummation of (i) any such acquisition,
disposition or recapitalization a fee equal to 1 percent of the aggregate
enterprise value of the acquired, divested or recapitalized entity or, if such
transaction is structured as an asset purchase or sale, 1 percent of the
consideration paid for or received in respect of the assets acquired or disposed
of and (ii) any such refinancing, a fee equal to 1 percent of the aggregate
value of the securities subject to such refinancing. Celanese Corporation agreed
to pay the Advisor aggregate fees of approximately (euro)3 million in connection
with Celanese Europe Holdings' acquisition of 5.9 million of additional CAG
Shares from two shareholders of CAG in August 2005. See Item 4. Business
Description - Acquisition of Celanese.

     The sponsor services agreement also provides for a right of first refusal
to the Advisor to provide Celanese Corporation and its subsidiaries with
services as a financial advisor, consultant, investment banker or any similar
advisor in connection with any merger, acquisition, disposition,
recapitalization, issuance of securities, financing or any similar transaction.

     In addition, Celanese Corporation and its subsidiaries have agreed to
indemnify the Advisor and its affiliates and their respective partners, members,
directors, officers, employees, agents and representatives for any and all
losses relating to services contemplated by these agreements and the engagement
of the Advisor pursuant to, and the performance by the Advisor of the services
contemplated by, these agreements. Celanese Corporation has also agreed to
reimburse the Advisor and its affiliates for their expenses incurred in
connection with the services provided under these agreements or in connection
with their ownership or subsequent sale of Celanese Corporation stock.

     Dresdner Bank and its subsidiaries provided various financial and
investment advisory services to Celanese in 2003, for which they were paid
reasonable and customary fees. Alfons Titzrath, who had been Chairman of the
supervisory board of Dresdner Bank until May 2002, was a shareholder
representative on Celanese AG's supervisory board from 1999 to 2004. See also
Item 4. Information on the Company - Acquisition of Celanese.

     Celanese entered into an agreement with Goldman, Sachs & Co. oHG, an
affiliate of Goldman, Sachs & Co., on December 15, 2003 (the "Goldman Sachs
Engagement Letter"), pursuant to which Goldman Sachs acted as its financial
advisor in connection with the Tender Offer. Pursuant to the terms of the
Goldman Sachs Engagement Letter, Celanese AG paid Goldman Sachs a financial
advisory fee equal to (euro)11,000,000 and a discretionary bonus of
(euro)4,000,000. Celanese AG has agreed to reimburse Goldman Sachs for all its
reasonable expenses and to indemnify Goldman Sachs and related persons for all
direct damages arising in connection with the Goldman Sachs Engagement Letter.
Kendrick R. Wilson, III, Vice Chairman - Investment Banking of Goldman Sachs,
was a shareholder representative on Celanese's supervisory board from 1999 to
2004.

ITEM 8. FINANCIAL INFORMATION

     See Item 18. Financial Statements and pages F-1 through F-69 for
Consolidated Financial Statements and Other Financial Information.


                                       85



EXPORT SALES

     During the period from August 25, 2005 to September 30, 2005, approximately
(euro)51 million or 93 percent of all Singapore sales and approximately (euro)87
million or 59 percent of all German sales were export sales. During the period
from October 1, 2004 to August 24, 2005, approximately (euro)452 million or 92
percent of all Singapore sales and approximately (euro)768 million or 58 percent
of all German sales were export sales.

LEGAL PROCEEDINGS

     Celanese is involved in a number of legal proceedings and claims incidental
to the normal conduct of its businesses, relating to such matters as product
liability, tax assessments, competition, past waste disposal practices and
release of chemicals into the environment. While it is impossible at this time
to determine with certainty the ultimate outcome of these proceedings and
claims, management believes that adequate provisions have been made and that the
ultimate outcomes will not have a material adverse effect on our financial
position, but may have a material adverse effect on the results of operations or
cash flows in any given accounting period. See also Note 24 to the Consolidated
Financial Statements.

Sorbates Antitrust Actions

     In May 2002, the European Commission informed Hoechst of its intent to
officially investigate the sorbates industry, and in early January 2003, the
European Commission served Hoechst, Nutrinova and a number of competitors with a
statement of objections alleging unlawful, anticompetitive behavior affecting
the European sorbates market. In October 2003, the European Commission ruled
that Hoechst, Chisso Corporation, Daicel Chemical Industries Ltd., The Nippon
Synthetic Chemical Industry Co. Ltd. and Ueno Fine Chemicals Industry Ltd.
operated a cartel in the European sorbates market between 1979 and 1996. The
European Commission imposed a total fine of (euro)138 million, of which (euro)99
million was assessed against Hoechst. The case against Nutrinova was closed. The
fine against Hoechst is based on the European Commission's finding that Hoechst
does not qualify under the leniency policy, is a repeat violator and, together
with Daicel, was a co-conspirator. In Hoechst's favor, the European Commission
gave a discount for cooperating in the investigation. Hoechst appealed the
European Commission's decision in December 2003, and that appeal is still
pending.

     In addition, several civil antitrust actions by sorbates customers, seeking
monetary damages and other relief for alleged conduct involving the sorbates
industry, have been filed in U.S. state and federal courts naming Hoechst,
Nutrinova, and our other subsidiaries, as well as other sorbates manufacturers,
as defendants. Many of these actions have been settled and dismissed by the
court. One private action, Kerr v. Eastman Chemical Co. et al., previously
pending in the Superior Court of New Jersey, Law Division, Gloucester County,
was dismissed in October 2005 for failure to prosecute. The only other private
action previously pending, Freeman v. Daicel et al., had been dismissed. The
plaintiffs lost their appeal to the Supreme Court of Tenneessee in August 2005
and have since filed a motion for leave.

     In July 2001, Hoechst and Nutrinova entered into an agreement with the
attorneys general of 33 states, pursuant to which the statutes of limitations
were tolled pending the states' investigations. This agreement expired in July
2003. Since October 2002, the Attorneys General for several states filed suit on
behalf of indirect purchasers in their respective states, all of which have
either been settled or dismissed, except as noted below. The Nevada action has
been dismissed as to Hoechst, Nutrinova and Celanese. The New York action, New
York v. Daicel Chemical Industries Ltd., et al. which was pending in the New
York State Supreme Court, New York County, was dismissed in August 2005;
however, appeals are pending. In January 2005, Hoechst, Nutrinova, and other
subsidiaries, as well as other sorbates manufacturers, entered into a settlement
agreement with the Attorneys General of Connecticut, Florida, Hawaii, Maryland,
South Carolina, Oregon and Washington before these states filed suit. Pursuant
to the terms of the settlement agreement, the defendants agreed to refrain from
engaging in anticompetitive conduct with respect to the sale or distribution of
sorbates and pay approximately (euro)1 million to the states in satisfaction of
all released claims.

     Although the outcome of the foregoing proceedings and claims cannot be
predicted with certainty, we believe that any resulting liabilities, net of
amounts recoverable from Hoechst, will not, in the aggregate, have a material
adverse effect on our financial position, but may have a material adverse effect
on the results of operations or cash flows in any given period. In the demerger
agreement, Hoechst agreed to pay 80 percent of liabilities that may arise from
the government investigation and the civil antitrust actions related to the
sorbates industry.


                                       86









Shareholder Litigation

     A number of minority shareholders of Celanese have filed lawsuits in the
Frankfurt District Court (Landgericht) that, among other things, request the
court to set aside shareholder resolutions passed at the extraordinary general
meeting held on July 30 and 31, 2004, as well as the confirmatory resolutions
passed at the annual general meeting held on May 19 and 20, 2005. On March 6,
2006, Celanese Europe Holding and Celanese signed a settlement agreement with
eleven minority shareholders who had filed such lawsuits (the "Settlement
Agreement"). Pursuant to the Settlement Agreement, the plaintiffs agreed to
withdraw the actions to which they are a party and to recognize the validity of
the Domination Agreement in exchange for Celanese Europe Holding to offer at
least (euro)51.00 per share as cash consideration to each shareholder who will
cease to be a shareholder in the context of the Squeeze-Out. The Celanese Europe
Holding further agreed to make early payment of the guaranteed annual payment
(Ausgleich) pursuant to the Domination Agreement for the financial year
2005/2006, ending on September 30, 2006. Such guaranteed annual payment normally
would have come due following the annual general meeting in 2007; however,
pursuant to the Settlement Agreement, it will be made on the first banking day
following the Celanese's annual general meeting that commences on May 30, 2006.
To receive the early compensation payment, the respective minority shareholder
will have to declare that (i) his claim for payment of compensation for the
financial year 2005/2006 pursuant to the Domination Agreement is settled by such
early payment and that (ii) in this respect, he indemnifies Celanese Europe
Holding against compensation claims by any legal successors to his shares.

     During August 2004, nine actions were brought by minority shareholders
against Celanese in the Frankfurt District Court (Landgericht), all of which
were consolidated in September 2004. Among other things, these actions requested
the court to set aside shareholder resolutions passed at the extraordinary
general meeting held on July 30 - 31, 2004, Several minority shareholders joined
these proceedings via a third party intervention in support of the plaintiffs.
The Purchaser joined the proceedings via a third party intervention in support
of Celanese. These actions will be withdrawn pursuant to the Settlement
Agreement.

     Twenty-seven minority shareholders filed lawsuits (Anfechtungs- und
Nichtigkeitsklagen) in the Frankfurt District Court (Landgericht) contesting the
shareholder resolutions passed at the annual general meeting of Celanese held
May 19-20, 2005, which confirmed the resolutions passed at the July 30-31, 2004
extraordinary general meeting of Celanese. Of these lawsuits, thirteen minority
shareholders also contested the resolutions regarding the ratification
(Entlastung) of the acts of the members of the board of management and the
supervisory board; two minority shareholders also contested the resolutions
regarding the election of the statutory auditors for the 2005 fiscal year, as
well as the amendment of the articles of association; and eight minority
shareholders also contested the dismissal of the motion to hold a special
investigation (Sonderpruefung) and have asked the court to declare that the
annual general meeting had in fact resolved in favor of such an investigation
(positive Beschlussfestellungsklage). All of these actions are based, among
other things, on the alleged violation of procedure requirements and information
rights of the shareholders. In February 2006, the court upheld only the
challenge to the resolutions regarding the ratification (Entlastung) of the acts
of the members of the board of management and the supervisory board. All other
claims, including those contesting the confirmatory resolutions, were dismissed.
This decision is subject to appeal.

     In conjunction with the acquisition of 5.9 million CAG Shares from two
shareholders in August 2005, two of those lawsuits relating to the resolutions
confirming the contested resolutions at the extraordinary general meeting and
the ratification of the acts of the members of the board of management and
supervisory board, as well as the dismissal of the special investigation, were
withdrawn in August 2005. A further ten of these lawsuits will be withrawn
pursuant to the Settlement Agreement.

     Celanese is also a defendant in five actions filed in the Frankfurt
District Court (Landgericht) requesting that the court declare some or all of
the shareholder resolutions passed at the extraordinary general meeting of
Celanese on July 30 and 31, 2004 null and void (Nichtigkeitsklage), based on
allegations that certain formal requirements necessary in connection with the
invitation to the extraordinary general meeting of Celanese had been violated.
The Frankfurt District Court (Landgericht) has suspended the proceedings
regarding the resolutions passed at the July 30-31, 2004 extraordinary general
meeting of Celanese described above so long as the lawsuits contesting the
confirmatory resolutions are pending.

     On August 2, 2004, two minority shareholders instituted public register
proceedings with the Konigstein local court (Amtsgericht) and the Frankfurt
District Court (Landgericht), both with a view to have the registration of the
Domination Agreement in the Commercial Register deleted
(Amtsloeschungsverfahren). These actions are based on an alleged violation of
procedural requirements at the extraordinary general meeting, an alleged
undercapitalization of Celanese Europe Holding and its related entities at the
time of the Tender Offer and an alleged misuse of discretion by the competent
court with respect to the registration of the Domination Agreement in the
Commercial Register. In April 2005, the court of appeals (Oberlandesgericht)
rejected the demand by one shareholder for injunctive relief, and in June 2005
the Frankfurt District Court (Landgericht) ruled that it does not have
jurisdiction over this matter. One of the claims in the Koenigstein Local Court
(Amtsgericht) is still pending, and the other will be withdrawn pursuant to the
Settlement Agreement.

     In February 2005, a minority shareholder also brought a lawsuit against
Celanese Europe Holding, as well as a former member of Celanese's board of
management and a former member of Celanese's supervisory board, in the Frankfurt
District Court (Landgericht). Among other things, this action seeks to unwind
the tender of the plaintiff's shares and seeks compensation for damages suffered
as a consequence of tendering such shares. The court ruled against the plaintiff
in this matter in June 2005. The plaintiff had appealed this decision with
respect to Celanese Europe Holding and the former member of the Celanese board
of management; however, the appeal will be withdrawn pursuant to the Settlement
Agreement.

     Based upon information available as of March 15, 2006, the outcome of
foregoing proceedings still pending cannot be predicted with certainty.

     The amounts of the fair cash compensation (Abfindung) and of the guaranteed
fixed annual payment (Ausgleich) offered under the Domination Agreement may be
increased in special award proceedings (Spruchverfahren) initiated by minority
shareholders. Several minority shareholders of Celanese had initiated special
award proceedings seeking the court's review of the amounts of the fair cash
compensation and of the guaranteed fixed annual payment offered under the
Domination Agreement. As a result of these proceedings, the amount of the fair
cash consideration and the guaranteed fixed annual payment offered under the
Domination Agreement could be increased by the court so that all minority
shareholders, including those who have already tendered their shares into the
Mandatory Offer and have received the fair cash compensation could claim the


                                       87



respective higher amounts. However, the court dismissed all of these proceedings
in March 2005 on the grounds of inadmissibility. Thirty-three plaintiffs
appealed the dismissal, and in January 2006, twenty-three of these appeals were
granted by the court. They were remanded back to the court of the first
instance, where the valuation will be further reviewed.

DIVIDEND POLICY

     For the short fiscal year ended September 30, 2004, Celanese was not able
to pay a dividend to its shareholders because of a non-cash impairment charge to
the value of CAC in Celanese AG's statutory amounts as of September 30, 2004.
Due to the size of this charge, Celanese did not have any distributable retained
earnings, which, under German law, prevented it from declaring a dividend to its
shareholders for the short fiscal year 2004. In lieu of any future dividends for
any fiscal years commencing after September 30, 2004, any minority shareholder
of Celanese shall receive the guaranteed fixed annual payment on its shares, as
long as the Domination Agreement remains in effect. The fixed annual payment for
the 2004/2005 fiscal year will be paid on the first business day after the
annual general meeting to be held in May 2006. In addition, pursuant to the
Settlement Agreement, the fixed annual payment for the 2005/2006 fiscal year
will also be paid on this date.


     The amount of the guaranteed fixed annual payment to be paid to any
minority shareholder who elects to retain its shares was based on an analysis of
the fair enterprise value of Celanese as of the date of the relevant
shareholders' meeting on July 30 - 31, 2004, assuming a full distribution of
profits. According to the Domination Agreement, the gross guaranteed fixed
annual payment is (euro)3.27 per share less certain corporate taxes. See Item 4.
Acquisition of Celanese - Domination and Profit and Loss Transfer Agreement.

SIGNIFICANT CHANGES

     The Company announced its intention to build a state-of-the-art vinyl
acetate ethylene and conventional emulsion polymer facility in China. Startup is
targeted for the first half of 2007. The China operations were transferred to
Celanese Corporation in March 2006.

     In November 2005, Celanese Corporation caused Celanese Europe Holding to
require, as permitted under German law, the transfer to Celanese Europe Holding
of the shares owned by the then-outstanding minority shareholders of Celanese in
exchange for fair cash compensation (the "Squeeze-Out"). The Squeeze-Out will
require the approval by the affirmative vote of the majority of the votes cast
at Celanese's annual general meeting in May 2006 and will become effective upon
its registration in the commercial register. On March 6, 2006, Celanese and
Celanese Europe Holding signed a settlement agreement with eleven minority
shareholders who had filed lawsuits in the Frankfurt District Court
(Landgericht) requesting that the resolutions of the extraordinary general
meeting on July 30-31, 2004 and the annual general meeting on May 19-20, 2005 be
set aside and/or be declared null and void (the "Settlement Agreement").
Pursuant to the Settlement Agreement, these minority shareholders agreed to
withdraw all actions filed by them in connection with the Domination Agreement,
as well as any other ancillary litigation, and to recognize the validity of the
Domination Agreement. Celanese Europe Holding agreed to offer at least
(euro)51.00 per share in cash as fair cash compensation in connection with the
Squeeze-Out, and agreed on an early payment to those shareholders affected by
the Squeeze-Out of the fixed annual payment (Ausgleich) for the 2005/2006 fiscal
year. Such fixed annual payment normally would have come due following the
annual general meeting in 2007; however, pursuant to the Settlement Agreement,
it will be paid immediately following the annual general meeting to be held in
May 2006. For more information, see "Legal Proceedings" above.

     On March 10, 2006, Celanese announced that Celanese Europe Holding has set
the cash compensation in connection with the Squeeze-Out at (euro)62.22 per
share. The amount of the cash compensation was based on an independent
valuation. Celanese has arranged for Deutsche Bank AG to issue a bank guarantee
of the cash compensation as required by law. For more information see Item 4.
Description of Business - Acquisition of Celanese."

     A number of minority shareholders have filed lawsuits in the Frankfurt
District Court (Landgericht) that, among other things, request the court to set
aside shareholder resolutions passed at the extraordinary general meeting held
on July 30 and 31, 2004, as well as the confirmatory resolutions passed at the
annual general meeting held on May 19 and 20, 2005. On March 6, 2006, Celanese
Europe Holding and Celanese signed a settlement agreement with eleven minority
shareholders who had filed such lawsuits (the "Settlement Agreement"). Pursuant
to the Settlement Agreement, the plaintiffs agreed to withdraw the actions to
which they are a party and to recognize the validity of the Domination Agreement
in exchange for Celanese Europe Holding to offer at least (euro)51.00 per share
as cash consideration to each shareholder who will cease to be a shareholder in
the context of the Squeeze-Out. Celanese Europe Holding further agreed to make
early payment of the guaranteed annual payment (Ausgleich) pursuant to the
Domination Agreement for the financial year 2005/2006, ending on September 30,
2006. Such guaranteed annual payment normally would have come due following the
annual general meeting in 2007; however, pursuant to the Settlement Agreement,
it will be made on the first banking day following the Celanese's annual general
meeting that commences on May 30, 2006. To receive the early compensation
payment, the respective minority shareholder will have to declare that (i) his
claim for payment of compensation for the financial year 2005/2006 pursuant to
the Domination Agreement is settled by such early payment and that (ii) in this
respect, he indemnifies Celanese Europe Holding against compensation claims by
any legal successors to his shares.

ITEM 9. THE OFFER AND LISTING

NATURE OF TRADING MARKET

     CAG Shares are listed on the Frankfurt Stock Exchange and trade under the
symbol "CZZ", under the German securities code number (Wertpapierkennnummer) 575
300 and under the International Securities Identification Number DE 0005753008.
Since the CAG Shares are in registered form, they may be traded in the United
States without a depositary receipt facility. CAG Shares were delisted from the
New York Stock Exchange on June 2, 2004. Since then, CAG Shares traded over the
counter in the United States. Because the


                                       88



shares are not traded in the United States on an organized exchange, trading
tends to be less frequent, which could result in a lack of liquidity for the
shares.

     The transfer agents for CAG Shares are registrar services GmbH in Germany,
or the Transfer Agent, and Mellon Investor Services in the United States, or the
U.S. Transfer Agent.

     The tables below set forth, for the periods indicated, the high and low
closing sales prices on the Frankfurt Stock Exchange for CAG Shares as reported
by the electronic cash market trading system (Xetra).

                                                                 PRICE PER
                                                              ORDINARY SHARE
                                                              --------------
                                                               HIGH     LOW
                                                              -----    -----
                                                                (IN (EURO))
Annual Highs and Lows
2001.......................................................   28.00    14.91
2002.......................................................   27.75    15.70
2003.......................................................   32.61    12.51
2004 (January 1 through September 30)......................   45.24    31.43
2005 (October 1, 2004 through September 30, 2005)..........   54.40    43.90
Quarterly Highs and Lows
2003
   First Quarter...........................................   22.52    12.51
   Second Quarter..........................................   22.10    15.70
   Third Quarter...........................................   31.88    20.52
   Fourth Quarter..........................................   32.61    25.99
2004
   First Quarter...........................................   33.95    31.43
   Second Quarter..........................................   44.00    33.25
   Third Quarter...........................................   45.24    43.26
2005
   First Quarter (October 1 through December 31, 2004).....   45.90    43.90
   Second Quarter (January 1 through March 31, 2005).......   50.90    45.13
   Third Quarter (April 1 through June 30, 2005)...........   49.10    46.13
   Fourth Quarter (July 1 through September 30, 2005)......   54.40    48.55

                                                                 PRICE PER
                                                              ORDINARY SHARE
                                                              --------------
                                                               HIGH     LOW
                                                              -----    -----
                                                                (IN (EURO))
Monthly Highs and Lows
2005
   July....................................................   52.00    48.55
   August .................................................   54.40    51.50
   September...............................................   52.95    51.03
   October.................................................   52.87    51.03
   November................................................   54.12    51.51
   December................................................   54.49    53.00
2006
   January.................................................   54.99    53.05
   February ...............................................   54.20    53.01
   March (through March 15, 2006) .........................   69.00    53.10

     Based on turnover statistics supplied by both the Frankfurt Stock Exchange
and Xetra, the average daily volume of CAG Shares traded between October 1, 2004
and September 30, 2005 was 2,822 on the Frankfurt Stock Exchange and 4,560 on
Xetra.


                                       89



     On February 15, 2006, the closing sales price per Celanese ordinary share
on the Xetra System was (euro)54.11. See the discussion under Item 3. Key
Information - Exchange Rate Information with respect to rates of exchange
between the dollar and the euro.

ITEM 10. ADDITIONAL INFORMATION

ARTICLES OF ASSOCIATION

Organization and Register

     Celanese AG is a stock corporation organized in the Federal Republic of
Germany under the Stock Corporation Act (Aktiengesetz). It is registered in the
Commercial Register (Handelsregister) maintained by the local court
(Amtsgericht) in Koenigstein im Taunus, Germany, under the entry number HRB
5277.

Objects and Purposes

     Section 2 of Celanese AG's Articles of Association states that the company
directs, as a holding company, a group of companies which conduct business, in
particular in the areas of chemicals and plastics. In addition, the company may
conduct business itself in these or other areas. It is entitled to take all
actions and measures which relate to or which otherwise directly or indirectly
serve its objectives. Celanese AG may also form, acquire or participate in
enterprises, or bring them together under common control, in particular with
regard to enterprises operating in the areas of chemicals and plastics. It is
entitled, mainly for investment purposes, to acquire interests in all kinds of
enterprises. With regard to group companies and other enterprises in which it
holds an interest, Celanese AG may restrict itself to the administration of its
interests, as well as dispose of them.

Management and Supervisory Boards

     In carrying out their duties, members of both the Celanese board of
management and the Celanese supervisory board must exercise the standard of care
of a prudent and diligent businessperson. Both the members of the Celanese board
of management and the members of the Celanese supervisory board owe a duty of
loyalty and care to Celanese, and must act only in the interest of Celanese and
not in his or her own or any third party's interest. The interests of Celanese
are deemed to include the interests of the shareholders, the interests of the
work force and, to some extent, the common interest, and both the Celanese board
of management and the Celanese supervisory board must take all these interests
into account when taking actions or making decisions.

     However, under the Domination Agreement that became effective on October 1,
2004, the Board of Management may be compelled to take actions that are
disadvantageous to Celanese if the board of management is instructed to do so by
Celanese Europe Holding, and provided that such instructions are in the interest
of Celanese Europe Holding or its affiliates. The board of management may only
refuse to comply with any such instruction, if, at the time such instruction is
given, (i) it is, in the opinion of the board of management, obviously not in
the interests of Celanese Europe Holding or its affiliates, (ii) compliance with
the instruction would violate legal or statutory restrictions, (iii) compliance
with the instruction would endanger the existence of Celanese; or (iv) it is
doubtful whether Celanese Europe Holding will be able to fully compensate
Celanese, as required by the Domination Agreement, for its annual loss
(Jahresfehlbetrag) incurred during the fiscal year in which such instruction is
given. The supervisory board is not bound by instructions issued by Celanese
Europe Holding under the Domination Agreement. If Celanese Europe Holding
instructs the board of management to take an action that requires the
supervisory board's approval and such approval is not given, the board of
management nevertheless has to comply with such instruction if Celanese Europe
Holding repeats it.

Interested Party Transactions; Loans to Board Members; Compensation

     According to the German Stock Corporation Act, the Celanese supervisory
board shall represent the interests of the company in the event Celanese enters
into a transaction or contract with a member of its board of management. Any
service or consulting agreement between the company and a member of its
supervisory board must be approved by a resolution of the supervisory board.
Further, a member of the management or supervisory board may not participate in
any resolution that involves a transaction between Celanese and the member, nor
the institution or settlement of legal proceedings between Celanese and the
member. A member of the management or supervisory board who is also a
shareholder may not vote his or her shares on any matter that concerns
ratification of his or her own acts or the release of his or her obligations.
Although the German Stock Corporation Act permits companies to grant certain
loans to members of its supervisory board, board or management, or other
executives, as well as to the families of these individuals with supervisory
board approval, the rules of procedure


                                       90



of the Personnel and Compensation Committee of Celanese's supervisory board may
permit the approval of such loans only if they would not violate U.S. law.
Celanese is in compliance with the provisions of the U.S. Sarbanes-Oxley Act
restricting loans to executive officers and directors, which explicitly
precludes the granting of such loans. Compensation of supervisory board members
requires shareholder approval.

Age Limit

     Celanese AG's Articles of Association do not mandate the retirement of
directors under an age limit requirement. However, the rules of the procedure
for the supervisory board's personnel and compensation committee prohibit the
proposal of candidates for the board of management and the supervisory board who
have reached the ages of 65 and 70, respectively.

Share Ownership Requirement

     Celanese AG's Articles of Association do not require members of its
supervisory board and board of management to be shareholders in the company.

Ordinary Shares

     The share capital of Celanese AG consists of (euro)140,069,354 divided into
54,790,369 ordinary shares of no par value issued in registered form, of which
4,425,351 ordinary shares are held by the company as treasury stock as of
September 30, 2005. Record holders of ordinary shares are registered in Celanese
AG's share register (Aktienregister). The share register is administered on
behalf of Celanese AG by registrar services GmbH, as transfer agent and
registrar in Germany and by Mellon Investor Services as transfer agent and
registrar in the United States.

     Celanese AG also has (euro)3,195,574 in contingent capital. The contingent
capital may only be used to grant stock options to members of the board of
management and other senior managers of Celanese AG and its subsidiaries.
Celanese does not expect to issue any further stock options.

Dividends

     Pursuant to the Domination Agreement, minority shareholders receive a
guaranteed fixed annual payment on their shares, in lieu of any future dividends
for the fiscal years starting after September 30, 2004. The amount of the
guaranteed fixed annual payment to be paid to any minority shareholder who
elects to retain his or her shares was based on an analysis of the fair
enterprise value of Celanese as of the date of the shareholders meeting on July
30 - 31, 2004, assuming a full distribution of profits. The gross guaranteed
fixed annual payment is (euro)3.27 per share less certain corporate taxes. See
Item 8. Financial Information - Dividend Policy

Voting Rights

     Each ordinary share entitles the owner to one vote at the general meeting.
Cumulative voting is not permitted under German law. Celanese AG's Articles of
Association provide that all resolutions of the general meeting may be passed by
a simple majority of votes cast and, if a majority of capital is required, by a
simple majority of the share capital represented in the meeting unless otherwise
mandatorily required by law. German law mandatorily requires that the following
matters, among others, be approved by the affirmative vote of 75 percent of the
issued shares present at the shareholders' meeting at which the matter is
proposed:

     o    Changing the objects and purposes provision in the articles of
          association,

     o    Capital decreases,

     o    Capital increases in the form of authorized and conditional capital,

     o    Excluding preemptive rights of shareholders to subscribe for new
          shares,

     o    Dissolution,

     o    A merger into, or a consolidation with, another stock corporation, and

     o    A transfer of all or virtually all of the assets.

     Celanese Europe Holding, through its 98 percent voting power at any
Celanese shareholders' meeting, has the ability to approve all of the above
items.


                                       91



Supervisory Board Terms

     The terms of the Celanese AG supervisory board members conclude at the
termination of the annual general meeting that votes on the ratification of
their acts for the fourth business year following the commencement of their term
of office, not counting the business year in which that term begins.
Shareholders at the annual general meeting may elect the shareholders'
representatives to the supervisory board to a shorter term. Supervisory board
members may also be re-elected.

Liquidation

     If Celanese AG were to be liquidated, any liquidation proceeds remaining
after all of its liabilities were paid would be distributed to its shareholders
in proportion to their shareholdings.

Capital Increases

     The share capital may be increased in consideration of contributions in
cash or in kind, or by establishing authorized capital or contingent capital.
Authorized capital provides the board of management with the flexibility to
issue new shares up to a maximum of 50 percent of the company's stated capital
for a period of up to five years. Contingent capital allows the board of
management to issue new shares up to a maximum of 50 percent of the company's
stated capital for specified purposes, including mergers and the issuance of
shares for convertible bonds. In the case of issuing new shares for employee
stock option plans no more than 10 percent of the company's stated capital may
be authorized. Capital increases require an amendment of the Articles of
Association approved, in the case of an increase in authorized or contingent
capital, by 75 percent of the issued shares present at the shareholders' meeting
at which the increase is proposed. The board of management must also obtain the
approval of the supervisory board before issuing new shares out of authorized
capital. Celanese AG's Articles of Association currently contain provisions for
contingent capital, but not for authorized capital; nor do they contain
conditions regarding changes in the share capital that are more stringent than
the law requires.

Redemption

     The share capital may be reduced by an amendment of the Articles of
Association approved by 75 percent of the issued shares present at the
shareholders' meeting. Shareholders may also authorize the board of management
for a period of up to 18 months to repurchase up to 10 percent of the issued and
outstanding shares for a specific purpose, such as employee share or option
grants or the cancellation of shares as may be authorized by the shareholders.
Such repurchase authorizations require approval by 50 percent of the issued
shares present at the shareholders' meeting unless the repurchased shares are to
be used in such a way that excludes shareholder subscription rights, in which
case a majority of 75 percent of the issued shares present is required.

Changes in Shareholder Rights

     As a general rule, changes in shareholder rights require approval of all
the shareholders affected. However, for some changes in shareholder rights (such
as changes in the preferential rights of preferred shares), the law only
requires a resolution to be passed by a specific majority of the affected
shareholders present at a general meeting. In addition to such approval from the
shareholders affected, the articles of association must be amended by a
resolution of the majority of the share capital represented at the meeting.

Shareholder Meetings

     German law requires a company's annual general meeting to be held within
the first eight months of each fiscal year. The board of management, supervisory
board, or shareholders owning an aggregate amount of at least 5 percent of the
issued shares may call a meeting of shareholders. There is no minimum quorum
requirement for shareholder meetings. Among other things, the annual general
meeting is asked to approve the appointment of an independent auditor, ratify
the actions of the management and supervisory boards during the prior year, and,
in certain instances, approve the annual accounts.

     According to Celanese AG's Articles of Association, shareholders listed in
the shareholder register as of the date of the general meeting and who have
indicated their desire to attend the general meeting no later than seven days
prior to the meeting (unless a different period is prescribed by the board of
management) are entitled to attend and vote at the meeting. Shareholders may
also vote by proxy. Unless such proxies are granted to a credit institute or
shareholders' association, they may be submitted by mail or telefax, as
determined by the board of management and set forth in the invitation to the
meeting.


                                       92



     The Articles of Association delegate the responsibility for determining the
order of agenda items, as well as the manner, form and order of voting, to the
chairman of the meeting. The chairman may also allow the transmission of the
general meeting as well as the participation in the general meeting, voting, or
the exercise of other shareholders' rights, in each case either directly or by
proxy, as permitted by law.

     Amendments to Celanese AG's Articles of Association may be proposed either
by the supervisory board and the board of management, or by a shareholder or
group of shareholders holding at least 195,583 shares.

No Limitation on Foreign Ownership

     There are no limitations under German law or in Celanese AG's Articles of
Association on the right of persons who are not citizens or residents of Germany
to hold or vote ordinary shares in Celanese AG.

Change in Control

     There are no provisions in the Articles of Association that would have an
effect of delaying, deferring or preventing a change in control of Celanese AG
and that would only operate with respect to a merger, acquisition or corporate
restructuring involving it or any of its subsidiaries. German law does not
specifically regulate business combinations with interested shareholders.
However, general principles of German law may restrict business combinations
under some circumstances.

     The German Takeover Act (Wertpapiererwerbs- und Uebernahmegesetz), which
became effective on January 1, 2002, standardizes the rules applicable to public
bids for the shares in German public stock corporations. The German Takeover Act
includes, among other things, a set of definitive rules applying to the
company's action in the case of a hostile takeover situation. As a general rule,
the board of management is obliged to remain neutral in such circumstances.
However, the board of management is allowed to proceed with actions which a
prudent (ordentlicher) and conscientious manager of a company, which is not
subject of a takeover offer, would have taken and, additionally, to seek
alternative offers from third parties. Any other actions of the board of
management which may have a negative impact on the takeover, require either the
approval by the shareholders or the consent of the supervisory board. Approvals
by the shareholders may either be granted by an extraordinary general meeting
called in connection with the hostile takeover bid or by way of shelf
resolutions passed before the commencement of such bid. However, such a shelf
resolution is limited to a maximum period of 18 months and requires a three
quarters majority of the present share capital in the general meeting.

Disclosure of Share Holdings

     The disclosure of shareholdings is governed by the German Securities
Trading Act (Wertpapierhandelsgesetz) and the German Takeover Act. Celanese AG
also complies with the disclosure requirements of the German Corporate
Governance Code.

     The German Securities Trading Act requires holders of voting securities of
a company whose shares are listed on a stock exchange to notify the company and
the German Federal Supervisory Authority for Securities Trading (Bundesanstalt
fur Finanzdienstleistungsaufsicht) of the number of shares they hold if that
number reaches, exceeds or falls below 5 percent, 10 percent, 25 percent, 50
percent and 75 percent of the company's outstanding voting rights. Moreover, the
German Securities Trading Act requires the board of management to publish this
information promptly.

     The German Takeover Act requires any person who directly or indirectly
obtains control over a listed company to publish this fact promptly and submit a
mandatory tender offer for the outstanding shares within four weeks following
the publication. The Takeover Act defines control in the meaning of this
requirement as the holding of at least 30 percent of the voting rights in the
relevant company. See Item 7. Major Shareholders and Related Party Transactions.

     The German Securities Trading Act requires members of the board of
management and supervisory board to disclose to the company promptly the
purchase and sale of shares in the company or its consolidated subsidiaries, as
well as options or other instruments thereof. The company must publish this
information promptly thereafter in a suitable electronic information system or
in at least one official stock exchange gazette.

MATERIAL CONTRACTS

     On October 5, 2004, pursuant to an instruction from Celanese Europe Holding
under the Domination Agreement Celanese entered into a Stock Purchase and Sale
Agreement with Celanese Europe Holding (then


                                       93



known as BCP Crystal Acquisition GmbH & Co. KG), pursuant to which Celanese
Europe Holding purchased from Celanese 3,000,000 shares of the Series A common
stock of CAC, par value US$100 per share, as well as 7,501,130 shares of the
common stock of CAC, par value US$100 per share, together representing all of
the issued and outstanding stock of CAC, in exchange for an intercompany note in
the principal amount of (euro)290,917,882.18.

     On August 19, 2005, Celanese Europe Holding and Paulson & Co., Inc.
("Paulson"), together with Arnhold & S. Bleichroeder Advisers, LLC ("ASB" or,
with Paulson, the "Sellers") entered into a Share Purchase and Transfer
Agreement and Settlement Agreement (the "Paulson Agreement"), whereby Paulson
and ASB agreed to sell 5,758,299 and 160,000 CAG Shares, respectively, for the
aggregate consideration of approximately (euro)302 million. In addition, we paid
to such shareholders an additional purchase price of approximately (euro)12
million in consideration for the settlement of certain claims and for such
shareholders agreeing to, among other things, (1) accept the shareholders'
resolutions passed at the extraordinary general meeting of Celanese held on July
30 and 31, 2004 and the annual general meeting of Celanese held on May 19 and
20, 2005; (2) to acknowledge the legal effectiveness of the Domination
Agreement; (3) irrevocably withdraw and abandon all actions, applications and
appeals each brought or joined in German legal proceedings related to, among
other things, challenging the effectiveness of the Domination Agreement and
amount of fair cash compensation offered by Celanese Europe Holding in the
Mandatory Offer required by Section 305(1) of the German Stock Corporation Act;
(4) refrain from acquiring any CAG Shares or any other investment in Celanese;
and (5) refrain from taking any future legal action shareholder resolutions or
corporate actions of Celanese. Celanese Europe Holding paid the aggregate
consideration of (euro)314 million for the additional CAG Shares acquired from
such shareholders and for the agreements described above using available cash.
The Paulson Agreement also provides that Celanese Europe Holding will undertake,
subject to compliance with applicable law, to increase the fair compensation
offered in the Mandatory Offer from (euro)41.92 per CAG Share (plus interest
under the terms of the Mandatory Offer) to (euro)51.00 per CAG Share (plus
interest under the terms of the Mandatory Offer) for the period from the date of
the revised offer to September 29, 2005, subject to the agreement by the
tendering minority holders of CAG Shares to waive their right to conduct special
award proceedings (Spruchverfahren) and their right to any awards pursuant to
such proceedings.

     Celanese has entered into several letters of support with Celanese
Corporation and Celanese Europe Holding, pursuant to which, Celanese Corporation
agreed to guarantee certain direct and contingent financial obligations of
Celanese Europe Holding and certain other direct and indirect subsidiaries of
Celanese Corporation toward Celanese, resulting from instructions (Weisungen)
given to Celanese under the Domination Agreement (the "Obligations"). As of
February 15, 2006, the Obligations relating to such letters of support include:

     o    Intercompany notes of Celanese Europe Holding in the principal amounts
          of approximately:

          o    (euro)291 million, representing the fair market value of CAC;

          o    (euro)677 million, representing a receivable for intercompany
               debt with CAC that was transferred from Celanese;

          o    (euro)223 million, representing the amount of the equity
               investment in a Canadian indirect subsidiary of Celanese in
               connection with its acquisition of Acetex Corporation;

     o    An intercompany rate of BCP Acquisition GmbH & Co. KG in the principal
          amount of approximately (EURO) 66 million, representing a receivable
          for intercompany debt with CAC that was transferred from Celanese AG
          to BCP Acquisition GmbH & Co. KG;



     o    Intercompany notes in the principal amounts of approximately
          GB(pound)17 million and(euro)6 million from Celanese Emulsions Ltd.,
          and Celanese Emulsions BV, respectively;

     o    Intercompany notes in the aggregate nominal amount of(euro)213 million
          from Acetex Chimie S.A., and Transatlantique Chimie S.A.; and

     o    Celanese Europe Holdings' obligation under the Domination Agreement to
          compensate Celanese for an annual loss (Jahresfehlbetrag), if any,
          incurred during a fiscal year.

EXCHANGE CONTROLS AND OTHER LIMITATIONS AFFECTING SECURITY HOLDERS

     The euro is a fully convertible currency. There are, except in limited
embargo circumstances, no legal restrictions in Germany on international capital
movements and foreign exchange transactions. For statistical purposes only,
every individual or corporation residing in Germany must report to the German
Central Bank (Deutsche Bundesbank), any payment (other than those for the import
or export of goods or the payment or


                                       94



repayment of short term loans and deposits) received from or made to an
individual or a corporation resident outside Germany if such payment exceeds
(euro)12,500 or the equivalent in a foreign currency. In addition, German
residents must report any claims against or any liabilities payable to
non-residents if such claims or liabilities, in the aggregate, exceed (euro)5
million or the equivalent in a foreign currency during any one month. German
residents must also report any direct investment outside Germany if such
investment exceeds 10 percent of the total investment and/or if total assets in
which the German resident is investing exceed (euro)3 million.

     Neither German law nor the Articles of Association of Celanese impose any
limitations on the right of non-resident or non-German owners to hold or vote
the CAG Shares.

TAXATION

     The following is a discussion of material United States federal income and
German tax consequences to Qualified Holders holding CAG Shares. This discussion
is based upon existing United States federal income and German tax law,
including legislation, regulations, administrative rulings and court decisions,
as in effect on the date of this annual report, all of which are subject to
change, possibly with retroactive effect. For purposes of this discussion, in
general, a "Qualified Holder" means a beneficial owner of CAG Shares that (1) is
a resident of the United States for purposes of the United States-Germany Income
Tax Treaty (the "Income Tax Treaty"), which generally includes an individual
United States resident, a corporation created or organized under the laws of the
United States, any state thereof or the District of Columbia and a partnership,
estate or trust, to the extent its income is subject to taxation in the United
States as the income of a United States resident, either in its hands or in the
hands of its partners or beneficiaries, (2) does not hold CAG Shares as part of
the business property of a permanent establishment located in Germany or as part
of a fixed base of an individual located in Germany and used for the performance
of independent personal services, (3) if not an individual, is not subject to
the limitation on benefits restrictions in the Income Tax Treaty and (4) owns,
directly or indirectly, less than 10 percent of the outstanding CAG Shares. This
discussion assumes that the Qualified Holder holds CAG Shares as a capital
asset. This discussion does not address all aspects of United States federal
income and German taxation that may be relevant to all Qualified Holders in
light of their particular circumstances, such as Qualified Holders whose shares
were acquired under the exercise of an employee stock option or otherwise as
compensation or Qualified Holders who are subject to special treatment under
United States federal income tax laws, for example, financial institutions,
insurance companies, tax-exempt organizations and broker-dealers. This
discussion also does not address any aspects of state, local or non-United
States tax law.

     EACH QUALIFIED HOLDER IS STRONGLY URGED TO CONSULT HIS OR HER TAX ADVISORS
AS TO THE UNITED STATES FEDERAL INCOME AND GERMAN TAX CONSEQUENCES OF HOLDING
CAG SHARES, INCLUDING THE PARTICULAR FACTS AND CIRCUMSTANCES THAT MAY BE UNIQUE
TO SUCH QUALIFIED HOLDER, AND AS TO ANY OTHER TAX CONSEQUENCES OF HOLDING CAG
SHARES.

Taxation of Dividends (including Fixed Annual Payments (Ausgleiche))

     Under German law, German corporations are required to withhold tax on
dividends distributed in 2005 out of prior year's profits in an amount equal to
20 percent of the gross amount paid to resident and nonresident shareholders.
Subject to limitations, a partial refund of this 20 percent withholding tax can
be obtained by Qualified Holders under the Income Tax Treaty. Qualified Holders
are generally subject to United States federal income tax on dividends paid by
German corporations. Subject to applicable limitations of United States federal
income tax law, Qualified Holders may be able to claim a foreign tax credit for
German withholding tax on dividends.

     In the case of any Qualified Holder, the German withholding tax on
dividends paid in 2005 is partially refunded under the Income Tax Treaty,
effectively reducing the withholding tax to 15 percent of the gross amount of
the dividend. Qualified Holders are not entitled to the dividends received
deduction for United States federal income tax purposes with respect to
dividends paid by non-United States corporations.

     Thus, for each U.S.$100 of gross dividend paid by Celanese in 2005 to a
Qualified Holder, the dividend after partial refund of the 20 percent
withholding tax under the Income Tax Treaty will be subject to a German
withholding tax of U.S.$15. Thus, for each U.S.$100 of gross dividend, the
Qualified Holder will include U.S.$100 in gross income and may be entitled to a
foreign tax credit of U.S.$15, subject to applicable limitations of United
States federal income tax law.


                                       95



     Dividends paid in euro to a Qualified Holder of CAG Shares will be included
in income in a U.S. dollar amount calculated by reference to the exchange rate
in effect on the date the dividends (including any deemed refund of German
corporate tax) are received or treated as received by such holder. If dividends
paid in euro are converted into dollars on the date received or treated as
received, Qualified Holders generally should not be required to recognize
foreign currency gain or loss in respect of each dividend.

     A surtax on the German withholding tax is currently levied on dividend
distributions paid by a German resident company. The rate of this surtax is 5.5
percent, which is 1.1 percent (5.5 percent x 20 percent) of the gross dividend
amount. Under the Income Tax Treaty, Qualified Holders are entitled to a full
refund of this surtax.

Refund Procedures

     To claim the refund reflecting the current reduction of the German
withholding tax from 20 percent to 15 percent, and the refund of the 5.5 percent
German surtax, when applicable, a Qualified Holder must submit a claim for
refund to the German tax authorities, with the original bank voucher (or
certified copy thereof) issued by the paying entity documenting the tax withheld
within four years from the end of the calendar year in which the dividend is
received. Claims for refunds are made on a special German claim for refund form,
which must be filed with the German tax authorities: Bundesamt fuer Finanzen,
Friedhofstrasse 1, 53225 Bonn, Germany. The German claim for refund forms may be
obtained from the German tax authorities at the same address where the
applications are filed or from the Embassy of the Federal Republic of Germany,
4645 Reservoir Road, N.W., Washington, D.C. 20007-1998.

     Qualified Holders must also submit to the German tax authorities
certification of their last filed United States federal income tax return. That
certification is obtained from the office of the Director of the Internal
Revenue Service Center by filing a request for the certification with the
Internal Revenue Service's Philadelphia Service Center, Foreign Certification
Request, P.O. Box 16347, Philadelphia, PA 19114-0447. Requests for certification
are to be made in writing and must include the Qualified Holder's name, social
security number or employer identification number, tax return form number and
tax period for which certification is requested. The Internal Revenue Service
("IRS") will send the certification directly to the German tax authorities if
the Qualified Holder authorizes the IRS to do so. This certification is valid
for three years and need only be resubmitted in a fourth year in the event of a
subsequent application for refund.

     In accordance with arrangements under the Sub-Agency Agreement between the
Transfer Agent and the U.S. Transfer Agent relating to CAG Shares traded in the
United States, the CAG Shares held by Qualified Holders will be registered with
the U.S. Transfer Agent, which will receive and distribute dividends to
Qualified Holders of CAG Shares and perform administrative functions necessary
to claim the refund reflecting the current reduction in German withholding tax
from 20 percent to 15 percent, and the refund of the 5.5 percent German surtax,
when applicable, for such Qualified Holders. These arrangements may be amended
or revoked at any time in the future.

     The U.S. Transfer Agent will prepare the German claim for refund forms on
behalf of the Qualified Holders of CAG Shares and file them with the German tax
authorities. In order for the U.S. Transfer Agent to file the claim for refund
forms, the U.S. Transfer Agent will prepare and mail to the Qualified Holders of
those CAG Shares, and those holders will be requested to sign and return to the
U.S. Transfer Agent, (i) a statement authorizing the U.S. Transfer Agent to
perform these procedures and agreeing that the German tax authorities may inform
the IRS of any refunds of German taxes and (ii) a written authorization to remit
the refund of withholding to an account other than that of the Qualified Holder.
Qualified Holders must also submit to the U.S. Transfer Agent certification of
their last filed United States federal income tax return. The U.S. Transfer
Agent will attach the signed statement, the certification and the documentation
issued by the paying agency documenting the dividend paid and the tax withheld
to the claim for refund form and file them with the German tax authorities.

     A simplified refund procedure for Qualified Holders whose CAG Shares are
held through participants of the Depository Trust Company is in effect between
the Depository Trust Company and the German tax authorities. Under this
simplified refund procedure, the Depository Trust Company provides the German
tax authorities with electronic certification of the U.S. taxpayer status of
such Qualified Holders based on information it receives


                                       96



from its participants, and claims a refund on behalf of those Qualified Holders.
Accordingly, Qualified Holders, using the simplified refund procedure, do not
need to file refund claim forms through the U.S. transfer agent.

     The German tax authorities will issue refunds denominated in euro. In the
case of CAG shares held by Qualified Holders, the refunds will be issued in the
name of the U.S. Transfer Agent, which will convert the refunds to U.S. dollars
and issue corresponding refund checks to the Qualified Holders of such CAG
Shares and brokers. Those brokers, in turn, will remit corresponding refund
amounts to the Qualified Holders holding CAG Shares registered with such
brokers. Qualified Holders of CAG Shares who receive a refund attributable to
reduced withholding taxes under the Income Tax Treaty may be required to
recognize foreign currency gain or loss, which will be treated as ordinary
income or loss, to the extent that the U.S. dollar value of the refund received
or treated as received by the Qualified Holder differs from the U.S. dollar
equivalent of the refund on the date the dividend on which such withholding
taxes were imposed was received or treated as received by the Qualified Holder.

Taxation of Capital Gains

     Under the Income Tax Treaty, a Qualified Holder will not be liable for
German tax on capital gains realized or accrued on the sale or other disposition
of CAG Shares.

     Upon a sale or other disposition of CAG Shares, a Qualified Holder will
recognize capital gain or loss for United States federal income tax purposes
equal to the difference between the amount realized and the Qualified Holder's
adjusted tax basis in CAG Shares. In the case of an individual Qualified Holder
of CAG Shares, any such capital gain will be subject to a maximum United States
federal income tax rate of 15 percent, if the individual Qualified Holder's
holding period in these CAG Shares is more than 12 months.

German Gift and Inheritance Taxes

     The United States-Germany estate tax treaty provides that an individual
whose domicile is determined to be in the United States for purposes of such
treaty will not be subject to German inheritance and gift tax (the equivalent of
the United States federal estate and gift tax) on the individual's death or
making of a gift unless the CAG Shares (1) are part of the business property of
a permanent establishment located in Germany or (2) are part of the assets of a
fixed base of an individual located in Germany and used for the performance of
independent personal services. An individual's domicile in the United States,
however, does not prevent imposition of German inheritance and gift tax with
respect to an heir, donee or other beneficiary who is domiciled in Germany at
the time the individual died or the gift was made.

     The United States-Germany estate tax treaty also provides a credit against
United States federal estate and gift tax liability for the amount of
inheritance and gift tax paid in Germany, subject to limitations, in a case
where the CAG Shares are subject to German inheritance or gift tax and United
States federal estate or gift tax.

German Capital Tax (Vermoegensteuer)

     The Income Tax Treaty provides that a Qualified Holder will not be subject
to German capital tax with respect to the CAG Shares. As a result of a judicial
decision, the German capital tax presently is not imposed.

United States Information Reporting and Backup Withholding

     Dividends on CAG Shares, and payments of the proceeds of a sale of CAG
Shares, paid within the United States or through U.S.-related financial
intermediaries are subject to information reporting and may be subject to backup
withholding at a 31 percent rate unless the Qualified Holder (1) is a
corporation or other exempt recipient or (2) provides a taxpayer identification
number and certifies that no loss of exemption from backup withholding has
occurred.

DOCUMENTS ON DISPLAY

     Celanese furnishes its U.S. shareholders in English all notices of
shareholders' meetings and other reports and communications that are made
generally available to shareholders. Celanese transmits the English versions of
these notices, reports and announcements to Mellon Investor Services, Celanese's
transfer agent and registrar in New York, New York. The transfer agent arranges
for the prompt mailing of copies of these materials to Celanese's U.S.
shareholders. As a foreign private issuer, Celanese is exempt under the
Securities Exchange Act of 1934, as amended, or the 1934 Act, from the proxy
rules and the short-swing profit recovery provisions of Section 16 of the 1934
Act.


                                       97



     Celanese is subject to the informational requirements of the 1934 Act and
files reports and other information with the Commission. Reports and other
information filed by Celanese may be examined, without charge, at the public
reference facilities maintained by the Commission at Room 1024, 450 Fifth
Street, N.W., Washington, D.C., 20549, and at the Commission's regional offices
located at 801 Brickell Ave., Suite 1800, Miami, FL 33131, 175 W. Jackson
Boulevard, Suite 900, Chicago, IL 60604, 1801 California Street, Suite 1500,
Denver, CO 80202-2656, 5670 Wilshire Boulevard, 11th Floor, Los Angeles, CA
90036-3648 and 3 World Financial Center, Room 4-300, New York, New York 10280.
Copies of such materials are also available by mail from the Commission's Public
Reference Branch at 450 Fifth Street, N.W., Washington, D.C. 20549, at
prescribed rates. More information on the public reference rooms can be obtained
by calling the Commission at 1-800-SEC-0330. The Commission also maintains a Web
site (http://www.sec.gov) that contains reports, proxy and information
statements and other information regarding registrants, such as Celanese, that
file electronically with the Commission.

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     The following tables present information regarding Celanese's use of
derivative financial instruments, and should be read together with Item 5.
Operating and Financial Review and Prospects, and Notes 2 and 23 to the
Consolidated Financial Statements.

INTEREST-RATE RISK MANAGEMENT

     The following tables provide information about Celanese's use of derivative
financial instruments and other financial instruments that are sensitive to
changes in interest rates as of September 30, 2005. The information is presented
in euro equivalents, which is Celanese's reporting currency, at September 30,
2005 exchange rates.

                      INTEREST-RATE RISK MANAGEMENT - DEBT
                PRINCIPAL (NOTIONAL) AMOUNT BY EXPECTED MATURITY
                              AVERAGE INTEREST RATE
                               SEPTEMBER 30, 2005



                                                                                                 FAIR VALUE
                                                                                                     AT
                                                                                                  SEPTEMBER
                                       2006    2007   2008   2009   2010   THEREAFTER    TOTAL    30, 2005
                                      ------   ----   ----   ----   ----   ----------   ------   ----------
                                                      (IN (EURO) MILLIONS, EXCEPT PERCENTAGES)

DEBT, INCLUDING CURRENT PORTION
Variable rate (U.S. dollar) .......     3.59     --     --     --     --      8.30       11.89      11.89
Average interest rate .............     4.07%    --     --     --     --      4.79%         --         --
Fixed rate (euro) .................    22.95   0.05   0.06   60.5   0.07      0.63       84.26      84.26
Average interest rate .............     4.76%  7.50%  7.50%  4.67%  7.50%     7.50%         --         --
Variable rate (euro) ..............   195.66     --     --     --     --        --      195.66     195.66
Average interest rate .............     2.17%    --     --     --     --        --          --         --
Other currencies ..................    30.32     --     --     --     --     10.65       40.97      40.97
   Total ..........................   252.52   0.05   0.06   60.5   0.07     19.58      332.78     332.78


     For Celanese's fixed rate and variable rate debt, the table presents
principal amounts and the related weighted average interest rates by expected
maturity date. Weighted average variable rates are based on the respective
implied forward rates at September 30, 2005. For interest rate swaps, the table
presents notional amounts and weighted average interest rates by expected
maturity date. Weighted average variable rates are based on the respective
implied forward rates at September 30, 2005.

FOREIGN-EXCHANGE RISK MANAGEMENT

     The table below provides information about Celanese's significant
derivative financial instruments that are sensitive to changes in exchange rates
as of September 30, 2005. For foreign currency forward contracts related to debt
management and certain sale and purchase transactions denominated in foreign
currencies, the table presents the notional amounts and the weighted average
contractual forward exchange rates. The foreign currency


                                       98



forward contracts entered into by Celanese have a term of generally less than
one year. Celanese had approximately (euro)420 million notional amount of
foreign currency forward contracts outstanding in various currencies at
September 30, 2005. There were no foreign currency options outstanding as of
September 30, 2005.



                                                         AVERAGE
                                          CONTRACT     CONTRACTUAL      FAIR VALUE
                                           AMOUNT        FORWARD      SEPTEMBER 30,
CURRENCY PAIRS                           BUY (SELL)   EXCHANGE RATE        2005
--------------------------------------   ----------   -------------   -------------
                                           (IN (EURO) MILLIONS, EXCEPT FOR AVERAGE
                                             CONTRACTUAL FORWARD EXCHANGE RATE)

   FOREIGN CURRENCY FORWARD CONTRACTS
Euro
U.S. dollar ..........................      328.4          1.2192          4.3
Japanese yen .........................     (102.7)       111.8353          1.0
British pound ........................      (16.8)         0.6840          0.0
Canadian dollar ......................       83.1          1.4270          1.0
Australian dollar ....................        2.2          1.5910          0.0
Swedish Krona ........................       (2.0)         9.3284          0.0


     Most of the foreign currency forward contracts are currency swaps entered
into to hedge intercompany loans.

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

     Not applicable.

                                     PART II

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

     None.

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF
     PROCEEDS

     We hereby incorporate information called for by this item by reference to
our Form 6-K filed on June 23, 2004. See also Item 4. Information on the Company
- Acquisition of Celanese - Domination and Profit and Loss Transfer Agreement.

ITEM 15. CONTROLS AND PROCEDURES

     In connection with the audit of Celanese Corporation's financial statements
as of and for the nine months ended December 31, 2004, Celanese Corporation
identified a material weakness in its internal controls for the same period,
which may have an effect on Celanese. On March 30, 2005, Celanese Corporation
received a letter from KPMG LLP, its independent auditors, who also identified
the same material weakness and a second material weakness in the course of their
audit. The additional material weakness identified by KPMG LLP related to
several deficiencies in the assessment of hedge effectiveness and documentation.
The required adjustments were made in the proper accounting period, except for
one immaterial hedging transaction adjusted during the quarter ended June 30,
2005. The material weakness identified by KPMG LLP and Celanese Corporation
related to conditions preventing its ability to adequately research, document,
review and draw conclusions on accounting and reporting matters, which had
previously resulted in adjustments that had to be recorded to prevent Celanese
Corporation's financial statements from being materially misleading. The
conditions largely related to significant increases in the frequency of, and the
limited number of personnel available to address, complex accounting matters and
transactions and as a result of the consummation of simultaneous debt and equity
offerings during the year-end closing process. Celanese Corporation does not
believe that the adjustments made in connection with these material weaknesses
had any material impact on previously reported financial information. In
response to the letter from KMPG with respect to the first material weakness
identified above, a team responsible for the identification and documentation of
potential derivative accounting transactions was organized and formal training
specifically related to derivative accounting was commenced for team members.
With respect to the second material weakness identified above, additional
accounting personnel have been hired, thereby ensuring that adequate personnel
is available to adequately research, document, review and conclude on accounting
and


                                       99



reporting matters and accounting resources have been increased. Additional
personnel responsible for the development and implementation of additional
internal reporting and accounting procedures, including derivative accounting
procedures were also hired. Both material weaknesses were identified during
Celanese Corporation's year-end closing process for the year ended December 31,
2004 and still existed as of September 30, 2005. Celanese Corporation believes
it completed remediation of these material weaknesses by the quarter ended
December 31, 2005.

     In addition, in September 2005, Celanese Corporation identified a
significant deficiency in internal controls relating to sales made by its
subsidiaries, including subsidiaries of Celanese AG, to countries and other
parties that are or have previously been subject to sanctions and embargoes
imposed by the U.S. government. This significant deficiency was identified as a
result of an internal investigation that was initiated in connection with the
Commission's review of a registration statement. Celanese Corporation
voluntarily disclosed this matter to the U.S. Treasury Department and the U.S.
Department of Commerce and we are currently engaged in discussions with them.
Immediate corrective actions have been taken, including a directive to senior
business leaders stating that they are prohibited from selling products into
certain countries subject to these trade restrictions, as well as modifications
to accounting systems to prevent the initiation of purchase orders and shipment
of products to these countries.

     Celanese, under the supervision and with the participation of Celanese's
management, including the chief executive officer (CEO) and chief financial
officer (CFO), performed an evaluation of the effectiveness of Celanese's
"disclosure controls and procedures" (as defined in Rule 13a-15(e) under the
1934 Act) as of September 30, 2005. Disclosure controls and procedures are
defined as controls and other procedures of an issuer that are designed to
ensure that information required to be disclosed by the issuer in the reports
that it files or submits under the 1934 Act is recorded, processed, summarized
and reported within the time periods specified in the rules and forms of the
Commission. Based on this evaluation, and as a result of the material weaknesses
that were identified and continued during the period covered by this annual
report, Celanese's CEO and CFO concluded that, as of September 30, 2005, the end
of the period covered by this annual report, Celanese's disclosure controls and
procedures were not effective for gathering, analyzing and disclosing the
material information Celanese is required to disclose in the reports it files
under the 1934 Act, within the time periods specified in the rules and forms of
the Commission.

     During 2005, Celanese Corporation and its subsidiaries, including Celanese
AG, have been implementing changes to strengthen their internal controls. As a
result of these changes and the remediation of the material weaknesses described
above during the first quarter of fiscal year 2006, Celanese's CEO and CFO
believe that, as of December 31, 2005, Celanese's disclosure controls and
procedures are effective for gathering, analyzing and disclosing on a timely
basis the material information required to be disclosed in the 1934 Act reports.
Moreover, Celanese continues to monitor its internal controls and procedures,
and will take additional measures as necessary to address any issues identified
by us and to ensure that our internal controls continue to be effective.

     Except as discussed above, there have been no changes in Celanese's
"internal controls over financial reporting" (as defined in Rule 13a-15(f) under
the 1934 Act) during the period covered by this annual report that have
materially affected or are reasonably likely to materially affect, internal
controls over financial reporting.

ITEM 16. RESERVED

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

     In the past, the Supervisory Board had determined that Alfons Titzrath
qualified as the financial expert of its finance and audit committee in
accordance with the Commission's rules in connection with the Sarbanes-Oxley Act
of 2002. Since Mr. Titzrath's resignation on May 7, 2004, the finance and audit
committee has not had a financial expert. On December 6, 2004, the Supervisory
Board determined that, since Celanese AG is no longer a New York Stock Exchange
listed company and since German law does not require the finance and audit
committee to have such a financial expert, it was not necessary to nominate a
financial expert in accordance with the Commission's rules in connection with
the Sarbanes-Oxley Act of 2002.

ITEM 16B. CODE OF ETHICS AND GOVERNANCE MATTERS

     The Global Business Conduct Policy or BCP for Celanese Corporation and its
subsidiaries, including Celanese AG, sets forth universal rules of conduct for
company management, including the Chief Executive Officer, Chief Financial
Officer, and Chief Accounting Officer, as well as for all employees. The policy
requires


                                      100



employees and management to act honestly and ethically in all their dealings,
and promotes the ethical handling of actual or apparent conflicts of interest.
It calls for full, fair, accurate, timely and understandable disclosure in
periodic reports and public communications and adherence to applicable laws,
rules and regulations. Violations of the BCP may be subject to severe
disciplinary action, up to and including termination of employment. A third
party help line has been established so that every Celanese employee, regardless
of where the employee works, can voice policy concerns or report policy
infringements or risks affecting Celanese. All Celanese management and employees
receive periodic BCP training, either electronically or in person, and
management must certify annually in writing that they have read, understood, and
are in compliance with the BCP. During the year ended September 30, 2005,
Celanese did not make any amendments to, or waivers from, the BCP relating to
its Chief Executive Officer or senior financial officers. The BCP can be found
on Celanese's website at www.celanese.com.

     Celanese currently communicates its governance standards internally and
externally. Celanese has a link on corporate governance issues on its internet
website at http://www.celanese.com/index/celanese_ag/governance.htm. This site
provides information about Celanese's corporate governance practices, such as
its corporate governance guidelines, the statement of compliance with the German
Corporate Governance Code, as well as any current certifications made by
Celanese or its responsible governing bodies. (See also Item 15. Controls and
Procedures)

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

     KPMG Deutsche Treuhand-Gesellschaft Aktiengesellschaft
Wirtschaftspruefungsgesellschaft or KPMG has served as Celanese's registered
public accounting firm for the year ended September 30, 2005, the nine months
ended September 30, 2004 and for the year ended December 31, 2003 and, for which
audited financial statements appear in this annual report. The independent
auditor is selected each year at the Annual General Meeting. Celanese's
supervisory board will propose to the Annual General Meeting to be held in May
2006 that KPMG be selected as the independent auditor for the 2006 fiscal year.

     In the annual meeting held on May 19-20, 2005, our shareholders appointed
KPMG, to serve as our independent auditors for the 2005 fiscal year. KPMG billed
the following fees for professional services during the twelve months ended
September 30, 2005, and the nine months ended September 30, 2004:

                                  FOR THE TWELVE
                                   MONTHS ENDED       FOR THE NINE
                                  SEPTEMBER 30,       MONTHS ENDED
                                       2005        SEPTEMBER 30, 2004
TYPE OF FEES                     ((EURO)MILLION)     ((EURO)MILLION)
------------------------------   ---------------   ------------------
Audit ........................         1.2                 2.1
Audit-Related ................          --                  .4
Tax ..........................         0.1                  .6
All Other ....................          --                  --
                                       ---                 ---
Total ........................         1.3                 3.1
                                       ===                 ===

     Audit fees are the aggregate fees billed by KPMG for the audit of our
consolidated and annual financial statements, reviews of interim financial
statements and attestation services that are provided in connection with
statutory and regulatory filings or engagements. Audit-Related fees are those
charged by KPMG for assurance and related services that are reasonably related
to the performance of the audit or review of our financial statements and are
not reported under Audit fees. This category comprises fees billed for the audit
of employee benefit plans and pension schemes, agreed-upon procedure engagements
and other attestation services subject to regulatory requirements, as well as
advisory services associated with financial reporting. Tax fees are fees for
professional services rendered by KPMG for tax compliance, tax advice on actual
or contemplated transactions and expatriate employee tax services.

                                      101



PRE-APPROVAL POLICIES AND PROCEDURES OF THE FINANCE AND AUDIT COMMITTEE

     The finance and audit committee of Celanese's supervisory board, among
other things, is responsible for monitoring the independent auditors and their
work. In particular it:

     o    Prepares the proposal of the supervisory board concerning the
          selection of the independent auditors by the annual general meeting;

     o    Reviews the independent auditors' engagement letter, including
          proposed fees;

     o    Defines the scope of the independent audit as well as key areas to be
          audited;

     o    Reviews the independent auditors' significant findings and
          recommendations together with the board of management's response; and

     o    Regularly reviews the independent auditors' quality control systems
          and oversees their independence.

     For more information on the finance and audit committee, see Item 6.
Directors, Senior Management and Employees - Board Practices.

     In accordance with the Sarbanes-Oxley Act, the finance and audit committee
must approve all audit and non-audit services provided by KPMG.

     In December 2004, the finance and audit committee approved the following
non-audit services to be provided by KPMG during fiscal year 2005, as well as
the work processes needed to control and monitor them:

     o    Continuing SAS 100 quarterly reviews that commenced in 2003;

     o    Continue to review selected documentation in connection with the
          implementation of the SAP system;

     o    Tax planning;

     o    Tax compliance;

     o    Pre-approval for due diligence procedures related to merger and
          acquisition candidates (assurance and tax planning); and

     o    Assistance with documentation of functional area process controls in
          preparation of the certification process pursuant to Section 404 of
          the Sarbanes-Oxley Act.

     o    Tax preparation for expatriate employees

     o    Due diligence procedures related to identified and unidentified merger
          and acquisition candidates (assurance and tax planning).

     In December 2005, the finance and audit committee approved the following
non-audit services to be provided by KPMG during fiscal year 2006, as well as
the work processes needed to control and monitor them:

     o    Continuation of SAS 100 Quarterly Reviews that commenced during the
          first quarter of 2003

     o    Continuation of the audit and evaluation of internal controls under
          the SAP system

     o    Documentation of functional area process controls in preparation of
          the certification process pursuant to Section 404 of the
          Sarbanes-Oxley Act of 2002

     o    Tax planning

     o    Tax compliance

     o    Due diligence procedures for risks related to identified and
          unidentified merger and acquisition candidates.


                                      102



ITEM 16D. EXEMPTION FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

     This section is not applicable as CAG Shares are no longer listed on the
New York Stock Exchange.

ITEM 16E PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

     Other than the shares tendered into the Mandatory Offer of (euro)41.92, the
Limited Offer of (euro)51.00, or the acquisition by Celanese Europe Holding of
5.9 million shares from two shareholders for the aggregate consideration of
approximately (euro)302 million in August 2005, all of which Celanese Europe
Holding reported to the Commission under Schedule 13D, neither Celanese nor its
affiliates have purchased any CAG Shares during the period from August 25, 2005
to September 30, 2005 or the period from October 1, 2004 to August 24, 2005.

                                    PART III

ITEM 17. FINANCIAL STATEMENTS

     Not applicable.

ITEM 18. FINANCIAL STATEMENTS

     Reference is made to Item 19 for a list of all financial statements filed
as part of this annual report.

ITEM 19. EXHIBITS

(a)  The following consolidated financial statements, together with the report
     of KPMG Deutsche Treuhand-Gesellschaft Aktiengesellschaft
     Wirtschaftspruefungsgesellschaft, are filed as part of this annual report:

     Report of the Board of Management

     Index to Consolidated Financial Statements

     Report of Independent Registered Public Accounting Firm

     Consolidated Financial Statements:

          Consolidated Statements of Operations for the period from August 25,
          2005 to September 30, 2005, the period from October 1, 2004 to August
          24, 2005, the Nine Months Ended September 30, 2004, the Nine Months
          Ended September 30, 2003 (unaudited) and the Year Ended December 31,
          2003

          Consolidated Balance Sheets as of September 30, 2005 and 2004

          Consolidated Statements of Shareholders' Equity for the period from
          August 25, 2005 to September 30, 2005, the period from October 1, 2004
          to August 24, 2005, the Nine Months Ended September 30, 2004 and the
          Year Ended December 31, 2003

          Consolidated Statements of Cash Flows for the period from August 25,
          2005 to September 30, 2005, the period from October 1, 2004 to August
          24, 2005, the Nine Months Ended September 30, the Nine Months Ended
          September 30, 2003 (unaudited) and the Year Ended December 31, 2003

          Notes to the Consolidated Financial Statements

     Schedule II - Valuation and Qualifying Accounts

     Other Schedules are omitted because they are not applicable or because the
required information is contained in the Consolidated Financial Statements or
Notes thereto.

(b)  Documents filed as exhibits to this annual report:

     1.1  English translation of Articles of Association (Satzung) of Celanese
          AG as amended to date

     2.1  Form of Definitive Stock Certificate of Celanese AG (filed as Exhibit
          4.1 to Celanese's Annual Report on Form 20-F for the year ended
          December 31, 1999, and incorporated herein by reference.)


                                       103



     4.1  Master Purchase Agreement between Madionova GmbH, as buyer and
          Clariant International AG, as seller, dated as of September 26, 2002
          (filed as Exhibit 4.1 to Celanese's Annual Report on Form 20-F for the
          year ended December 31, 2002, and incorporated herein by reference)

     4.2  English translation of Domination and Profit and Loss Transfer
          Agreement, dated as of June 22, 2004, between BCP Crystal Acquisition
          GmbH & Co. KG, as the dominating company, and Celanese AG, as
          dominated company (filed as Exhibit 4.2 to Celanese Annual Report on
          Form 20-F for the nine months ended September 30, 2004, and
          incorporated herein by reference).

     4.3  English translation of Service Agreement between Celanese AG and Peter
          Jakobsmeier, dated as of November 1, 2004 (filed as Exhibit 4.3 to
          Celanese Annual Report on Form 20-F for the nine months ended
          September 30, 2004, and incorporated herein by reference).

     4.4  English translation of Service Agreement between Celanese AG and
          Lyndon Cole, effective as of November 1, 2004 (filed as Exhibit 4.4 to
          Celanese Annual Report on Form 20-F for the nine months ended
          September 30, 2004, and incorporated herein by reference).

     4.5  English translation of Service Agreement between Celanese AG and
          Andreas Pohlmann effective as of November 1, 2004 (filed as Exhibit
          4.5 to Celanese Annual Report on Form 20-F for the nine months ended
          September 30, 2004, and incorporated herein by reference).

     4.6  Stock Purchase and Sale Agreement dated October 5, 2004 between
          Celanese AG and BCP Crystal Acquisition GmbH & Co. KG (filed as
          Exhibit 99.15 to Schedule 13D/A filed with the Commission on October
          7, 2004 and incorporated herein by reference).

     4.7  Share Purchase and Transfer Agreement and Settlement Agreement, dated
          August 19, 2005, between Celanese Europe Holding GmbH & Co. KG, as the
          purchaser and Paulson & Co. Inc. and Arnhold and S. Bleichroeder
          Advisers, LLC, each on behalf of its own and with respect to shares
          owned by the investment funds and separate accounts managed by it, as
          the sellers (filed as Exhibit 99.A.5.A.III to the Amendment to the
          Going Private Disclosure Document on Form SC13E3/A filed with the
          Commission on August 19, 2005 and incorporated herein by reference.)

     4.8  Form of Letter of Support between Celanese AG, Celanese Europe Holding
          GmbH & Co. KG, and Celanese Corporation.

     4.9  The total amount of long-term debt securities of Celanese AG or any of
          its subsidiaries authorized under any instrument does not exceed 10
          percent of the total assets of Celanese on a consolidated basis.
          Celanese agrees to furnish the Commission upon request a copy of any
          instrument with respect to long-term debt of Celanese AG and any
          subsidiary for which consolidated or unconsolidated financial
          statements are required to be filed and as to which the amount of
          securities authorized thereunder does not exceed 10 percent of the
          total assets of Celanese AG and its subsidiaries on a consolidated
          basis.

     8.1  Significant subsidiaries as of the end of the fiscal year covered by
          this annual report: See Significant Subsidiaries in Item 4.
          Information on the Company.

     11.1 Celanese Global Business Conduct Policy.

     12.1 Certification of the Chief Executive Officer pursuant to Section 302
          of the Sarbanes-Oxley Act of 2002.

     12.2 Certification of the Chief Financial Officer pursuant to Section 302
          of the Sarbanes-Oxley Act of 2002.

     13.1 Certification of the Chief Executive Officer pursuant to 18 U.S.C.
          Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
          Act of 2002.

     13.2 Certification of the Chief Financial Officer pursuant to 18 U.S.C.
          Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
          Act of 2002.


                                       104



                                   SIGNATURES

     Pursuant to the requirements of Section 12 of the securities exchange act
of 1934, the registrant certifies that it meets all of the requirements for
filing on form 20-F and has duly caused this annual report to be signed on its
behalf by the undersigned, thereunto duly authorized.

                                      Celanese AG
                                      (Registrant)

Date: March 31, 2006


                                      By: /s/ Andreas Pohlmann
                                          --------------------------------------
                                      Name: Andreas Pohlmann
                                      Title: Chairman of the Board of Management


                                      By: /s/ Peter Jakobsmeier
                                          --------------------------------------
                                      Name: Peter Jakobsmeier
                                      Title: Member of the Board of Management
                                             and Chief Financial Officer


                                       105



                        REPORT OF THE BOARD OF MANAGEMENT

     The Board of Management of Celanese AG is responsible for the preparation,
the completeness, and the integrity of the consolidated financial statements as
well as for the information contained in the management report of Celanese AG
and subsidiaries ("Celanese").

     Celanese has prepared the consolidated financial statements in accordance
with United States generally accepted accounting principles and has applied the
exemption of article 292a HGB.

     The companies included in the consolidated financial statements are
required to maintain orderly accounting records and to establish effective
control systems. These control systems, which our corporate auditing function
reviews for reliability and effectiveness, are intended to enable the Board of
Management to recognize the potential impact of negative factors on Celanese's
assets and developments in a timely fashion. This ensures that the underlying
accounting records correctly reflect all business developments, thereby creating
a reliable basis for the consolidated financial statements.

     The Board of Management runs Celanese in the interests of its stockholders
and in awareness of its responsibility towards employees and society. We manage
the resources entrusted to us to increase the value of Celanese. However, under
the domination and profit and loss transfer agreement in place between Celanese
AG and its parent company, Celanese AG's Board of Management may be required to
carry out instructions issued by its parent company that are disadvantageous to
Celanese.

     Pursuant to a resolution passed at the last General Meeting, the
Supervisory Board has engaged KPMG Deutsche Treuhand-Gesellschaft
Aktiengesellschaft Wirtschaftsprufungsgesellschaft as independent auditors to
audit the consolidated financial statements. A separate long-form audit report
in accordance with German requirements is being prepared by the independent
auditors. The Finance and Audit Committee of the Supervisory Board will examine
the consolidated financial statements including the management report as well as
the audit report during its meeting on the annual financial statements, which
will be attended by the members of the Board of Management and the independent
auditors. Thereafter, the Supervisory Board will review the information relating
to the consolidated financial statements. The results of this review can be
inferred from the report of the Supervisory Board.

Kronberg im Taunus, February 7, 2006
The Board of Management


/s/ Andreas Pohlmann
---------------------------------
Andreas Pohlmann


/s/ Lyndon Cole                         /s/ Peter Jakobsmeier
---------------------------------       ------------------------------
Lyndon Cole                             Peter Jakobsmeier


                                       F-1



                   INDEX TO CONSOLIDATED FINANCIAL STATEMENTS



                                                                                                  PAGE
                                                                                                  ----

CONSOLIDATED FINANCIAL STATEMENTS
   Report of Independent Registered Public Accounting Firm.....................................    F-3
   Consolidated Statements of Operations for the Period August 25, 2005 to September 30, 2005,
      the Period October 1, 2004 to August 24, 2005, the Nine Months Ended September 30,
      2004, the Nine Months Ended September 30, 2003 (unaudited) and the Year Ended
      December 31, 2003........................................................................    F-5
   Consolidated Balance Sheets as of September 30, 2005 and 2004...............................    F-6
   Consolidated Statements of Shareholders' Equity for the Period August 25, 2005 to September
      30, 2005, the Period October 1, 2004 to August 24, 2005, the Nine Months Ended
      September 30, 2004 and the Year Ended December 31, 2003..................................    F-8
   Consolidated Statements of Cash Flows for the Period August 25, 2005 to September 30,
      2005, the Period October 1, 2004 to August 24, 2005, the Nine Months Ended September
      30, 2004, the Nine Months Ended September 30, 2003 (unaudited) and the Year Ended
      December 31, 2003........................................................................    F-9
   Notes to Consolidated Financial Statements..................................................   F-10
CONSOLIDATED FINANCIAL STATEMENT SCHEDULE
   Schedule II - Valuation and Qualifying Accounts.............................................   F-64



                                       F-2



             REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Supervisory Board
Celanese AG:

     We have audited the accompanying consolidated balance sheets of Celanese AG
and subsidiaries ("Celanese") as of September 30, 2005 and 2004, and the related
consolidated statements of operations, shareholders' equity, and cash flows for
the period August 25, 2005 to September 30, 2005, the period October 1, 2004 to
August 24, 2005, the nine months ended September 30, 2004 and the year ended
December 31, 2003. In connection with our audits of the consolidated financial
statements, we also have audited the consolidated financial statement schedule
as listed in the accompanying index. These consolidated financial statements and
schedule are the responsibility of Celanese's management. Our responsibility is
to express an opinion on these consolidated financial statements and the
consolidated financial statement schedule based on our audits.

     We conducted our audits in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards require that
we plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audits provide a reasonable basis for our opinion.

     In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of Celanese as
of September 30, 2005 and 2004 and the results of its operation and its cash
flows for the period August 25, 2005 to September 30, 2005, the period October
1, 2004 to August 24, 2005, the nine months ended September 30, 2004 and the
year ended December 31, 2003 in conformity with U.S. generally accepted
accounting principles. Also, in our opinion, the related consolidated financial
statement schedule, when considered in relation to the basic consolidated
financial statements taken as a whole, presents fairly, in all material
respects, the information set forth therein.



                                       F-3



     The accompanying consolidated statements of operations and cash flows for
the nine months ended September 30, 2003, were not audited by us and,
accordingly, we do not express an opinion on them.

     As discussed in Note 5 to the consolidated financial statements, Celanese
adopted Financial Accounting Standards Board Interpretation No. 46 (Revised),
"Consolidation of Variable Interest Entities - an interpretation of ARB No. 51",
effective December 31, 2003.

     As discussed in Note 2 to the consolidated financial statements, Celanese
Europe Holding GmbH & Co. KG, formerly known as BCP Crystal Acquisition GmbH &
Co. KG (the "Purchaser"), increased its investment in Celanese AG from
approximately 84% to approximately 96%. The acquisition has been accounted for
as a purchase and the Purchaser's basis in Celanese has been pushed down to the
Celanese's accounting records, creating a new basis of accounting effective
August 25, 2005. As a result of the acquisition, the consolidated financial
information for the period after the acquisition is presented on a different
cost basis than for the periods before the acquisition and, therefore, is not
comparable.


KPMG Deutsche Treuhand-Gesellschaft Aktiengesellschaft
Wirtschaftspruefungsgesellschaft
Frankfurt am Main, Germany
February 8, 2006, except for Note 31, which is as of March 31, 2006.


                                       F-4



                          CELANESE AG AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS



                                                      SUCCESSOR                          PREDECESSOR
                                                     ----------   ---------------------------------------------------------
                                                     AUGUST 25,   OCTOBER 1,    NINE MONTHS     NINE MONTHS
                                                       2005 TO      2004 TO        ENDED           ENDED        YEAR ENDED
                                                      SEPTEMBER     AUGUST     SEPTEMBER 30,   SEPTEMBER 30,   DECEMBER 31,
                                                      30, 2005     24, 2005         2004            2003           2003
                                                     ----------   ----------   -------------   -------------   ------------
                                                                                                (UNAUDITED)
                                                            (IN (EURO) MILLIONS EXCEPT FOR SHARE AND PER SHARE DATA

Net sales.........................................          238        1,972         1,520           1,579           2,041
Cost of sales.....................................         (218)      (1,481)       (1,193)         (1,263)         (1,655)
Selling, general and administrative expenses......          (18)        (153)         (154)           (153)           (207)
Research and development expenses.................           (4)         (36)          (33)            (32)            (43)
Special charges:
   Sorbates antitrust matters.....................           --           --            --             (84)            (84)
   Restructuring, impairment and other
      special charges.............................           (1)         (49)          (26)             (5)            (17)
Foreign exchange gain (loss)......................            1            3            (2)              1               2
Gain on disposition of assets.....................           --           --            --              --               1
                                                     ----------   ----------    ----------      ----------      ----------
   Operating profit (loss)........................           (2)         256           112              43              38
Equity in net earnings of affiliates..............            3            9            15              12              14
Interest expense..................................           (3)         (10)          (11)            (10)            (15)
Interest and other income, net....................            7           76            41              38              29
                                                     ----------   ----------    ----------      ----------      ----------
   Earnings from continuing operations
      before tax and minority interests...........            5          331           157              83              66
Income tax provision..............................           (1)         (77)          (39)            (24)            (30)
                                                     ----------   ----------    ----------      ----------      ----------
   Earnings (loss) from continuing operations
      before minority interests...................            4          254           118              59              36
Minority interests................................           (2)         (43)          (18)             (7)            (12)
                                                     ----------   ----------    ----------      ----------      ----------
   Earnings (loss) from continuing operations.....            2          211           100              52              24
Earnings (loss) from discontinued operations:
   Gain (loss)  from operation of discontinued
      operations..................................           --           --           (31)             93             127
   Gain (loss) on disposal of discontinued
      operations..................................           --           22            --              (1)             (1)
   Income tax provision...........................           --           --          (139)            (28)            (18)
                                                     ----------   ----------    ----------      ----------      ----------
   Earnings (loss) from discontinued operations...           --           22          (170)             64             108
                                                     ----------   ----------    ----------      ----------      ----------
   Net earnings (loss)............................            2          233           (70)            116             132
                                                     ==========   ==========    ==========      ==========      ==========
Earnings (loss) per common share - basic:
   Continuing operations..........................         0.04         4.20          2.02            1.05            0.47
   Discontinued operations........................           --         0.44         (3.44)           1.29            2.20
                                                     ----------   ----------    ----------      ----------      ----------
   Net earnings (loss)............................         0.04         4.64         (1.42)           2.34            2.67
                                                     ==========   ==========    ==========      ==========      ==========
Weighted average shares - basic:..................   50,365,018   50,269,363    49,401,898      49,487,911      49,445,958
Earnings (loss) per common share - diluted:
   Continuing operations..........................         0.04         4.19          2.02            1.05            0.47
   Discontinued operations........................           --         0.44         (3.44)           1.29            2.20
                                                     ----------   ----------    ----------      ----------      ----------
   Net earnings (loss)............................         0.04         4.63         (1.42)           2.34            2.67
                                                     ==========   ==========    ==========      ==========      ==========
Weighted average shares - diluted:................   50,365,018   50,331,758    49,401,898      49,487,911      49,457,145


        SEE THE ACCOMPANYING NOTES TO CONSOLIDATED FINANCIAL STATEMENTS.


                                       F-5



                          CELANESE AG AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS

                                                  SUCCESSOR      PREDECESSOR
                                                -------------   -------------
                                                    AS OF           AS OF
                                                SEPTEMBER 30,   SEPTEMBER 30,
                                                     2005            2004
                                                -------------   -------------
                                                     (IN (EURO) MILLIONS)
ASSETS
Current assets:
   Cash and cash equivalents.................         176              91
   Receivables, net:
      Trade receivables, net - third party...         303             359
      Trade and other receivables - Related
         Entities and Affiliates.............         403             944
      Other receivables......................         111             123
   Inventories...............................         178             157
   Deferred income taxes.....................          --               7
   Other assets..............................           4               3
   Assets of discontinued operations.........          --           1,966
                                                    -----           -----
         Total current assets................       1,175           3,650
                                                    -----           -----
Investments..................................         261             237
Property, plant and equipment, net...........         584             566
Deferred income taxes........................          71              80
Notes receivable from Related Entities.......       1,257             193
Other assets.................................         124             150
Goodwill.....................................         194             441
Other intangible assets, net.................         254              23
                                                    -----           -----
         Total assets........................       3,920           5,340
                                                    =====           =====

        SEE THE ACCOMPANYING NOTES TO CONSOLIDATED FINANCIAL STATEMENTS.


                                       F-6



                          CELANESE AG AND SUBSIDIARIES
                     CONSOLIDATED BALANCE SHEETS (CONTINUED)



                                                        SUCCESSOR      PREDECESSOR
                                                      -------------   -------------
                                                          AS OF           AS OF
                                                      SEPTEMBER 30,   SEPTEMBER 30,
                                                          2005             2004
                                                      -------------   -------------
                                                           (IN (EURO) MILLIONS)

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
   Short-term borrowings and current
      installments of long-term debt - third
      party, Related Entities and Affiliates                252           170
   Accounts payable and accrued liabilities:
      Trade payables - third party                          138           214
      Trade payables - Related Entities and
         Affiliates                                         131            66
      Other current liabilities                             275           293
   Deferred income taxes                                      9            14
   Income taxes payable                                     109            82
   Liabilities of discontinued operations                    --         2,016
                                                          -----         -----
         Total current liabilities                          914         2,855
                                                          -----         -----
Long-term debt - third party and Related
   Entities                                                  80           331
Deferred income taxes                                       205            85
Benefit obligations                                          74            43
Other liabilities                                            32            27
Minority interests                                          159           111
Commitments and contingencies
Shareholders' equity:
   Common stock, no par value, (euro)140 million
      aggregate registered value; 54,790,369
      shares authorized and issued; 50,365,018
      and 49,881,618 shares outstanding at
      September 30, 2005 and September 30, 2004,
      respectively)                                         140           140
   Additional paid-in capital                             2,415         2,545
   Retained earnings (accumulated deficit)                    2           (96)
   Accumulated other comprehensive loss                      (5)         (595)
                                                          -----         -----
                                                          2,552         1,994
   Treasury stock at cost (4,425,351 and
      4,908,751 shares at September 30, 2005 and
      September 30, 2004, respectively)                     (96)         (106)
                                                          -----         -----
      Total shareholders' equity                          2,456         1,888
                                                          -----         -----
      Total liabilities and shareholders' equity          3,920         5,340
                                                          =====         =====


        SEE THE ACCOMPANYING NOTES TO CONSOLIDATED FINANCIAL STATEMENTS.


                                       F-7



                          CELANESE AG AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
      AUGUST 25 TO SEPTEMBER 30, 2005, OCTOBER 1, 2004 TO AUGUST 24, 2005,
      NINE MONTHS ENDED SEPTEMBER 30, 2004 AND YEAR ENDED DECEMBER 31, 2003



                                                                                  RETAINED     ACCUMULATED
                                                                    ADDITIONAL    EARNINGS/       OTHER                    TOTAL
                                                                     PAID-IN    (ACCUMULATED  COMPREHENSIVE  TREASURY  SHAREHOLDERS'
                                                      COMMON STOCK   CAPITAL      DEFICIT)         LOSS        STOCK       EQUITY
                                                      ------------  ----------  ------------  -------------  --------  -------------
                                                                                   (IN (EURO) MILLIONS)

PREDECESSOR:
Balance at December 31, 2002........................       140         2,496        (130)         (402)        (104)       2,000
Comprehensive income (loss), net of tax:
   Net earnings.....................................        --            --         132            --           --          132
   Other comprehensive income (loss):
      Unrealized gain on securities (1).............        --            --          --             3           --            3
      Foreign currency translation..................        --            --          --          (114)          --         (114)
      Additional minimum pension liability (2)......        --            --          --            10           --           10
      Unrealized gain on derivative contracts (3)...        --            --          --             5           --            5
                                                                                                  ----                     -----
      Other comprehensive loss......................        --            --          --           (96)          --          (96)
                                                                                                                           -----
Comprehensive income................................        --            --          --            --           --           36
Dividends ((euro)0.44 per share)....................        --            --         (22)           --           --          (22)
Amortization of deferred compensation...............        --             5          --            --           --            5
Settlement of demerger liability (4)................        --            39          --            --           --           39
Purchase of treasury stock..........................        --            --          --            --          (14)         (14)
                                                           ---         -----        ----          ----         ----        -----
Balance at December 31, 2003........................       140         2,540         (20)         (498)        (118)       2,044
                                                           ---         -----        ----          ----         ----        -----
Comprehensive income (loss), net of tax:
   Net loss.........................................        --            --         (70)           --           --